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 Colloidal delivery systems have drawn increasing attention in food science 
area. Biopolymers, i.e. proteins and polysaccharides originated from foods, with low 
toxicity, high biocompatibility and biodegradability, are the ideal biomaterials to 
develop delivery systems for nutraceuticals. The present work is dedicated to develop 
delivery systems for nutraceuticals, using food derived biopolymers, e.g. chitosan and 
zein. In the first part of this study, different core-shell structured nanoparticles were 
developed for encapsulating both hydrophilic and hydrophobic nutracetuicals. For 
chitosan nanoparticles with zein coating, the hydrophilic nutraceutical, selenite, was 
encapsulated and the physicochemical properties was improved after zein coating. 
Then, zein nanoparticles with chitosan (CS) or carboxymethyl chitosan (CMCS) 
coating were developed to encapsulate hydrophobic nutraceuticals, including vitamin 
E, vitamin D3, indole-3-carbinol and diindolylmethane. The fabrication parameters 
were systematically studied and the effects of encapsulation on stabilities of 
nutraceuticals were investigated under different conditions. 
 
 
 Subsequently, a novel approach to prepare CMCS hydrogel beads was 
developed. CMCS, a water-soluble derivative of CS, was known as unable to form 
hydrogel beads by itself in aqueous solution due to chain rigidity and inefficient 
entanglement. In this part, the formation of CMCS hydrogel beads was studied in 
aqueous-alcohol binary solutions. Chemical crosslinking was required to maintain its 
integrity upon drying. Different drying methods (i.e. freeze and air drying) were also 
investigated to understand their effects on swelling and release profile in simulated 
gastrointestinal conditions. Some possible mechanisms were discussed. 
 Lastly, cellular evaluation of zein nanoparticles stabilized by caseinate was 
carried out. The zein-caseinate nanoparticles had a good redispersibility after freeze-
drying and were able to maintain original particle size in different cell culture 
medium and buffer at 37°C over time. The zein-caseinate nanoparticles had no 
cytotoxicity at concentrations up to 1 mg/ml over 3 days. Then, coumarin 6, a 
fluorescent marker, was encapsulated into zein-caseinate nanoparticles to investigate 
their cell uptake and epithelial transport. The cell uptake was clearly visualized by 
fluorescent microscopy and the uptake mechanisms were investigated. The epithelial 
transport was investigated on Caco-2 cell monolayers. The results suggested caseinate 
not only stabilized zein nanoparticles in different buffers, but also improved cell 
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Chapter 1: Literature Review 
1.1 Overview of Encapsulation Technology 
Encapsulation technology is an emerging technology developed in recent decades. It 
may be defined as the process to entrap one or several substance within a certain matrix. The 
substance encapsulated in the matrix is defined as core materials, which could be drug, 
nutraceuticals, or any bioactive compounds. The matrix is named wall or shell materials, 
which are usually large molecules, such as polymers. Encapsulation technology has been 
applied in pharmaceutical and cosmetic industry for decades and become a popular approach 
in food industry in recent years for improving stability of  labile nutraceuticals and flavors 
and enhancing delivery bioactive compounds. In the majority of cases, encapsulation 
technology has been studied extensively to package solids, liquids, or gaseous materials in 
small capsules that are expected to be released at controlled rates over prolonged periods and 
under specific conditions (Desai & Park, 2005). 
Various materials have been studied to fabricate the matrix or shell of these particles, 
including natural and synthetic polymers. Different from pharmaceutical or cosmetic industry 
where synthetic materials have been extensively investigated to fabricate nano- or micro-
particles to encapsulate drugs, materials used in food industry are more concerned to be 
natural, edible and non-toxic. The ideal materials used in food industry are biopolymers, 
especially those originated from foods, such as food proteins and polysaccharides. 
Meanwhile, the fabrication process of encapsulation applicable to food industry must also be 
safe and green, without any toxic reagents or intensive conditions as possible. When it comes 
to food industry, there are bunch of benefits brought by encapsulation technology, and several 
groups of compounds have already been studied using this novel technology, such as natural 




small capsule. The function of encapsulation include improving their stabilities during long 
storage periods, protecting nutritional loss during extreme processing environments, and 
preserving their functionalilities in digestive conditions.  
However, we are still facing a lot of problems with encapsulation technology in food 
industry, such as insufficient protection of nutraceuticals from degrading due to exposure of 
light, oxygen and heat, fast isomerization of consumed nutrients in gastric fluid, ineffective 
absorption and delivery of consumed bioactives after encapsulation. Therefore, two or more 
materials are being explored as a combination to encapsulate substances in recent years. More 
and more attention has been drawn to use those biopolymer complexes of food proteins and 
polysaccharides as wall materials to encapsulate nutrients (Cooper, Dubin, Kayitmazer, & 
Turksen, 2005).  
1.2 Food Polymer-Based Nanoparticles for Encapsulation of Nutraceuticals  
Nanotechnology is an enabling technology that offers the great potential to 
revolutionize agricultural and food systems. Due to the unique characteristics of nano-scale 
materials (10-9 m), it provides numerous benefits to food and nutrition applications, such as 
faster intestinal absorption after oral administration, higher cellular uptake, desired delivery 
of nutraceuticals to specific site, and maximized in vivo effect. After the first feature research 
paper in Food Nanotechnology was published in 2003 (Moraru, Panchapakesan, Huang, 
Takhistov, Liu, & Kokini, 2003), the growing of research interests on this novel area has 
never ended. As more and more concern is drawn to the application of nanotechnology in 
food systems, biopolymers have been the most investigated materials used for food 
nanotechnologies. Because biopolymers are derived from living organisms, especially from 
edible plants and animals, they are biocompatible, biodegradable, and non-toxic by oral 




origins. Both food protein and polysaccharide have high nutritional value and are generally 
recognized as safe (GRAS).  
In general, protein has various functional groups in the primary sequences of 
polypeptides and the diverse chain folding structures, and therefore they are able to interact 
with nutraceutical compounds and encapsulate and protect them. Various food proteins have 
been studied as wall materials for nutraceuticals delivery systems, including zein, whey 
protein, egg white, ß-lactoglobulin, gelatin, collagen, casein, albumin, soy glycinin (Chen, 
Remondetto, & Subirade, 2006). Different methods have been developed to produce 
micro/nano-particles, films, fibers, and hydrogels based on the properties of protein used. For 
globular water-soluble protein, thermal treatments, including heat- and cooling- induced 
gelation, are popular approaches to obtain protein hydrogels. In some cases, ions (Ca2+) are 
added to the protein suspension to form hydrogel through electrostatic interaction with 
carboxyl groups on protein molecules. For the water-insoluble protein, such as corn zein and 
wheat gliadin, phase separation is a unique technique to produce nanoparticles. Due to the 
simplicity and low cost of phase separation method, water-insoluble food proteins have been 
attracted much attention in recent years to fabricate nanoparticles. The hydrophobic cores of 
these proteins could act as reservoirs or microcontainers for various bioactive substances. 
Therefore, hydrophobic proteins, especially zein, are specifically used to encapsulate 
lipophilic nutraceuticals due to the strong driving force of hydrophobic interaction between 
nutraceutical and protein molecules.  
Polysaccharides are the polymers of monosaccharides and they are stable, abundant 
and non-toxic in nature. Among food polysaccharides, there are usually two subgroups: 
polyelectrolytes and non-polyelectrolytes. Polyelectrolytes are of greater interests because 
there are charges on their surface, resulting in some unique properties; they can be further 




polysaccharides (e.g. alginate, hyaluronic acid, pectin, etc). Due to various derivable 
functional groups on their molecular chains, they can be easily modified to produce various 
derivatives with desirable properties. In addition, most of them have amino and carboxyl 
groups which are ready to interact with biological tissues, e.g. mainly epithelia and mucous 
membrane, to enhance intestinal absorption of nutraceuticals encapsulated (Liu, Jiao, Wang, 
Zhou, & Zhang, 2008). These properties make food polysaccharides promising biopolymers 
to prepare nanoparticles as delivery systems of nutraceuticals, without issues of safety, 
toxicity and availability. In recent years, numerous studies have been conducted on food 
polysaccharides, especially polyelectrolytes, due to the simplicity of nanoparticles fabrication 
via electrostatic interaction. 
1.3 Chitosan (CS) and its Derivatives 
1.3.1 Chitin and CS 
 
 




Chitin, as a natural polysaccharide, is mostly found in the exoskeleton of crustaceans, 
insects, and fungi. It is ubiquitous in nature, being the second most abundant biopolymer, 
next to cellulose. Chitosan (CS), the N-deacetylation product of chitin, is a linear 
polysaccharide, composed of glucosamine and N-acteyl glucosamine units via ß(1-4) linkage, 
randomly or block distributed throughout the biopolymer chain, depending on the preparation 
method to derive CS from chitin (Fig. 1.1). The deacetylation degree is defined as the ratio of 




applications. After deacetylation process, CS could be dissolved in acidic medium and 
become the only polysaccharide in nature that possesses high density of positive surface 
charge, due to the protanation of amino groups on its backbone. Besides this unique 
characteristic, CS has been proved to have many other intrinsic properties, such as non-
toxicity, biocompatibility and biodegradability (Kean & Thanou, 2010). Therefore, CS has 
been received significant scientific interests and become one of the hottest topics in this 
decade, especially for its medical and pharmaceutical applications, including drug delivery 
(Bhattarai, Gunn & Zhang, 2010; Hejazi & Amiji, 2003) and tissue engineering (Di Martino, 
Sittinger, & Risbud, 2005; Thein-Han, Kitiyanant, & Misra, 2008). 
1.3.2 CS Applications in Food Science 
CS has been widely used as a food additive in Japan and Korea since 1983 and 1995, 
respectively (KFDA, 1995; Weiner, 1992). The biological safety data were firstly established 
in 1990 using animal trials (Hirano, Itakura, Seino, Akiyama, Nonaka, Kanbara, et al., 1990). 
Since then numerous studies have been conducted to explore CS applications in food industry, 
and various functional properties of CS have been discovered. In 2005, the US FDA 
approved a shrimp-derived CS as a GRAS (generally recognized as safe) for its general 
applications in food industry.  
1.3.2.1 Antimicrobial Activity and Film Forming Property 
The antimicrobial activity of CS has been attracted notable attention as a potent food 
preservative of natural origin. CS has been proved to be a wide-spectrum antimicrobial, 
including foodborne filamentous fungi, yeast, and bacteria (Rabea, Badawy, Stevens, 
Smagghe, & Steurbaut, 2003). Recently, edible coating on fresh-produce or minimally 
processed fruits is a hot topic in food industry and CS is one of the popular biopolymers that 
have been extensively studied in this area, thanks to its excellent capability to form 




a recent study reveals that CS coating on fresh-cut strawberries can significantly improve 
shelf life and product quality by providing excellent inhibitory effect on the growth of 
microorganisms during storage under different temperatures (Campaniello, Bevilacqua, 
Sinigaglia, & Corbo, 2008). The combination of CS and other antimicrobial agent is a novel 
approach to maximize the antimicrobial effects and quality improvement. The CS coating 
enriched with thyme oil on mushrooms showed a better efficacy than thyme oil or CS coating 
itself, in terms of maintaining postharvest quality and extending shelf life by inhibiting 
microorganism growth (Jiang, Feng, & Zheng, 2011). The combination of CS and sodium 
chlorite coating on fresh-cut pears also exhibited enhanced antimicrobial effects (Xiao, Luo, 
& Wang, 2011). CS film incorporating with green tea extract has been recently demonstrated 
to not only inhibit microbial growth, reduce lipid oxidation, but also improve the qualities 
and prolong shelf life of refrigerator stored pork sausages (Siripatrawan & Noipha, 2012). 
The antimicrobial efficacy of CS, however, varies with the species of microbial as 
well as the types of foods. For instance, Simpson and co-workers reported that the different 
cultures of bacteria had significant different susceptibilities to CS, e.g. CS bactericidal 
concentration of 0.02% for Bacillus cereus, 0.0075% for Escherichia coli and Proteus 
vulgaris (Simpson, Gagne, Ashie, & Noroozi, 1997). Some other studies also suggested 
different efficacy of CS to B. cereus (Chang, Cho, Gao, & Choe, 1989). The discrepancy in 
studies may be partly due to the reason that a lot of factors may affect CS antimicrobial 
effects. One of the major mechanisms of antimicrobial activity of CS is that the positive 
surface charge of CS molecules can interact with negatively charged microbial cell 
membranes, resulting in the leakage of proteinaceous and other intracellular constituents (No, 
Meyers, Prinyawiwatkul, & Xu, 2007). The molecular weight and deacetylation degree of CS 
may significantly affect its surface charge density, which will in turn influence its 




different foods contains different compositions, such as the salt concentration, pH, textures, 
etc., all of which will determine the protonation of CS molecules. Last but not least, the 
technique used to test antimicrobial activity may also contribute to large variations of the 
biocide properties of CS (Fernandez-Saiz, Lagaron, & Ocio, 2009).  
1.3.2.2 Food Emulsion Stabilizer and Quality Enhancer 
CS, as a food polysaccharide, is a well-known amphiphilic polyelectrolyte and thus 
possesses both the electrosteric and stabilizing properties. CS has been widely used to 
stabilize and improve overall quality of mutilple-layer emulsions. Both of the molecular 
weight and decacetylation degree will influence the particle size and stability of CS-stabilized 
emulsions. The higher molecular weight and lower decacetylation degree produced more 
stable emulsion with smaller particle size (Mun, Decker, & McClements, 2006). Recently, 
maillard reaction is applied to conjugate CS and other polymers in order to produce the 
complex emulsifier with better properties, since the reaction may bring the products with 
combined beneficial properties with two or more biopolymers. The maillard production of 
lactoglobulin and CS exhibited enhanced bactericidal activity against E. coli than their 
individual effects (Mun, Decker, & McClements, 2006). The CS-glucose maillard product 
has been recently developed using gamma radiation method, to improve the rheological 
properties and enhance the stability of β-carotenen against oxidation during storage (Rao, 
Chawla, Chander, & Sharma, 2011). 
1.3.2.3 Nutritional Properties and Biological Activities 
In addition to the applications of CS as food additives and stabilizers, considerable 
attention has also been attracted by its nutritional properties and biological activities, namely, 
hypocholesterolemic, immunity-enhancing, anticancer effects, accelerating mineral 
absorption, etc. (Xia, Liu, Zhang, & Chen, 2011). Similar as physicochemical properties of 




activities. However, the majority studies of nutritional properties of CS are focused on low 
molecular weight CS, which is proven to be more effective using in vivo animal models than 
high molecular weight CS. For instance, the CS with low molecular weight has shown 
significantly better hypolipidemic activity in rats through increasing serum and liver 
lipoprotein lipase activity, than the CS with high molecular weight (Zhang, Zhang, 
Mamadouba, & Xia, 2012). CS not only improve lipid metabolism but also helps with kidney 
functions. A new study reported that the oral administration of low molecular weight CS to 
mice can effectively reverse aristolochic acid-induced renal lesions by suppressing the 
elevation of urinary and blood nitrogen concentration (Chang, Chang, Huang, Chen, Lee, & 
Chung, 2011). The CS oligosaccharides have also been shown to exhibit excellent therapeutic 
effects against mase cell-mediated allergic inflammatory responses and airway inflammation 
in allergic inflammatory diseases, including asthma (Chung, Park, & Park, 2012). 
1.3.3 Applications of CS Particulate Systems in Nutraceutical Delivery 
Due to the unique physicochemeical properties of CS, including mucoadhesive, 
positive surface charge, low toxicity, biodegradable, etc., it has been extensively studied for 
encapsulation and delivery of drug/nutraceuticals in various fields.  Many types of delivery 
systems can be easily developed from CS by various methods, such as tables, nano/micro 
particles, hydrogels, beads, emulsions, and films. Some of the popular types of CS-based 
particulate delivery systems widely used in food science field are discussed below. 
1.3.3.1 Nano- / Micro- Particles of CS 
Many reports are available on the fabrication and evaluation of CS particulate 
delivery systems. The particles are simply prepared via electrostatic interactions between 
positively charged CS and negative charged molecules. The negatively charged 
polyelectrolytes can be small molecules, such as sodium tripolyphosphate, and 




nanoparticles offers simple and mild preparation conditions as well clear processing window 
for manipulation of physicochemical properties of the nanoparticles, such as size and surface 
charge (Gan & Wang, 2007). Because of these beneficial characteristics, increasing attention 
has been drawn to the applications of CS-based micro and nanoparticles in the 
pharmaceutical and nutraceutical fields (Grenha, Seijo, & Remuñán-López, 2005; Kockisch, 
Rees, Young, Tsibouklis, & Smart, 2003; Shah, Pal, Kaushik, & Devi, 2009). Among various 
polyanions, tripolyphosphate (TPP) is the most investigated one due to its quick gelling 
capability and non-toxic property. CS/TPP nanoparticles have been proved to be excellent 
carriers for drug and nutrient in therapeutic and nutritional applications, such as providing 
efficient and target delivery of shRNA sequence (Wang, Yao, Guo, Dong, Li, Gu, et al., 
2009), lowering toxicity of therapeutic antisense oligonucleiotide (Dung, Lee, Han, Kim, Ju, 
Kim, et al., 2007), increasing bioavailability of nutraceuticals (Dudhani & Kosaraju, 2010; 
Hu, Pan, Sun, Hou, Ye, & Zeng, 2008; Zhang, Yang, Tang, Hu, & Zou, 2008), as well as 
achieving long term controlled release of protein, e.g., bovine serum albumin (Gan & Wang, 
2007) and unstable drugs, e.g., venlafaxin hydrochloride (Shah, Pal, Kaushik, & Devi, 2009). 
In addition to small anionic molecules, CS can form nano/microparticles with 
macromolecules which carry negative surface charges, including both natural and synthetic 
polymers (Hamman, 2010). The particles formed with macromolecules are generally defined 
as polyelectrolyte complexes (PECs). Among the natural polymers that can form PECs with 
CS, alginate, carrageenan, pectin, and hyaluronic acid are the most investigated ones. 
Generally speaking, the PECs demonstrated some superior properties over the particles 
formed by CS and small molecules.   
1.3.3.3 CS Hydrogel Beads 
Hydrogels are the crosslinked polymer networks that hold a large amount of water. 




groups and the formed networks are prevented from dissolving due to the chemical or 
physical bonds between the polymer chains. Water can penetrate into the networks, resulting 
in the swelling of the hydrogels. Based on different fabrication parameters, the dimensions of 
hydrogels can vary widely, from nanometer to centimeters in width. The CS hydrogels are 
prepared with various approaches to produce different shapes, geometries, including liquid 
gels, films, capsules, sponges, microparticles, composites, beads, etc. The hydrogels 
discussed in this study are the hydrogel beads, whose dimension are generally from hundreds 
of micrometers to several millimeters. Compared to other delivery systems, hydrogel beads 
have some unique features depending on the polymer used, including slow release profile due 
to physical or chemical crosslinking, enhanced drug residence time and tissue permeability, 
mucoadhesive characteristics, survival against gastrointestinal tract and colon delivery, etc 
(Bhattarai, Gunn, & Zhang, 2010). Further, for food industry, hydrogel beads may be more 
feasible to achieve and industrialize, due to the low cost and controllable preparation 
parameters, and scalable procedures, compared with nano/microparticles delivery systems in 
food industry. 
The crosslinking approaches are normally adopted to prepare CS hydrogel beads, 
physical crosslinking via ionic gelation with anionic molecules, and irreversible chemical 
crosslinking. While physical crosslinking is more preferred due to low toxicity and higher 
biocompatibility, it has certain limitations, such as hard to control pore size, fast degradation 
or dissolution, quick release of encapsulated nutraceuticals, compared with chemical 
crosslinking. Both approaches have been extensively studied for their drug delivery 
applications in food and/or pharmaceutical areas in recent decades.  
For instance, CS hydrogel beads by physically crosslinked with TPP was developed 
as a pH-sensitive drug release system to encapsulate glipizide, an insulin stimulating drug. 




subcutaneous injection, with good tolerability and prolonged half life (Sun, Li, Li, Wei, & 
Tian, 2011). Many other drugs/nutraceuticals were also encapsulated into CS-based pH-
sensitive hydrogel beads for oral or injection delivery recently (Dai, Li, Zhang, Wang, & Wei, 
2008; Elzatahry, Eldin, Soliman, & Hassan, 2009; Meng, Li, Wei, & Zhang, 2011; J. Yang, 
Chen, Pan, Wan, & Wang, 2012). In food science area, another major application of CS-
based hydrogel beads is the enzyme immobilizations for various applications. During last 
decade, numerous CS-based hydrogel beads have been developed to immobilize hundreds of 
enzymes for multiple applications in food and agricultural industries, such as organic 
compounds removal from wastewaters, measurement of environmental pollutants, metabolite 
control, and so on (Krajewska, 2004). 
1.3.4 Carboxylmethyl Chitosan (CMCS) and its Application in Drug Delivery 
 
Fig. 1.2 Molecular structure of carboxymethyl chitosan (CMCS) 
 
In addition to native CS, its derivatives have also been extensively studied in drug 
delivery. The presence of functional groups, such as –NH2 group at the C-2 position or –OH 
groups at C-3 and C-6 positions, offers great opportunities for chemical modification, leading 
to various applications that native CS cannot achieve. CS derivatives include quaternized CS, 
carboxyalkyl CS, thiolated CS, sugar-bearing CS, cyclodextrin-linked CS, etc. The chemical 
modifications of CS are designed to provide specific properties to improve its special 
applications. Carboxylmethyl CS (CMCS, Fig. 1.2) is one of the most investigated 




applications, including wound dressings, artificial bone and skin, bacteriostatic agents and 
blood anticoagulants (Sahoo, Sahoo, Mohanty, Sasmal, & Nayak, 2009). It is soluble in 
neutral aqueous solution, and it has been shown that negatively charged CMCS is able to 
form nanoparticles spontaneously with positively charged ions (Shi, Du, Yang, Zhang, & Sun, 
2006). Several bioactive compounds have already been successfully encapsulated into CMCS 
nanoparticles to achieve controlled release and target delivery properties (Anitha, Maya, 
Deepa, Chennazhi, Nair, Tamura, et al., 2011; Kim, Jeong, Choi, Roh, Kang, Jang, et al., 
2006). CMCS has also been modified by cholesterol to form self-assembled nanoparticles 
able to deliver anticancer drugs with higher targeting efficiency and longer retention time in 
the liver than those of pure drug solution (Wang, Jiang, Li, Liu, Zhang, & Zhao, 2008). In 
addition, it is newly elucidated that negatively charged CMCS nanoparticles with particle size 
around 150 nm had a better in vitro cellular uptake and more efficient in vivo targeting 
delivery of entrapped drug to tumor (He, Hu, Yin, Tang, & Yin, 2010). 
1.4 Zein 
1.4.1 Introduction of Zein 
Zein is a maize prolamine protein with three-fourths lipophilic and one-fourth 
hydrophilic amino acid residues, leading to its unique aqueous-alcohol solubility and film 
forming properties. Due to the poor solubility in water and the imbalanced essential amino 
acid profile, zein isolate is not used directly for human consumption. Since 1990s, a lot of 
research was focused on the extraction of zein from corn to lower the cost of manufacturing 
zein (Shukla & Cheryan, 2001). After the first U.S. patent of the application of zein for 
encapsulation was published in 1992, more interests have been gradually drawn to explore 
the novel applications of zein as a biodegradable biopolymer and many patents about the 




2001). During last decade, more and more research interests have been focused on the 
applications of zein in food, pharmaceutical and biodegradable plastic industries (Anderson 
& Lamsal, 2011). 
1.4.2 Zein Application for Encapsualtion of Nutraceuticals 
1.4.2.1 Zein Nanoparticles: Preparation and Application 
Liquid-liquid phase separation is the widely used method to produce zein nano/micro 
particles, due to the unique solubility of zein. So far, several methodologies were developed 
by different researchers. In a simple method, zein microspheres and the hydrophobic drugs 
were first dissolved in aqueous-alcohol solution together, then water was added into the zein 
solutions (Hurtado-López & Murdan, 2006; X. Liu, Sun, Wang, Zhang, & Wang, 2005). 
Upon the decrease of alcohol concentrations, the zein became not dissolvable and co-
precipitated with the hydrophobic drug. Another approach was to shear zein aqueous-alcohol 
solution into a bulk water phase. This method has been used to produce zein nanoparticles to 
encapsulate essential oils (Parris, Cooke, & Hicks, 2005). A recent study reported the 
variables during the production of zein nanoparticles using this method (Zhong & Jin, 2009a). 
The report suggested that this method was simple and scalable for food industries, and the 
particle size and viscosity could be easily modulated by controlling fabrication parameters, 
such as shearing rate, alcohol and zein concentrations. The liquid-liquid phase separation 
method has been widely applied in recent years to encapsulate various nutraceuticals or drugs 
(Lai & Guo, 2011; Lau, Johnson, Mikkelsen, Halley, & Steadman, 2012; Podaralla & 
Perumal, 2010; Wu, Luo, & Wang, 2012; Zou, Li, Percival, Bonard, & Gu, 2011). While 
many literatures have been reported on the preparation and encapsulation of drugs or 
nutraceuticals of zein nanoparticles, so far, only a few literatures studied the bioavailability 
and efficacy of zein nanoparticles as delivery systems. Zein nanoparticles have been reported 




5-fluorouracil (Lai & Guo, 2011). Another study showed that zein nanoparticles 
encapsulating cranberry procyanidins decreased the cytotoxicity compared to free cranberry 
procyanidins to human promyelocytic leukemia HL-60 cells, partly attributed to the 
encapsulation and controlled release properties (Zou, Li, Percival, Bonard, & Gu, 2011). 
In addition to liquid-liquid phase separation method, spray drying was also developed 
to produce zein microparticles in recent years, especially for encapsulation of antimicrobials.  
For instance, it has been reported that lysozyme (Jin, Davidson, Zivanovic, & Zhong, 2009; 
Zhong & Jin, 2009b), flax oil (Quispe-Condori, Saldaña, & Temelli, 2011), nisin (Xiao & 
Zhong, 2011), and thymol (Xiao, Davidson, & Zhong, 2011) are successfully encapsulated 
into zein microparticles by spray drying. The release profiles of the antimicrobials from zein 
microparticles were significantly dependent on the preparation parameters, including the 
mass ratio of zein/antimicrobials, surfactant, inlet temperatures, as well as the pH value of the 
release medium. The antimicrobials-encapsulated zein microparticles by spray drying 
demonstrated better antilisterial properties than free antimicrials in fat milk, especially when 
glycerol was added as plasticizer during the preparation (Xiao, Davidson, & Zhong, 2011). 
However, more work needs to be done to further improve the antimicrobial efficacy and 
release profiles in various food systems.  
1.4.2.2 Zein Fiber by Electrospinning  
Electrospinning is novel method developed in recent years to prepare ultrathin fiber 
networks by using high electrostatic potentials from biomaterials. This process involves use 
of strong electrostatic field by high voltage to produce ultrathin fiber. Zein is becoming a 
popular protein to produce nanofibers by electrospinning during this decade, and fabrication 
variables during the electrospinning process have been extensively investigated  and 
physicochemical properties of electrospun zein fiber have also been fully characterized in 




2012; Torres-Giner, Gimenez, & Lagaron, 2008; Yao, Li, & Song, 2006). Jiang and Yang 
reported a new method to modify electrospun zein fiber by crosslinking with citric acid (Jiang 
& Yang, 2011). The crosslinking process could remarkably enhance its both dry and wet 
tensile strength, and the crosslinked zein fiber was able to maintain fibrous structure for 15 
days in PBS at 37°C.  
In recent years, the increasing attention has been drawn to the applications of zein 
electrospun fiber in encapsulation and controlled delivery, as well as stabilization sensitive 
antioxidants in food area. The light sensitive antioxidant, β-carotene has been successfully 
encapsulated into untrafine zein fiber by electrospinning (Fernandez, Torres-Giner, & 
Lagaron, 2009). The study demonstrated that the dimension of electrospun zein fiber was in 
the range of micro- and nanoscale in the cross-section. The β-carotene was shown to be stable 
and widely dispersed inside the zein fibers and its light stability was significantly improved 
when exposed to UV-vis irradiation, compared with unencapsulated β-carotene. Ultrafine 
zein fibers were also tested for encapsulation of green tea polyphenol, epigallocatechin 
gallate to improve its stability (Li, Lim, & Kakuda, 2009). The study suggested that aging at 
0% relative humidity for at least 1 d was required for better protection and recovery of 
polyphenol, compared with freshly spun fibers. Many other nutrients were also encapsulated 
into electrospun zein fibers to improve their stabilities with controlled release (Neo, Ray, Jin, 
Gizdavic-Nikolaidis, Nieuwoudt, Liu, et al., 2012; Yang, Zha, Yu, & Liu, 2012). 
1.4.2.3 Zein Film 
Film forming properties of zein has been well documented since 1970s, and the 
coatings of zein films appear to be one of the most promising applications in industries, 
including food, pharmaceutics, and cosmetics (Shukla & Cheryan, 2001). The recent 




industries. Several most recent literatures on zein film application in food science areas are 
discussed below. 
Food safety is one of the hottest areas of zein film applications, with aim to improve 
fresh produce, including minimally process and fresh-cut foods, and ready-to-eat foods which 
are the most susceptible of microbial contaminations. Several antimicrobials have been 
encapsulated into zein films for edible coating applications. For instance, Janes and others 
investigated the effect of nisin encapsulated in zein film coatings on ready-to-eat chicken 
against L. monocytogenes (Janes, Kooshesh, & Johnson, 2006). Their results showed that 
adding nisin into zein films coating significantly inhibited the growth of L. monocytogenes 
from day 0 to day 24 at 8°C, and even maintain its level as undetectable at 4°C. The 
mutilayers of zein-based films loaded with spelt bran and thymol has been recently developed 
as an effective packaging material to control the thymol release rate with sustained 
antimicrobial efficacy (Mastromatteo, Barbuzzi, Conte, & Del Nobile, 2009).  
In addition to food safety, another top area of zein film applications is the food 
quality improvement, such as food packaging. Zein is considered as a novel biodegradable 
material for modified atmosphere packaging, but sometimes plasticization or modification 
may be needed to enhance its efficacy. The zein films plasticized with oleic acid have been 
shown to possess better water vapor and gas barrier propties, compared with untreated zein 
films (Rakotonirainy, Wang, & Padua, 2001). This modified zein films have been tested as 
modified atmosphere package for fresh broccoli florets to maintain their original firmness and 
color. Zein edible film is also reported as an effective coating to improve the quality of dried 
tomatoes to inhibit microbial growth and preserve original color (Baysal, Ersus, & Apaydın, 
2009). The study demonstrated that addition of potassium sorbate into zein film coating could 




1.5 Biopolymer Complex in Encapsulation of Nutraceuticals 
Several studies reported that encapsulation of nutraceuticals into the nanoparticles 
formed by single polymer (single layer) may not be effective to protect the encapsulated 
nutraceutical under simulated gastric fluid, because highly water-soluble proteins undergo 
quick degradation by enzymatic hydrolysis in stomach with presence of pepsin. In this 
scenario, many researchers began to coat the protein nanoparticles with a second polymer to 
form double layer. Therefore, more and more studies have been carried out to investigate the 
preparation, characterization, and application of micro-/nanocomplexes formed by two or 
more polymers (Berger, Reist, Mayer, Felt, Peppas, & Gurny, 2004; Wang & Uludag, 2008).  
Polysaccharides are the popular candidates to coat protein nanoparticles, because 
protein and polysaccharide can be easily associated via physical interactions upon mixing 
together. The non-covalent interactions include electrostatic and hydrophobic interactions, 
steric exclusion, hydrogen bonding, etc. Due to the polysaccharide coatings on the protein, 
the digestive enzymes may need longer time to pass through polysaccharide coating and 
hydrolyze protein molecules, resulting in the retarded controlled release of encapsulated 
nutraceuticals in stomach. Furthermore, higher encapsulation efficiency could be achieved by 
the coating of polysaccharide on protein particles. For instance, several studies reported the 
coating of different polysaccharides, i.e. CS and alginate, on ß-lactoglobulin nanoparticles 
could signicantly improve physicochemical properties (Chen & Subirade, 2005; Somchue, 
Sermsri, Shiowatana, & Siripinyanond, 2009). 
1.6 Call for Encapsulation of Nutraceuticals – Significance & Benefits 
Nutraceuticals are the bioactive compounds from foods and provide health-promoting 
effects, including prevention and treatment against diseases. They may have different forms 
in the market, including pills, powders, capsules, vials, etc. However, the application of 




manufacturing or storage of the commercial products, nutraceuticals are often subjected to 
thermal, oxidative, acidic, basic, humidity, and light (both UV and visible) stress, resulting in 
degradation or iosermerization and thus loss their beneficiary efficacy. In addition to process 
and storage conditions, the food-related factors also demonstrated great impact on the 
stability of nutraceuticals, including moisture content, water activity, lipid oxidation, alkaline 
media, small amounts of transition metals, as well as the interactions with other ingredients 
present in food products. For example, vitamins, especially lipophilic vitamins (A, D, E, & 
K), are the most sensitive nutraceuticals, they must be protected from pro-oxidant elements 
which could greatly impact their chemical integrity and efficacy (Gonnet, Lethuaut, & Boury, 
2010). For instance, the contents of vitamin E in milk-based infant formula decreased by 
more than 50% during 17-month storage time (Miquel, Alegrı́a, Barberá, Farré, & Clemente, 
2004). Therefore, encapsulation technology constitutes a promising approach to preserve 
sensitive nutraceuticals from various conditions, as the nutraceuticals are buried in the core 
structure with a protection barrier of a polymer-based shell structure. The call for 
encapsulation of nutraceuticals is recently becoming more and more significant and numerous 
studies are being carried out in this fast-growing area. In this dissertation, one hydrophilic 
nutraceutical (selenite) and four hydrophobic nutraceuticals (vitamin E, vitamin D3, indole-3-





Chapter 2: Preparation, Characterization and Evaluation of 
Selenite-loaded Chitosan/TPP Nanoparticles with or without 
Zein Coating 
Luo, Y., Zhang, B., Cheng, W-H., Wang, Q. Carbohydrate Polymers, 82 (3), 942-951. 
 
2.1 Abstract 
The selenite-loaded chitosan (CS) nanoparticles using tripolyphosphate (TPP) as a 
crosslinking agent with or without zein coating were prepared to obtain selenite supplement 
formulations with low toxicity and improved antioxidant property. Scanning electron 
microscopy observation showed selenite-loaded CS/TPP nanoparticles had a spherical shape 
with uniform diameter. The results demonstrated that particle size, surface charge, 
encapsulation efficiency, and release profile could be modulated by fabricating conditions. 
After zein coating, the particle size maintained nano-scale while encapsulation efficiency 
increased from 60% to 95%. The release profile was also prominently improved with zein 
coating, the released selenite reduced from 85% to 30% within 4 hours in PBS. In simulated 
gastrointestinal condition with enzymes, 93% of selenite released from non-coated CS/TPP 
nanoparticles into gastric fluid, however, the releasing rate decreased to 46% after coated 
with zein. Moreover, due to high antioxidant activity of CS, the in vitro antioxidant properties 
of selenite-loaded CS/TPP nanoparticles were significantly enhanced, compared with pure 
selenite. 
2.2 Introduction 
Selenium is an essential trace element in human nutrition closely associated with the 




hypercholesterolemia, (Navas-Acien, Bley, & Guallar, 2008), cardiovascular disease 
(Thomson, 2004; Ray et al., 2006), and certain cancers (Ferguson, Philpott, & Karunasinghe, 
2006). Although food and vegetables can be the major source of selenium intake, selenium 
supplementation is still needed in the low selenium areas (Navarro-Alarcon, & Cabrera-
Vique, 2008). Available dietary supplement of selenium mainly consists of two inorganic 
forms, selenite and selenate, both of them are considered toxic if consumed in large quantity. 
Sodium selenite has been used in the selenium-fortified milk formula, especially for infants, 
however, many studies reported that 50-90% of consumed selenite was lost and excreted in 
urine due to the short retention time in gastrointestinal tract (Zachara, Gromadzinska, 
Wasowizc, & Zbrog, 2006; Dael, Davidsson, Munoz-Box, Ray, & Barclay, 2001). It has been 
also evidenced that supplementation of selenite to mice and cells may cause various adverse 
effects due to its pro-oxidant property, which depends on the concentration and other factors 
(Cheng, 2009; Shimizu, Ueno, Okuno, Sakazaki, & Nakamuro, 2009; Xiang, Zhao, & Zhong, 
2009; Björkhem-Bergman et al., 2002; Moak, & Christensen, 2000). Therefore, how to 
provide efficient and safe application of dietary selenite supplementation has become a 
challenge topic in recent years.  
 Chitosan (CS), the N-deacetylation form of chitin mostly found in the exoskeleton of 
crustacean, insects, and fungi, is a natural polysaccharide. CS is not only non-toxic and 
biodegradable with low immunogenicity, but also possesses a high density of positive charge 
in an acid solution attributed to the glucosamine group on its backbone. Because of these 
beneficial characteristics, increasing attention has been drawn to the applications of CS-based 
micro- and nanoparticles in the pharmaceutical and nutraceutical field (Shah, Pal, Kaushik, & 
Devi, 2009; Grenha, Seijo, & Remuñán-López, 2005; Khlifi, EI Hachimi, Khalil, Es-Safi, & 
EI Abbouyi, 2005; Kockisch, Ress, Young, Tsibouklis, & Smart, 2003). Ionic gelation is the 




and multivalent polyanions interact to form CS nanoparticles under simple and mild 
conditions. Among various polyanions, tripolyphosphate (TPP) is the most investigated due 
to its quick gelling capability and non-toxic property. CS/TPP nanoparticles have been 
proved to be excellent carriers for drug and nutrient in therapeutic and nutritional 
applications, such as providing efficient and target delivery of shRNA sequence (Wang et al., 
2009), lowering toxicity of therapeutic antisense oligonucleiotide (Dung et al., 2007), 
increasing bioavailability of nutraceuticals (Dudhani, & Kosaraju, 2010; Hu, Pan, Hou, Ye, 
Hu, & Zeng, 2008; Zhang, Yang, Tang, Hu, & Zou, 2008), as well as achieving long term 
controlled release of protein, e.g., bovine serum albumin (Gan, & Wang, 2007) and unstable 
drugs, e.g., venlafaxin hydrochloride (Shah et al., 2009). 
 In the last decade, CS has already been introduced to decrease toxic effects and 
enhance beneficial properties of therapeutic treatment of selenium compounds. CS hydrogen 
selenite was prepared by the reaction between CS and selenous acid (Qin, Xiao, Du, & Gao, 
2002). It was found that CS hydrogen selenite inhibited the growth against sarcoma 180 solid 
tumor cell with lower acute toxicity, comparing to sodium selenite. Seleno-short chain CS is 
a newly developed CS derivative modified by introducing selenic acid groups (–SeO3) to 
amino positions of CS (Patent Number CN1600793A), and proved to possess a therapeutic 
potential in human treatment with improved efficacy (Liu, Song, Cao, Liu, & Jia, 2008).  
In this study, CS/TPP was chosen to form nanoparticles with sodium selenite to decrease the 
toxicity (personal communication with Dr. Wen-Hsing Cheng) and enhance the antioxidant 
property of selenite dietary supplement. The ionic gelation method was used to prepare 
CS/TPP nanoparticles to encapsulate sodium selenite. Different fabricating conditions were 
evaluated in terms of their effects on physicochemical properties of selenite-loaded CS/TPP 
nanoparticles, including morphology, particles size, surface charge, the encapsulation 




water insoluble corn protein, was chosen as a coating material to achieve better encapsulation 
efficiency and controlled release profiles of selenite loaded CS/TPP nanoparticles. 
2.3 Materials and Methods 
2.3.1 Materials 
Low molecular weight CS with 92% deacytelation degree (Batch No.: MKBB4232), 
TPP, sodium selenite, 2,3-diaminonaphthalene (DAN), linoleic acid, 1,10-phenanthroline, 
and pepsin were purchased from Sigma-Aldrich Chemical Co. Ltd (St. Louis, MO). 
Disodium salt of ethylenediaminetetraacetic acid (EDTA) solution (5 M) was obtained from 
Boston Bioproducts Incorporation (Boston, MA). Phosphate butter saline (PBS) was 
purchased from EMD Chemicals Incorporation (Gibbstown, NJ). Simulated gastric fluid 
without pepsin (SGF) and simulated intestinal fluid with pancreatin (SIF) were purchased 
from RICCA chemical company (Arlington, TX). All other reagents, including FeSO4 and 
H2O2, were of analytical grade. DAN was dissolved in 0.1 M hydrochloric acid to prepare a 
0.1% solution; once dissolved, it was extracted with cyclohexane three times to remove 
impurities.   
 
2.3.2 Preparation of Selenite-Loaded CS/TPP Nanoparticles 
CS solution (5 mg/ml) was prepared by dissolving CS in 1% (w/v) acetic acid 
solution under stirring overnight at room temperature. The CS solution was diluted with 
deionized water (refer to water thereafter) to produce different concentrations. CS/TPP 
nanoparticles were prepared according to the ionotropic gelation process. In brief, TPP 
aqueous solution (0.5 mg/ml) was added dropwise to the CS solution and stirred (600 rpm) 
for 30 minutes at room temperature to obtain blank nanoparticles. For preparation of selenite-




slowly to CS solution with mild stirring (600 rpm) for 30 minutes at room temperature, and 
then TPP solution was added dropwise to the mixture with mild stirring (600 rpm) for another 
30 minutes. The CS/TPP weight ratio used throughout this study was 5:1, which was obtained 
from the results of several trials. 
2.3.3 Fourier transform infrared spectroscopy (FTIR) 
FTIR was used to measure changes in chemical structure of the CS, blank 
nanoparticles, and selenite-loaded nanoparticle samples. The samples were first lyophilized 
(RVT 4104-115, Refrigerated Vapor Trap, Thermo Savant, Waltham, MA), and then ground 
into homogeneous powders. The spectra were acquired at 600-4000 cm-1 wavenumbers with 
a 4 cm-1 resolution utilizing a NEXUS 670 FTIR spectrophotometer (Thermo Nicolet Corp. 
Madison, WI) equipped with a diamond ATR cell. 
2.3.4 Morphology Mbservation 
Morphological structures of TPP, selenite, CS, CS/TPP and selenite-loaded CS/TPP 
nanoparticles were obtained by a scanning electron microscopy (SEM, Hitachi SU-70 
Pleasanton, CA). Samples were first cast-dried on an aluminum pan before cutting into an 
appropriate size, and then adhered to conductive carbon tapes (Electron Microscopy Sciences, 
Ft. Washington, PA). Subsequently, they were mounted on specimen stubs, and coated with a 
thin (<20 nm) conductive gold and platinum layer using a sputter coater (Hummer XP, 
Anatech, CA). Representative SEM images were reported in the result section. 
2.3.5 Particle Size and Surface Charge 
Hydrodynamic diameter of selenite-loaded CS/TPP nanoparticles was measured by a 
dynamic light scattering instrument (DLS, BI-200SM, Brookhaven Instruments Corporation, 
Holtsville, NY). DLS is equipped with a 35 mW HeNe laser beam at a wavelength of 637 




were 1.590 and 0.8904 centipoise, respectively, which were used for calculating effective 
diameter from autocorrelation. Surface charges of the nanoparticles were measured by a laser 
Doppler velocimetry (Zetasizer Nano ZS90, Malvern, UK), using a fold capillary cuvette 
(Folded Capillary Cell-DTS1060, Malvern, UK). The freshly prepared solutions of 
nanoparticles were used for particle size and surface charge measurement. All measurements 
were conducted in triplicate. 
2.3.6 Encapsulation Efficiency 
The encapsulation efficiency (EE) of the nanoparticles was defined as the drug 
content that is entrapped into nanoparticles (Shah et al., 2009; Hu et al., 2008), and calculated 
as follows:  
EE (%) = Total selenite amount – Free selenite amount × 100 Total selenite amount 
The total selenite amount was the added selenite. Amount of free selenite molecules 
were obtained using a membrane separation method. First, free selenite were separated from 
nanoparticles using an Ultra-15 centrifugal filter device (Millipore corp., Ann Arbor, MI) 
with 10 kDa molecular weight cut off, according to the previously reported method (Hu et al., 
2008). Being centrifuged at 4,000g for 30 min, free selenite molecules would penetrate into 
the filtrate receiver, and the CS nanoparticles would stay in the filter unit. The separated 
nanoparticles were then lyophilized for further characterization. The free selenite content in 
the filtrate was measured using the method of Veiga, Rivero-Huguet, and Huertas (2008) with 
modifications. In brief, nanoparticles solution was diluted with water, and then 5 ml sample 
solution was poured into a test tube, followed by adding 2 ml 0.05 M EDTA and 2 ml 0.1% 
DAN solution. The tubes were warmed at 60oC for 30 min. The formed piaselenol was 
extracted by 4 ml cyclohexane. The absorbance in the cyclohexane layer was measured at 378 
nm by a spectrophotometer (Beckman Coulter, DU-730, Fullerton, CA). The amount of 




each measurement was conducted in triplicate. And the content of selenite entrapped in the 
CS/TPP matrix was measured right after the separation using the same method to confirm 
that the addition of free selenite and encapsulated selenite equaled to the total content of 
added selenite. 
2.3.7 In vitro Release 
In vitro release study of selenite from nanoparticles was carried out in PBS medium, 
according to a reported procedure (Shah et al., 2009). Certain amount (5-10 mg) of 
nanoparticles were resuspended in PBS with pH 7.4 and placed in a dialysis membrane bag 
with molecular weight cut off at 10 kDa. The membrane bag was placed in 50 ml PBS. The 
entire system was then kept at 37°C with mild and continuous stirring. At certain time 
intervals, 5 ml release medium was collected and 5 ml fresh PBS was replaced into release 
system. The release of selenite from nanoparticles were also investigated under simulated 
gastrointestinal tract (GI tract), according to the reported method (Somchue, Sermsri, 
Shiowatana, & Siripinyanond, 2009). The nanoparticles with or without coating were first 
incubated in 10 ml of SGF with 0.1% pepsin (w/v) at 37°C under mild stirring for 2 hours. 
The supernatant was separated by centrifugation for determination of selenite content. The 
swollen aggregates were collected and subsequently incubated in SIF with 1.0% pancreatin 
(w/v) at 37°C under mild stirring for 4 hours. The supernatant was separated by 
centrifugation for determination of selenite content. The content of selenite was measured at 
378 nm absorbance by the method described in section 1.1.6. 
2.3.8 Antioxidative Properties 
Two methods, hydroxyl radical scavenging effect and inhibitory effect against lipid 





Hydroxyl radical scavenging effect (HRSE): The hydroxyl radical-scavenging 
experiment was carried out using the method described by Tian et al. (2009) with some 
modifications. In brief, 1,10-phenanthroline (1 ml, 0.93 mM), the selenite, CS, or selenite-
loaded nanoparticles sample (1 ml), and an acetate buffer (1 ml, 0.3 M, pH=3.6) were added 
to a screw-capped tube orderly and mixed thoroughly. Then, FeSO4·7H2O (1 ml, 0.93 mM) 
was pipetted to the mixture. The reaction was initiated by adding H2O2 (1 ml, 0.025% v/v). 
The mixture was incubated at 37°C for 60 min, and the absorbance was measured at 509 nm 
against reagent blank. The negative control was prepared by replacing 1 ml sample with 
water, and the blank control was prepared by replacing 1 ml H2O2 with 1 ml water. The 









where AB, AN and AB were the absorbance values of the sample, negative control, and blank 
control, respectively. Determination of each sample was performed in triplicate. 
 
Inhibitory effect against lipid peroxidation (IEALP): The inhibitory effect of selenite, 
CS, and selenite-loaded nanoparticles against lipid peroxidation was evaluated by the 
formation of conjugated dienes in linoleic acid emulsion system, according to the procedure 
prescribed by Khlifi et al. (2005), with minor modification. In brief, a 100 µl sample was 
added to 2.0 ml of 10 mM linoleic acid in phosphate buffer (pH 7.0, 10 mM) emulsified with 
Tween 20. The mixture was incubated in darkness at 37°C to accelerate oxidation. The 
control was prepared by replacing 100 µl sample with 100 µl water. After incubation for 15 
h, the absorbance was measured at 234 nm against reagent blank with a spectrophotometer 










where AC and AS were the absorbance of the control and sample, respectively. 
 
2.3.9 Improved Nanoparticle Formulation with Zein Coating 
To prepare zein-coated selenite-loaded CS/TPP nanoparticles, the selenite-loaded 
CS/TPP nanoparticles was first prepared (CS concentration, 1.5 mg/ml; selenite loading 
concentration, 0.6 mg/ml) and then mixed with proper volume of ethanol. Then, the 
appropriate concentration of zein was dropwise added to above solution under mild stirring 
for 30 min. The mass ratio of CS to zein was 1:1 and 1:3. The particle size, encapsulation 
efficiency and release profile were further evaluated and compared with nanoparticles 
without zein coating. 
2.3.10 Statistical Analysis 
All the experiments were conducted in triplicate with data reported as mean ± 
standard error. Experimental statistics were performed using the SAS software (Version 9.2, 
SAS Institute Inc., Cary, NC). The student’s t test was used to compare the treatment means 
of antioxidant activities between nanoparticles and selenite or CS. The analysis of variance 
(ANOVA) Tukey’s multiple comparison tests was used in analysis of differences between 
physicochemical properties of nanoparticles with and without zein coating. The significance 




2.4 Results and Discussion 
2.4.1 Physicochemical Characterization 
The molecular structures of selenite, TPP, and CS are shown in Fig. 2.1. CS is a 
cationic polyelectrolyte polysaccharide due to the protonation of amino groups in acidic 
solution. Each selenite and TPP molecule carries a maximum of two and five negative 
charges, respectively. 
 
Fig. 2.1 Molecular structure of selenite, TPP and CS. 
 
2.4.1.1 FTIR study 
The intermolecular interaction of nanoparticles was characterized by FTIR (Fig. 2.2). 
Six characterization peaks, observed in CS (Fig. 2.2A) at 3358.52, 1648.61, 1586.59, 
1418.88, 1375.24, and 1025.94 cm-1, were thought to be O–H stretch, C=O stretching from 
amide I, N–H bending and C-N stretching from amide II, –CH2 bending, –CH3 symmetrical 
deformation, and skeletal vibration of C–O stretching, respectively (Shah et al., 2009; Lawrie, 
keen, Drew, Chandle-Temple, Rintoul, & Fredericks, 2007). It was observed that the 
spectrum of CS/TPP nanoparticles was different from that of CS matrix (Fig. 2.2B), 
highlighted in the wavenumber range from 1400 to 1650 cm-1. The peak of 3358.52 cm-1 
became wider and flatter, indicating that hydrogen bonding was enhanced (Wu, Yang, Wang, 
Hu, & Fu, 2005). The peaks of amide I and amide II in CS/TPP nanoparticles shifted to 
1635.52 and 1558.23 cm-1, respectively, due to the electrostatic interaction between 
phosphoric groups of TPP and amino groups of CS in nanoparticles. These observations were 




2005). Compared with the spectrum of CS/TPP nanoparticles, the electrostatic interaction 
between selenite and amino groups was confirmed by the shift of absorption peaks of amide 
II from 1558.23 to 1539.41 in the spectrum of selenite-loaded CS/TPP nanoparticles (Fig. 
2.2C). This phenomenon was further confirmed by surface charge results presented in section 
1.2.3. 
 
Fig. 2.2. FTIR spectra of individual components and nanoparticles. A, CS; B, CS/TPP 
nanoparticles; and C, selenite-CS/TPP nanoparticles. 
 
 
2.4.1.2 Morphological Observation 
The morphological changes of each ingredient and nanoparticles after cast drying on 
an aluminum surface were observed with a SEM, as shown in Fig. 2.3. Positively charged 
pure CS exhibited rough membrane structures (Fig. 2.3A) due to its ability to form films by 
cast drying (Picker-Freyer & Brink, 2006), while the negatively charged TPP formed smooth 
film (Fig. 2.3B). As an inorganic molecule, sodium selenite crystallized into a needle-shaped 
structure with a diameter of 1-2 µm (Fig. 2.3C). When mixing CS and TPP together with or 
without selenite, spherical particles with uniform particle size in the nanoscale formed, 
ranging from 200 to 300 nm (Fig. 2.3D and E). The aggregates, usually having a rod shape, 




size of nanoparticles obtained after cast drying was in good agreement with that measured in 
an acidic aqueous system presented in the next section. 
 
Fig. 2.3. Scanning electron microscopy (SEM) photographs of individual components 
and nanoparticles. A, CS; B, TPP; C, selenite; D, CS/TPP nanoparticles, and E, selenite-
loaded CS/TPP nanoparticles. 
 
2.4.2 Effect of Formulations on Particle Size 
The effects of CS concentration and selenite loading concentration on particle size 
and polydispersity index (PDI) of selenite-loaded CS/TPP nanoparticles were summarized in 
Table 2.1. The particle size increased linearly from 120 to 300 nm with the increase of CS 
concentration in the range of 0.5-2.5 mg/ml (R2 = 0.9528). These trends were in accordance 
with previously reported results (Hu et al., 2008; Gan, Wang, Cochrane, & McCarron, 2005). 




decreased slightly from 300 to 200 nm, showing a linearly negative correlation between 
selenite loading concentration and CS concentration (R2 = 0.9597). This result is expected 
since selenite carried negative charges and electrostatically interacted with CS, which would 
promote formation of nanoparticles through ionic cross-linking. All formulations of selenite-
loaded nanoparticles had a small polydispersity, and increased slightly with increasing of 
chitosan concentrations (Table 2.1). 
Table 2.1 The particle size and PDI of different formulations 
Nanoparticles Particle size PDI Nanoparticles Particle size PDI 
A1 124.27 ± 4.39 0.16 B1 ± 0.03 302.63 ± 6.23 0.21 ± 0.05 
A2 203.53 ± 4.93 0.18 ± 0.03 B2 276.00 ± 4.5 0.19 ± 0.05 
A3 233.05 ± 9.86 0.18 ± 0.03 B3 233.05 ± 9.86 0.18 ± 0.03 
A4 254.55 ± 9.67 0.29 ± 0.01 B4 229.20 ± 5.31 0.23 ± 0.02 
A5 304.20 ± 9.11 0.28 ± 0.01 B5 214.43 ± 11.64 0.28 ± 0.01 
PDI, Polydispersity index. A1, A2, A3, A4, and A5 were the nanoparticle samples with CS 
concentrations of 0.5, 1.0, 1.5, 2.0, and 2.5 mg/ml, respectively, while the selenite loading 
concentration and CS-TPP mass ratio are fixed at 0.6 mg/ml and 5:1, respectively. B1, B2, 
B3, B4, and B5 were the nanoparticles samples with selenite loading concentrations of 0.2, 
0.4, 0.6, 0.8, and 1.0 mg/ml, respectively, while the CS concentration and CS-TPP mass ratio 
were fixed at 1.5 mg/ml and 5:1, respectively. 
 
Particle size is one of the most important parameters determining biocompatibilities 
and bioactivities of micro and nanoparticles. Small nanoparticles have a higher intracellular 
uptake than large ones.  Desai, Labhasetwar, Amidon, and Levy (1996) reported that the 
gastrointestinal uptake of particles of 100 nm was 15-250 fold greater than larger size 
microparticles. In another study, they also pointed out that the uptake mechanism of 
biodegradable microparticles in Caco-2 cells was largely dependent on particle sizes, as the 
cell uptakes of particles with 100 nm diameter was 2.5 and 6 times greater than those with 1 
µm and 10 µm, respectively (Desai, Labhasetwar, Walter, & Levy, 1997). Since particle size 




nanoparticles (Gan et al., 2005), it is possible to enhance the mucoadhesive properties of CS 
nanoparticles by decreasing its particle size, and thus to improve mucosal uptake of selenium 
from selenite.  
2.4.3 Effect of Formulations on Surface Charge 
As soon as CS and TPP were mixed together in an acetic acid, the nanoparticles were 
formed spontaneously with a significant positive surface charge obtained by the zeta potential 
measurement (37 to 50 mV, Fig. 2.4). Since CS/TPP nanoparticles were formed by the 
interaction between protonized –NH3+ in CS and the polyanionic phosphate groups in TPP, 
the zeta potential of nanoparticles increased linearly due to a more available protonized –
NH3+ on the surface of nanoparticles formed with higher CS concentration (Fig.2. 4A). 
However, zeta potential decreased slightly with the increase of selenite concentration (Fig. 
2.4B), owing to an electrostatic interaction between protonized –NH3+ of CS and selenite that 
resulted in reduced surface charge.   
Zeta potential is another key parameter contributing to various nutritional properties 
of CS nanoparticles. It has been well documented that CS possesses mucoadhesive properties 
(Sinha, Singla, Wadlhawan, Kaushik, & Kumria, 2004; Kockisch et al., 2003; Shimoda, 
Onishi, & Machida, 2001) due to molecular attractive forces formed by an electrostatic 
interaction between positively charged CS and negatively charged mucosal surfaces. Since 
most tumor cell membranes are negatively charged, CS nanoparticles have recently been 
studied to develop tumor-specific delivery of anticancer drugs. For example, encapsulation of 
paclitaxel using CS-modified nanoparticles could significantly increase lung tumor-specific 
distribution and enhance the uptake across the endothelial cells of the lung tumor capillary 
(Yang et al., 2009). Thus, it is possible that encapsulation of selenite into CS/TPP 
nanoparticles may contribute to the increased efficiency of targeted delivery to tumors and 






Fig. 2.4. Effect of nanoparticle formulations on zeta potential and encapsulation 
efficiency. 
(A) Effect of CS concentrations (selenite loading concentration = 0.6 mg/ml, CS-TPP mass 
ratio = 5:1). (B) Effect of selenite loading concentration (CS concentration = 1.5 mg/ml, CS-
TPP mass ratio = 5:1). Values were expressed as mean ± standard error. 
 
2.4.4 Effect of Formulations on Encapsulation Efficiency 
Encapsulation efficiency is defined as percentage of selenite loading content that can 
be entrapped into CS/TPP nanoparticles. The effects of CS concentration and selenite loading 
concentration on encapsulation efficiency are demonstrated in Fig. 2.4A and 2.4B, 




more protonized CS (–NH3+) were available in the system, evidenced by increased surface 
charge, leading to a stronger electrostatic attraction between selenite and CS. Thus, the 
encapsulation efficiency of selenite increased linearly with the increase of CS concentration 
(Fig. 2.4A). This observation was accordance with the previous studies, showing the 
encapsulation efficiency of catechins was positively associated with CS initial concentration 
(Hu et al., 2008). As shown in Fig. 2.4B, encapsulation efficiency was affected by the initial 
concentration of selenite in a CS solution. A dramatic decrease of encapsulation efficiency 
from 85% to 42% was observed when loading concentration of selenite increased from 0.2 to 
1.0 mg/mL. A reversed linear correlation was obtained between encapsulation efficiency and 
selenite loading concentration. As the selenite loading concentration increased, more selenite 
molecules were just electrostatically adsorbed onto the surface of CS and were easily 
separated from CS-nanoparticles by centrifugation. Similar results were also reported by Wu 
et al. (2005) showing that encapsulation efficiency of ammonium glycyrrhizinate in CS/TPP 
nanoparticles decreased with increasing drug loading concentration.  
2.4.5 Effect of Formulations on Release Profile 
Fig. 2.5 presented the in vitro release profiles of selenite from CS/TPP nanoparticles, 
with respect to different CS concentration (Fig. 2.5A) and different selenite loading 
concentration (Fig. 2.5B). Analyses of selenite release showed a very rapid initial burst (0 to 
60 minutes), followed by a very slow release in all samples. Accumulative release at 240 
minutes was reduced from 98% to 85% with CS concentration increased from 0.5 to 2.5 
mg/ml, and the initial burst effect also reduced slightly. These results indicated that the higher 
the CS concentration was (Fig. 2.5A), the lower the release rate would be. Similar results 
were also reported in other studies (Hu et al., 2008; Ko, Park, Hwang, Park, & Lee, 2002). 
This phenomenon was attributed to that the increased viscosity at higher CS concentration 




TPP, and thus the greater cross-linking density and less swelling ability (Shah et al., 2009). In 
addition, increasing CS concentration would lower the membrane permeability of CS 
nanoparticles, leading to increased chain packing and rigidity, as well as interchain bonding. 
Selenite release from the nanoparticles was also dependent on selenite loading 
concentration (Fig. 2.5B). As the selenite loading concentration increased from 0.2 to 1.0 
mg/ml, greater initial burst effect was observed at higher selenite loading concentration. 
Almost 85% selenite was released from nanoparticles at 1.0 mg/ml selenite loading 
concentration within 30 min, whereas the amount of selenite released from nanoparticles 
decreased to 60% when 0.2 mg/ml selenite loading concentration was used.   
 
  
Fig. 2.5. Kinetic release profile of selenite from nanoparticles in different formulations. 
(A) Effect of CS concentrations on release profile of selenite-loaded CS/TPP nanoparticles 
(selenite loading concentration = 0.6 mg/ml, CS-TPP mass ratio = 5:1). (B) Effect of selenite 
loading concentrations on release profile of selenite-loaded CS/TPP nanoparticles (CS 





          Drug molecules diffusion and polymer matrix degradation have been suggested as 
mechanisms of release profile from nanoparticles and microspheres (Zhou et al., 2001). By 
studying ammonium glycyrrhizinate loaded CS nanoparticles, Wu et al. (2005) proposed that 
drug molecule diffusion played a predominant role in release profile when the size of 
encapsulated drug molecule was much smaller than the formed nanoparticles. Thus, as 
demonstrated by the release profiles, due to the much smaller size of selenite used in this 
study, the selenite could diffuse very easily through the surface or the pore of nanoparticles in 
a very short period of time. Since the formulated selenite loaded CS/TPP nanoparticles had 
fast releasing property that is hard to achieve the controlled release purpose, zein was further 
formulated as a hydrophobic material to coat the nanoparticles to obtain better encapsulation 
efficiency and release profile and the results were presented in section 2.4.7. 
2.4.6 Evaluation of Antioxidative Properties 
2.4.6.1. Hydroxyl Radical Scavenging Effect (HRSE) 
Results presented in Fig. 2.6 demonstrated the scavenging effect of selenite-loaded 
nanoparticles, CS (Fig. 2.6A) and selenite (Fig. 2.6B) on hydroxyl radicals. From Fig. 2.6A, 
it was observed that HRSE of nanoparticles increased from 34.1 to 42.5% as the CS 
concentration increased from 0.5 to 2.5 mg/ml, and that there was no significant difference 
between HRSE of CS and that of selenite-loaded CS nanoparticles at higher CS 
concentrations. From Fig. 2.6B, it was found that HRSE of nanoparticles was also slightly 
enhanced with an increase in selenite loading concentration. However, the HRSE of 
nanoparticles was 2 to 13 times greater than that of sodium selenite at the equivalent selenite 






Fig. 2.6. Hydroxyl radical scavenging effect of selenited-loaded nanoparticles. 
(A) Effect of CS concentrations on scavenging effect of selenite-loaded CS/TPP 
nanoparticles against hydroxyl radicals (selenite loading concentration = 0.6 mg/ml, CS-TPP 
mass ratio = 5:1). (B) Effects of selenite loading concentrations on scavenging effect of 
nanoparticles against hydroxyl radicals (CS concentration = 1.5 mg/ml, CS-TPP mass ratio = 
5:1). Values were expressed as mean ± standard error. (*) P < 0.05, compared with CS (A) or 
selenite (B) at the equivalent concentration. 
 
 
1.4.6.2. Inhibitory Effect against Lipid Peroxidation (IEALP) 
The inhibitory effect of selenite-loaded nanoparticles, CS and selenite against lipid 
peroxidation in linoleic acid system were presented in Fig. 2.7. CS possessed higher IEALP 
in higher concentrations, while that selenite-loaded nanoparticles had a similar trend on 




(Fig. 2.7A). No significant difference was observed between IEALP of CS and that of 
nanoparticles at higher CS concentration. The IEALP of nanoparticles slightly increased from 
79 to 88% as the selenite loading concentration increased from 0.2 to 1.0 mg/ml. The IEALP 
of nanoparticles were significantly improved (P < 0.05), compared with selenite at equivalent 
concentrations (Fig. 2.7B). Although the IEALP of selenite was stronger at higher 
concentration reaching 58% at 1.0 mg/ml, when considering the decreased encapsulation 
efficiency of selenite (45%) at 1.0 mg/ml (Fig. 2.4B), the increase of selenite loading 
concentration would not efficiently enhance the antioxidant activities of nanoparticles.  
It was reported that when the gold nanoparticles were prepared using CS as a 
stabilizer, the catalytic activity of gold nanoparticles upon elimination of hydroxyl radicals 
was remarkably elevated, which was 80-fold higher than that of nanoparticles stabilized by an 
ascorbic acid (Esumi, Takei, & Yoshimura, 2003). Recently, fungal CS and crab CS have 
been discovered to possess potent antioxidant properties, including scavenging ability on 
hydroxyl radicals and inhibitory effect against linoleic acid oxidation (Yen et al., 2007, 
2008). Based on our results, it is suggested that although both selenite and CS contributed to 
the antioxidant properties of the nanoparticles, the contribution of CS was much greater than 
that of selenite. The encapsulation of selenite into CS nanoparticles could significantly 
improve the antioxidant profile of selenite supplementation in vitro; however, the in vivo 







Fig. 2.7. Inhibitory effect against lipid peroxidation of selenite-loaded nanoparticles 
(A) Effect of CS concentrations on inhibitory effect of selenite-loaded CS/TPP nanoparticles 
against lipid peroxidation (selenite loading concentration = 0.6 mg/ml, CS-TPP mass ratio = 
5:1). (B) Effects of selenite loading concentrations on inhibitory effect of selenite loaded 
CS/TPP nanoparticles against lipid peroxidation (CS concentration = 1.5 mg/ml, CS-TPP 
mass ratio = 5:1). Values were expressed as mean ± standard error. (*) P < 0.05, compared 
with pure ingredient at the equivalent concentration. 
 
 
2.4.7 Zein Coating on Nanoparticles 
Studies have shown that a large portion of dietary supplements of selenite cannot be 
effectively absorbed because of short retention time in gastrointestinal tract (Zachara et al., 




utilization in the body, selenite needs to be protected in the encapsulated nanoparticles until it 
reaches the target site, the intestine. However, all formulations of selenite-loaded CS/TPP 
nanoparticles had fast release effect in PBS and the selenite contents dropped to ~10% within 
4 hours (Fig. 2.5). Therefore, zein was proposed as a hydrophobic coating material for the 
prepared nanoparticles and it could be considered as water barrier to inhibit CS swelling and 
strengthen the polymer matrix through hydrogen bond with CS.  
 
Table 2.2. Effects of zein coating on physicochemical properties of selenite-loaded 
CS/TPP nanoparticles 
Formulations Particle size (nm) PDI EE (%) Stimulated GI tract Release (%) SGF (2h) SIF (4h) 
Without zein coating 233.05 ± 9.86 0.18 ± 0.03 a 63.34 ± 2.54 93.37 ± 2.25a  a 
Coated with zein 
(CS to Zein 1:1) 236.93 ± 22.14 0.21 ± 0.06 
a 96.16 ± 3.80 49.06 ± 4.35b 50.43 ± 5.72 b 
Coated with zein 
(CS to Zein 1:3) 454.13 ± 21.15 0.28 ± 0.06 
b 95.71 ± 2.10 45.94 ± 3.33b 53. 39 ± 4.47 b 
Note: The selenite-loaded CS/TPP nanoparticles without zein coating: CS concenctration, 1.5 mg/ml; 
selenite loading concentration, 0.6 mg/ml; CS-TPP mass ratio, 5:1. EE, encapsulation efficiency; SGF, 
simulated gastric fluid; SIF, simulated intestinal fluid. Values were expressed as mean ± standard error. 
The values with different letter in the same column were significantly different at P < 0.05. 
 
As shown in Table 2.2, after coating with zein, the encapsulation efficiency of 
selenite was significantly improved from 60 to 95%. Particle size of zein coated nanoparticles 
increased with zein concentration, and reached 450 nm when the mass ratio of CS to zein was 
1:3. Interestingly, as the mass ratio of CS to zein was 1:1, the particle size of coated 
nanoparticles maintained around 260 nm, similar to that of the uncoated nanoparticles, 
whereas the encapsulation efficiency achieved 96%. Thus, nanoparticles with mass ratio of 
CS to zein as 1:1 might be the optimal formulation to obtain both small particle size and high 
encapsulation efficiency. Zein has been proved to possess film-forming ability when treated 
in acidic system (Wang, Yin, & Padua, 2008), including acetic acid (Shi, Kokini, & Huang, 




zein can form a coating film around the nanoparticles (Fig. 2.8A and 2.8B), and with higher 
concentration of zein, the coating was denser and thicker, resulting in increased diameter 
tested by DLS. 
 
Fig. 2.8. Scanning electron microscopy (SEM) photographs of selenite-loaded CS/TPP 
nanoparticles with zein coating. 
(A), CS : zein = 1:1; (B), CS : zein = 1:3. 
 
 
Fig. 2.9. Effects of zein coating on selenite release profile from nanoparticles. 
CS concentration = 1.5 mg/ml, selenite loading concentration = 0.6 mg/ml, CS-TPP mass 
ratio = 5:1. Values were expressed as mean ± standard error. The values with different letter 
were significantly different at P < 0.05. 
 
 The release profile of zein-coated nanoparticles in PBS medium was illustrated in 
Fig. 2.9. Comparing to selenite loaded CS/TPP nanoparticles without coating, both the burst 
effect and accumulative release were greatly improved. Burst effect for the coated 




matrix, while burst effect for the non-coated nanoparticles occurred at 60 minutes and more 
than 85% of selenite released out. The accumulative release of selenite within 4 hours 
decreased dramatically from 98% for non-coated nanoparticles to 32% for coated ones. To 
further investigate the protective effect of zein coating on selenite release, the release profile 
was examined under simulated gastric fluid (SGF) and simulated intestinal fluid (SIF) 
digestion conditions with the presence of enzymes (pepsin and pancreatin, respectively). 
Table 2.2 showed the selenite encapsulated in CS/TPP nanoparticles without zein coating 
almost completely released in SGF (93.37 ± 2.25%) in 2 hours. However, after coated with 
zein, the selenite release was greatly prolonged and nanoparticles was well-protected against 
gastric condition, showing that only about 50% of encapsulated selenite released in SGF. The 
release of the remaining selenite completed after 4 hours of incubation in SIF for both coated 
samples. No significant difference was observed between the two experimented 
concentrations of zein coating. Coating the particles with another polymer has been proposed 
as an effective approach to prolong the controlled release of encapsulated nutraceuticals. 
Somchue et al. (2009) found after α-tocopherol encapsulated protein-based delivery particles 
were coated with alginate, the release profile of delivery was retarded prominently. From our 
study, the release of selenite as well as encapsulation efficiency of CS/TPP nanoparticles was 
dramatically improved by zein coatings. 
 
2.5 Conclusion 
The present study demonstrated that selenite-loaded CS/TPP nanoparticles can be 
successfully prepared under mild conditions via ionic gelation method. Physicochemical 
properties, such as particle size, surface charge, encapsulation efficiency, and controlled 
release can be modulated by controlling critical fabricating parameters including the CS and 




improve the in vitro antioxidant properties, compared with free selenite. After coated with 
zein, the encapsulation efficiency was greatly increased and release profile was dramatically 
retarded, indicating that zein-coated selenite CS/TPP nanoparticles possess a high potential to 
be developed as an alternative to traditional selenium treatment or supplementation. 
Moreover, the in vitro cytotoxicity evaluation of selenite encapsulated nanoparticle 
formulations are being studied in Dr. Cheng’s lab, which would give further information on 





Chapter 3: Preparation, Characterization of Zein/Chitosan 
Complex for Encapsulation of α-Tocopherol and in vitro 
Controlled Release Study  
Luo, Y., Zhang, B., Whent, M., Yu L., Wang, Q. Colloids and Surfaces B: 
Biointerfaces, 85 (2), 145-152 
 
3.1 Abstract 
Chitosan (CS) nanoparticles coated with zein has been newly demonstrated as a 
promising encapsulation and delivery system for hydrophilic nutrient with enhanced 
bioactivities in our previous study. In this study, a hydrophobic nutrient, α-tocopherol (TOC), 
was successfully encapsulated into zein/CS complex. The fabrication parameters, including 
zein concentration, zein/CS weight ratio, and TOC loading percentage, were systematically 
investigated. The physicochemical structure analysis showed that the electrostatic interactions 
and hydrogen bonds were major forces responsible for complex formation. The scanning 
electron microscopy study revealed the spherical nature with smooth surface of complex. 
TOC encapsulation was also evidenced by differential scanning calorimetry. The particle size 
and zeta potential of complex varied from 200 to 800 nm and +22.8 to +40.9 mV, 
respectively. The kinetic release profile of TOC showed burst effect followed by slow 
release. Compared with zein nanoparticles, zein/CS complex could provide better protection 
of TOC release against gastrointestinal conditions, due to CS coatings. Zein/CS complex is 
believed to be a promising delivery system for supplementation or treatment of hydrophobic 





Vitamin E is the main dietary fat-soluble antioxidant, playing important roles in the 
body. It is a family of four tocopherols (α, β, γ, and δ) and four corresponding tocotrienols (α, 
β, γ, and δ), of which α-tocopherol (TOC) has the highest biological activity.  Vitamin E acts 
as a chain-breaking antioxidant preventing the propagation of free radical reactions, and thus 
consumption of vitamin E has been widely considered to help reduce risk of many chronic 
diseases, such as cardiovascular diseases (Herrera & Barbas, 2001; Tucker & Townsend, 
2005). Although the overt deficiency of vitamin E is rare in humans, the marginal vitamin E 
deficiency could lead to increased susceptibility to free radical damage, especially in 
premature infants and hypercholesterolemic subjects, resulting in neuromuscular 
abnormalities, myophthies, and other neurological diseases (Brigelius-Flohe & Traber, 1998; 
Simon, Paul, Atger, Simon, & Moatti, 1998). Therefore, supplementation of vitamin E is 
required in aforementioned cases. However, like other lipophilic nutraceuticals, TOC is 
poorly soluble in water and biologically unstable when exposed to environmental factors, 
such as light, temperature, and oxygen (Miquel, Algeria, Barbera, Farre, & Clemente, 2004; 
Sabliov, Fronczek, Astete, Khachaturyan, Khachatryan, & Leonardi, 2009). 
In order to overcome the susceptibility and improve the stability of bioactive 
compounds during processing and storage, the emerging technology of nano-/micro-
encapsulation has been recently applied in food and nutraceutical industries. Besides 
protecting them from the harsh processing conditions and adverse storage environment, the 
encapsulations of bioactive compounds can also achieve targeted delivery and controlled 
release of entrapped nutrients to the specific site. TOC has been early encapsulated into 
gliadin, a plant protein from wheat gluten, to form microparticles around 900 nm, however, 
the controlled release was only performed in organic medium (decane) at 25 oC, which is 




Nakache, 2002). The controlled release of TOC in simulated gastric fluid (SGF) and 
simulated intestinal fluid (SIF) without enzymes could be achieved by microencapsulation of 
TOC in calcium-alginate gels (Yoo, Song, Chang, & Lee, 2006) and calcium-pectinate 
microcapsules (Song, Lee, & Lee, 2009).  The in vivo study also revealed that encapsulation 
of TOC in calsium-pectinate microcapsules could provide sustained release of TOC in plasma 
and thus improve the bioavailability of TOC through oral administration. A new study 
showed that free TOC decomposed rapidly when it was incubated in simulated 
gastrointestinal tract (SGI) with presence of enzymes, however, its stability was dramatically 
improved after encapsulated into ß-lactoglobulin emulsion gels (Liang, Line, Remondetto, & 
Subirade, 2010). Therefore, encapsulation of TOC by polymer-based delivery systems could 
not only improve the stability and controlled release of TOC in vivo but also enhance the 
bioavailability of TOC in vivo. To the best of our knowledge, however, most delivery 
systems of TOC with controlled release are at micro-scale beads or gels; the encapsulation 
and delivery systems at nano-scale have not been fully developed and characterized. 
Zein is considered as generally recognized as safe (GRAS) and food-grade ingredient 
by the Food and Drug Administration (FDA). It contains three quarter of lipophilic and one 
quarter of hydrophilic amino acid residues. Because of its high hydrophobicity, zein has been 
successfully applied as a promising carrier for encapsulation and controlled release of fat-
soluble compounds (e.g. gitoxin, fish oil, etc.) in the pharmacuetical and food areas 
(Muthuselvi & Dhathathreyan, 2006; Zhong, Tian, & Zivanovic, 2009). Chitosan (CS) is a 
linear polysaccharide consisting of randomly distributed N-acetyl-D-glucosamine and ß-(1-
4)-linked D-glucosamine units. CS has been widely considered as a versatile polymer used in 
pharmaceutical and nutraceutical areas as wall materials for development of delivery systems, 
due to its favorable biological properties such as biodegradability, biocompatibility, and low 




systems, nano- or micro-particles prepared by CS have a special feature of being able to 
adhere to mucosal surface and transiently open tight junction between epithelial cells, due to 
its positive surface charge of CS molecules. In recent years, CS has been involved in delivery 
systems of TOC. For instance, CS has been used as a wall material to coat TOC encapsulated 
liposome nanoparticles, resulting in a great improvement of TOC stability, compared with 
non-coated liposome nanoparticles (Liu & Park, 2009). Also, it has recently been shown that 
TOC encapsulated CS nanoparticles can be successfully prepared by ultrasound 
(Naghibzadeh, Amani, Amini, Esmaeilzadeh, Mottaghi-Dastjerdi, & Faramarzi, 2010). 
However, it has been shown that CS-tripolyphosphate (CS-TPP) nanoparticles might not 
provide adequate protection and sustained release of small molecular drugs encapsulated in 
gastrointestinal environment, due to the high solubility of CS in aqueous acidic conditions 
resulting in the fast release of encapsulated drugs (Yoksan, Jirawutthiwongchai, & Arpo, 
2010; Luo, Zhang, Cheng, & Wang, 2010). Therefore, in order to overcome these obstacles, it 
would be helpful to introduce a second polymer to form stronger polymeric complex with CS. 
Recently, many studies have been carried out to investigate the preparation, 
characterization, and application of micro-/nanocomplexes formed by two or more polymers 
(Berger, Reist, Mayer, Felt, Peppas, & Gurny, 2004; Wang, & Uludag, 2008). Zein and CS 
complexes have been newly developed to form antimicrobial ultrathin fiber structure by 
electrospinning (Torres-Giner, Ocio, & Lagaron, 2009; Song, Yao, & Li, 2010). However, 
the investigation of polymeric complexes of zein and CS through their self-assembly 
properties is still lacking in the literature. A CS/zein nano-delivery system has been 
successfully developed in our lab to encapsulate hydrophilic nutrient with high bioactivities, 
and the release profile of hydrophilic nutrient from CS nanoparticles can be greatly improved 
after the nanoparticles are coated by zein protein (Luo et al., 2010). In present study, a novel 




protection of TOC against gastrointestinal conditions and controlled release. The various 
formulations with different zein concentrations, ratios of zein/CS, and loading concentrations 
of TOC were investigated. Characterization was carried out by evaluating the particle size, 
zeta potential, and encapsulation efficiency of TOC/zein-CS complexes. The molecular 
interactions were investigated by Fourier transform Infrared spectroscopy (FTIR) and 
differential scanning calorimetry (DSC). The controlled release of encapsulated TOC in 
different media with or without presence of enzymes was also studied. 
3.3 Materials and Methods 
3.3.1 Materials 
Low molecular weight CS with 92% deacytelation degree (Batch No.: MKBB4232), 
vitamin E (TOC, Fluka >= 97%), Tween-20 (Tw), and pepsin were obtained from Sigma-
Aldrich Chemical Co. Ltd. (St. Louis, MO). Zein sample with a minimum protein content of 
97% was provided by Showa Sangyo (Tokyo, Japan). Phosphate buffer saline (PBS) was 
purchased from EMD Chemicals Incorporation (Gibbstown, NJ). Simulated gastric fluid 
without pepsin (SGF) and simulated intestinal fluid with pancreatin (SIF) were purchased 
from RICCA chemical company (Arlington, TX). All other reagents were of analytical grade. 
3.3.2 Preparation of TOC-Encapsulated Zein-CS (TOC/Zein-CS) Complex 
Different amount of TOC was first encapsulated into zein by adding TOC (dissolved 
in pure ethanol) dropwise to zein (dissolved in 75% ethanol) solutions with magnetic stirring 
at 600 rpm for 60 min. CS with different concentrations dissolved in 1% acetic acid was then 
added to the above solution dropwise with magnetic stirring for 60 min, followed by adding 
Tw solution (1% in ethanol) dropwise with magnetic stirring for another 60 min. The final 
concentration of Tw was 0.44%. The different formulations prepared in this study were 




size, zeta potential, and encapsulation efficiency measurements. Samples for release profile 
measurements were freeze-dried right away after ethanol was removed under nitrogen stream 
using a nitrogen evaporator (N-EVAP 111, Organomation Associates, Inc., MA), and stored 
at -20 oC for further assay. TOC-encapsulated zein nanoparticle without CS coating 
(TOC/zein) was prepared as control nanoparticles, zein-CS complex without TOC was 
prepared as blank complex. 
 
Table 3.1. Different formulations of complex developed in this study 
Samples Zein (mg/ml) TOC loading percentage Weight ratio of zein/CS 
A1 5 
20% 10/1 A2 10 
A3 15 
A4 20 















3.3.3 Fourier Transform Infrared Spectroscopy (FTIR) and Differential Scanning 
Calorimetry (DSC) 
The chemical structure of zein, CS, TOC, Tw, TOC/zein nanoparticles, and 
TOC/zein-CS complex were monitored by FTIR of Jasco 4100 series with an attenuated total 




tray for 24 h, and then mounted onto ATR crystal directly. The spectra were acquired at 550-
4000 cm-1 wavenumbers with a 4 cm-1 resolution.  
DSC analysis of pure zein, CS, zein-CS physical mixture, TOC/zein nanoparticles, 
TOC/zein-CS complex were performed using Differential Scanning Calorimeter (Pyris-1, 
Perkin-Elmer, Waltham, MA), calibrated with indium. Each sample (5 mg) was placed onto a 
standard aluminum pan, crimped and heated from room temperature to 250 oC, with constant 
heating rate 10 oC/min under continuous purging of nitrogen (20 ml/min). An empty sealed 
aluminum pan was applied as baseline. 
3.3.4 Morphology Observation 
Morphological structures of zein, CS, TOC/zein nanoparticles and TOC/zein-CS 
complex were obtained by a scanning electron microscopy (SEM, Hitachi SU-70 Pleasanton, 
CA). Samples were first cast-dried on an aluminum pan before cutting into an appropriate 
size, and then adhered to conductive carbon tapes (Electron Microscopy Sciences, Ft. 
Washington, PA). Subsequently, they were mounted on specimen stubs and coated with a 
thin (<20 nm) conductive gold and platinum layer using a sputter coater (Hummer XP, 
Anatech, CA). Representative SEM images were reported. 
2.3.5 Particle Size and Surface Charge 
The freshly prepared complex samples at pH range of 5.3‒5.5, TOC (4 mg/ml) 
dissolved in pure ethanol solution at pH 5.9, and zein solutions (10 mg/ml) dissolved in 75% 
ethanol solution at pH 5.8 were used for particle size and zeta potential measurement. 
Hydrodynamic diameters of different treatments were measured by a dynamic light scattering 
instrument (DLS, BI-200SM, Brookhaven Instruments Corp., Holtsville, NY). DLS is 
equipped with a 35mW HeNe laser beam at a wavelength of 637 nm. All DLS measurements 




Doppler velocimetry (Zetasizer Nano ZS90, Malvern, UK), using a fold capillary cuvette 
(Folded Capillary Cell - DTS1060, Malvern, UK).  Zeta potential was expressed by zeta 
potential, which was converted from the measured electrophoretic mobility using the 
Smoluchowski theory. All the measurements were performed in three replicates. 
3.3.6 Encapsulation Efficiency (EE) 
The encapsulation efficiency was defined as the drug content that is entrapped into 




The total TOC amount was the added TOC. The free TOC was obtained using a 
membrane separation method with an Ultra-15 centrifugal filter device (Millipore Corp., Ann 
Arbor, MI), as described in previous studies (Luo et al., 2010; Hu, Pan, Sun, Hou, Ye, Hu, & 
Zeng, 2008). Being centrifuged at 4000 × g for 30 min, free TOC would penetrate into the 
filtrate receiver, and the TOC encapsulated in zein nanoparticles or TOC/zein-CS complex 
would stay in the filter unit. Free TOC obtained in the filtrate was first dried by nitrogen 
stream to remove ethanol and extracted by hexane to appropriate concentration, and then 
vortexed thoroughly. The absorbance at 297 nm was measured with a UV/vis 
spectrophotometer (Beckman Coulter, DU-730, Fullerton, CA) (Somchue, Sermsri, 
Shiowatana, & Siripinyanond, 2009). The amount of TOC was calculated by appropriate 
calibration curve of free TOC in hexane (R2=0.9994). The encapsulated TOC retaining in the 
filter unit were then lyophilized for further characterization. All measurements were 




3.3.7 In vitro Release 
After removal of free TOC by membrane separation, the complex samples were then 
freeze-dried and subjected for in vitro release profile test to investigate the effect of CS 
coating. Certain amount of complex samples with or without CS coatings were incubated in 
30 ml PBS (pH 7.4) containing Tw (0.5% w/v) to increase TOC solubility, at 37°C. Release 
medium from each sample was periodically removed and replaced with fresh PBS (pH 7.4) 
containing Tw. The removed medium was first dried under nitrogen stream and then TOC 
was extracted by hexane. The resultant extract was analyzed using an UV-visible to measure 
TOC content as described in section 2.3.6. The accumulative release was plotted as a function 
of incubation time (up to 6.5 h). Each experiment was carried out in three replicates. The 
kinetic release profile of TOC in PBS medium was reported. 
The release profile of TOC in simulated gastrointestinal (SGI) tract containing 
enzymes was also evaluated, using the method as previously reported (Liu, Sun, Wang, 
Zhang, & Wang, 2005). The treatment of SGI tract conditions refers to dissolution carried out 
in SGF for 0.5 h followed by SIF for 6 h. The complex samples were first incubated in 30 ml 
SGF with 0.1% pepsin (w/v) at 37°C under mild stirring for 0.5 h. The digestion was stopped 
by raising pH to 7.5 with NaOH. The supernatant was separated from the swollen aggregates 
by centrifugation. The released TOC content was analyzed as aforementioned. Subsequently, 
the swollen aggregate was then digested by 30 ml of SIF with 1.0% pancreatin (w/v) at 37°C 
under mild stirring for 6 h. The release medium was periodically withdrawn and fresh SIF 
was replaced to release system. TOC content was analyzed and accumulative percentage of 





3.4 Results and Discussion 
3.4.1 Physicochemical Characterization 
2.4.1.1. FTIR Study 
FTIR was applied to characterize the intermolecular interactions of complex. The 
representative spectra of each component and their composites were shown in Fig. 3.1. In the 
original spectra of zein (Fig. 3.1A), CS (Fig. 3.1B), and TOC (Fig. 3.1C), the bands of 
hydrogen bonds were at 3312, 3368, and 3477 cm-1, respectively. However, after formation of 
complex, shift of hydrogen bands occurred, and the peaks were at 3312, 3309, 3315 cm-1 in 
the spectra of TOC/zein nanoparticles, zein-CS blank complex, TOC/zein-CS complex, 
respectively. Hydrogen bonds can be formed between amide groups of glutamine in zein and 
hydroxyl groups in TOC. CS has both amide and hydroxyl groups, thus the hydrogen bonds 
can be easily formed between CS and TOC, CS and zein. Particularly, the hydrogen bonds of 
TOC at 3477 cm-1 disappeared and merged into the intensifier vibration at 3312 and 3315 cm-
1 in TOC/zein nanoparticles and TOC/zein-CS complex, respectively, showing that strong 
hydrogen bonds formed between TOC and zein or zein/CS complex systems. Additionally, as 
both TOC and zein are hydrophobic compounds, the hydrophobic attraction could be another 






Fig. 3.1. FTIR spectra of individual components and their complex samples.  
A, zein, powder; B, α-tocopherol, original oil droplets; C, CS, powder; D, TOC/zein 
nanoparticles, sample B1; E, zein-CS blank complex, sample B3 without TOC; F, TOC/zein-
CS complex, sample B3. Refer to Table 3.1 for the abbreviation of each formulation. 
 
Another peak area of interest was between 1500 to 1700 cm-1, representing amide I 
and amide II groups. Comparing the spectra of zein with TOC/zein nanoparticles, the bands 
of amide I and amide II groups shifted from 1664 and 1550 to 1660 and 1547 cm-1, 
respectively, suggesting that the electrostatic interactions be another intermolecular force 
between TOC and zein. Compared with zein , the bands of amide I and amide II groups 
shifted to 1657 and 1542 cm-1 (Fig. 3.1E), respectively, in zein-CS blank complex, indicating 
the electrostatic interactions between zein and CS. Further shift of these bands occurred after 
TOC was encapsulated into complex, as shown in Fig. 3.1F. The electrostatic interactions 
among zein, CS, and TOC were further confirmed by zeta-potential measurement in the 
following section. 
3.4.1.2 DSC Thermal Analysis 
DSC thermograms of zein (Fig. 3.2A) and CS (Fig. 3.2B) showed characteristic 
endothermic peaks at 73.2 and 91.2 oC, respectively. These endotherms for zein and CS could 




other studies indicating the strong affinity between polymer and water (Dudhani & Kosaraju, 
2005; Parveen, Mitra, Krishnakumar, & Sahoo, 2010). Compared with CS, the first 
endotherms of TOC/zein nanoparticles (Fig. 3.2D) and TOC/zein-CS complexes (Fig. 3.2E) 
shifted to lower temperature, indicating lower affinity with water, perhaps due to the 
encapsulation of hydrophobic molecules. It was reported that the shift of endothermic peak in 
CS and CS derivatives was associated with the strength of water-polymer interactions as well 
as water holding capacity (Kittur, Prashanth, Sankar, & Tharanathan, 2002). Therefore, the 
presence of hydrophilic group could increase the bindings of water molecules to polymer 
network and consequently increase the content of bound water; whereas the presence of 
hydrophobic groups could thus decrease the content of bound water. Similar observation was 
also reported that the encapsulation of essential oil into chitosan/cashew gum beads resulted 
in the shift of endothermic peak to lower temperature (Paula, Sombra, Cavalcante, Abreu, & 
de Paula, 2011). 
 
 
Fig. 3.2. DSC thermograms of pure polymers and their complex samples.  
A, Zein, powder; B, CS, powder; C, Zein-CS physical mixture, powder; D, TOC/zein 





3.4.2 Morphological Observation 
The morphological observation of zein, CS, TOC/zein nanoparticles and TOC/zein-
CS complex were performed by SEM after samples were cast dried on an aluminum surface. 
The representative photographs were shown in Fig. 3.3. The self-assembled zein 
nanoparticles with diameter around 500 nm formed by cast drying (Fig. 3.3A). This 
observation was consistent with our previous study (Zhang, Luo, & Wang, 2011).  As shown 
in Fig. 3.3B, a rough membrane structure was observed after CS was cast dried, indicating 
the film-forming ability of pure CS and its potential to be applied as a coating material. 
TOC/zein nanoparticles exhibited nanospheres with smooth surface (Fig. 3.3C), however the 
diameter was not homogenous varying from 300 to 1000 nm. Furthermore, TOC/zein 
nanoparticles formed the dark core and bright shell structure under SEM observation. The 
color contrast might be caused by evaporation of TOC, an oil molecule, under vacuum 
condition of SEM. This similar structure was also reported by other studies of oil-
encapsulated micro-/nanoparticles (Naghibzadeh, et al., 2010; Klaypradit, & Huang, 2008). 
As shown in Fig. 3.3D, TOC/zein-CS complex formed sphere nanoparticles with smooth 
surface and much smaller and more homogeneous diameter (around 400-500 nm), compared 
with TOC/zein nanoparticles. The reduced particle size might be contributed by the 
electrostatic interactions between TOC/zein nanoparticles and CS molecules. CS molecules 
carried high positive surface charge, which could interact with TOC/zein nanoparticles 
carrying small negative charges, thus facilitate a thin membrane coated at the surface of 






Fig. 3.3. Scanning electron microscopy (SEM) of single ingredients and their complex 
samples.  
A, Zein, 10 mg/ml; B, CS, 1.0 mg/ml; C, TOC/zein nanoparticles, sample B1; D, TOC/zein-
CS complex, sample B3.  
 
3.4.2 Effect of Formulations on Particle Size 
 The effects of different formulations on particle size and polydispersity index (PDI) 
of complex were summarized in Table 3.2. As zein concentration increased from 5 to 15 
mg/ml, particle size of TOC/zein nanoparticles decreased from 444.6 to 351.0 nm. However, 
particle size increased to 537.2 nm as zein concentration increased to 20 mg/ml. At low 
concentration of zein with low TOC loading and CS concentrations, the oil molecules might 
mainly deposit on the surfaces of zein spheres leading to the large hydrodynamic size of 
complex. As further increase of TOC content and CS concentration, TOC might migrate to 
the internal parts of the complex resulting in a decrease of hydrodynamic diameter. However, 




increase due to the formation of larger self-assembled nanospheres. This interesting 
phenomenon has also been reported by Naghibzadeh et al. (2010), demonstrating that particle 
size of TOC-loaded CS nanoparticles decreased with increase of TOC content in the 
formulation. With the increase of CS concentrations and TOC loading percentage, particle 
size of TOC/zein-CS complex increased from around 200 to 800 nm, indicating denser 
complex formed at greater concentrations. All samples had a small PDI less than 0.3 except 
for TOC/zein nanoparticle which had a greater PDI of 0.45. This indicated that the particle 
size of TOC/zein nanoparticles was not as homogenous as other formulations, which was 
consistent with the SEM results (Fig. 3.3). 
 
Table 3.2 Particle size, surface charge, and encapsulation efficiency of different samples 
 
Samplesa Particle size (nm) PDI Zeta potential Encapsulation Efficiency 
A1 444.6 ± 7.9 0.24 ± 0.01 37.7 ± 1.4 76.6 ± 1.2 
A2 364.1 ± 9.2 0.21 ± 0.02 30.8 ± 0.5 82.3 ± 0.5 
A3 351.0 ± 11.2 0.31 ± 0.04 35.6 ± 1.0 84.3 ± 0.6 
A4 537.2 ± 10.0 0.25 ± 0.02 33.6 ± 1.4 86.5 ± 0.3 
B1 795.9 ± 8.4 0.45 ± 0.02 -2.8 ± 0.5 82.5 ± 2.6 
B2 211.3 ± 19.1 0.20 ± 0.01 22.8 ± 2.2 81.3 ± 1.7 
B3 364.1 ± 9.2 0.21 ± 0.01 30.8 ± 1.0 82.3 ± 0.5 
B4 862.1 ± 29.0 0.38 ± 0.02 40.9 ± 1.0 85.0 ± 1.3 
C1 294.9 ± 9.7 0.14 ± 0.04 28.3 ± 0.9 87.7 ± 0.9 
C2 364.1 ± 9.2 0.19 ± 0.03 30.8 ± 1.0 82.3 ± 0.5 
C3 811.4 ± 17.3 0.15 ± 0.05 32.7 ± 1.1 81.3 ± 0.7 
Note: a Refer to Table 3.1 for the abbreviation of each formulation. Values are expressed as 
mean ± standard error (n=3). 
 
 
Interestingly, the particle size of TOC/zein nanoparticles without CS coating was 
around 800 nm; however, particle size decreased to around 364 nm after coating with CS, at 
the equivalent zein concentration (10 mg/ml) and TOC loading percentage (20%). This 




TOC/zein nanoparticles and CS. As the increase of CS concentration or TOC loading 
percentage, the particle size of complex incremented gradually to around 800 nm (sample B4 
and C3), which might be caused by the excess of CS and TOC concentration. Similar 
observations were also reported by other studies, showing that CS concentration as well as 
CS molecular weight could greatly affect the particle size (Hu et al., 2008; Gan & Wang, 
2007). It is well known that reducing the particle size of encapsulated delivery system could 
improve the uptake of encapsulated drug from nano-/microparticles in cells.  As reported in a 
recent study, encapsulation of vitamin E into polyethylene glycol-based nanospheres 
improved the efficacy of vitamin E against oxidative stress, compared with unencapsulated 
vitamin E (Shea, Ortiz, Nicolosi, Kumar, & Watterson, 2005). Thus, it was proposed that 
coating TOC/zein nanoparticles with CS might contribute to better absorption and enhanced 
efficacy than uncoated TOC/zein nanoparticles. Further study needs to be conducted to 
confirm this expectation. 
3.4.3 Effect of Formulations on Zeta Potential 
Opposite surface charge of two compounds is one of the major forces when they are 
mixing together to form nanoparticles or complex. Surface charge, as expressed by zeta 
potential, of each formulation and pure ingredient was shown in Table 3.2. The TOC/zein 
nanoparticle (B1) was found to be slight negatively charged with zeta potential of -2.8 mV. 
Although the driving force between TOC and zein was considered as hydrophobic 
interactions, the electrostatic interactions might also contribute to the encapsulation of TOC 
into zein Because it was found that TOC and zein carried opposite charge, although the 
charge density of each was not high (+13.1 and -2.8 mV, respectively). After TOC /zein 
nanoparticles were coated by CS, the zeta potential of complex became highly positive in the 
range of +22.8 to +40.9 mV. These observations confirmed that CS was successfully coated 




potential of the complex samples slightly augmented with the increase of TOC loading 
percentage, which evidenced the electrostatic interactions between TOC and zein. The similar 
observation was also revealed in other studies (Naghibzadeh et al., 2010; Hatanka, 
Chikamori, Sato, Uchida, Debari, Onoue, & Yamada, 2010). By studying on the 
encapsulation of TOC in negatively charged polymeric systems (i.e. water soluble CS 
nanoparticles and lecithin nano-emulsion), it was found in their studies that the increase of 
TOC content in nanoparticles could interact and offset the negative charges, and consequently 
change the zeta potential to a less negative value. 
High positive zeta potential demonstrated the potentiality of TOC-zein/CS complex 
as a promising targeted delivery system of TOC in vivo, due to the interactions with 
negatively charged biological membranes with improved stability in the presence of 
biological cations. The mucoadhesive ability of CS nanoparticles could improve the 
adsorption/bioavailability of drugs or nutrients with poor absorption characteristics. For 
example, selenite-loaded CS nanoparticles has been demonstrated to have better efficacy of 
delivering selenium into cells and also to provide better protection of cells against selenium-
induced DNA damage response, compared with free selenium (Zhang, Luo, Zeng, Wang, 
Tian, Song, & Cheng, 2011). Duan and cowkers studied the synthesis of CS-coated curcumin 
nanoparticles with high positive zeta potential and also the in vivo evaluation of CS-coated 
nanoparticles using animal model (Duan, Zhang, Han, Chen, Li, Liao, et al., 2010). Higher 
plasma concentration of curcumin was discovered in animals treated with intravenous 
injection of CS-coated nanoparticles, compared with uncoated nanoparticles. Because the 
positive surface charge on nanoparticles could prolong the retention of drug in the blood 




3.4.4 Effect of Formulationson EE 
The encapsulation efficiency of different formulations was also demonstrated in 
Table 3.2. It was observed that the higher zein concentration or CS content in the 
formulation, the greater encapsulation efficiency of TOC, in the range of 76.5 to 86.5%. As 
TOC loading percentage increased from 10 to 30%, encapsulation efficiency of TOC in 
zein/CS complex slightly decreased from 87.7 to 81.3%, which might be due to the excessive 
loading of TOC. This phenomenon was also observed in other polymeric matrices that over-
loading of encapsulated material will cause a decrease of encapsulation efficiency (Liu et al., 
2009; Shah, Pal, Kaushik, Devi, & 2009). It was found that there was no significant 
difference between the encapsulation efficiency of TOC/zein nanoparticles and TOC/zein-CS 
complex. This result suggested that CS coating did not affect the encapsulation efficiency of 
TOC/zein nanoparticles, maybe because TOC had been encapsulated into zein nanospheres 
before CS coating was applied. 
3.4.5 Release Profile  
3.4.5.1 Kinetic Release Profile of TOC in PBS medium 
The kinetic release profiles of complex with different formulations were investigated 
in PBS medium, and results were shown in Fig. 3.4. The kinetic release profile of TOC from 
complex can be described as a two-step biphasic process, i.e., an initial burst effect followed 
by subsequent slower release. Fig. 3.4A presented the kinetic release profile as a function of 
zein concentration, which was found to be concentration dependent. At low concentration of 
zein (5 mg/ml), burst effect occurred within 1.5 h and more than 85% encapsulated TOC 
released from the complex. As zein concentration increased, the burst effect was dramatically 
alleviated and the accumulative release after 6.5 h was reduced from 93 to 55%, as zein 





 Fig. 3.4. Kinetic release profiles of TOC from zein/CS complex in PBS medium.  
A, effect of zein concentration (mg/ml); B, effect of weight ratio of zein/CS; C, effect of TOC 
loading percentage. Values were expressed as mean ± standard error (n=3). 
 
Fig. 3.4B demonstrated kinetic release profile of TOC with different weight ratio of 




ratio of zein/CS decreased, and only about 30% of TOC released out due to burst effect in the 
formulation with lowest zein/CS weight ratio as 5/1. The accumulative release was also 
greatly reduced as increase of CS content in the formulation. However, in the formulation 
with highest zein/CS weight ratio, the burst effect was even greater than TOC/zein 
nanoparticles without CS coating, although their accumulative release of TOC after 6.5 h was 
similar. This could be mainly attributed to the particle size of these two formulations. 
Complex with smaller particle size would have greater surface-to-volume ratio, thus may 
result in fast release of TOC adsorbed on the surface. Another possible reason was that the 
electrostatic and hydrogen bond interactions between zein and CS were not strong enough to 
act as a barrier against hydrophilic environment due to the low concentration and hydrophilic 
property of CS. But when the zein/CS weight ratio decreased further to 10/1 and 5/1, 
TOC/zein-CS complex was able to improve the kinetic release profiles compared with 
TOC/zein nanoparticles without CS coatings.  
The kinetic release profile of TOC/zein-CS complex with different TOC loading 
percentage was shown in Fig. 3.4C. With increase of TOC loading percentage, both burst 
effect and accumulative release of TOC were improved. When loading percentage was 30%, 
TOC content released due to burst effect and accumulative release was less than 30% and 
40%, respectively. Zein, as a protein, possessed the ability to capture the oil molecule and 
formed a film structure to wrap it. As more oil molecules exist in the system, zein protein 
would form thicker film to capture them, resulting in augment of particle size (Table 3.2) and 
thicker and denser complex with slow release profile. 
3.4.5.2 Accumulative Release Profile in SGI 
To speculate release profile of TOC from complex in vivo, all formulations were 
subjected to release measurement in SGI tract with presence of pepsin and pancreatin for 6.5 




3.5A), weight ratio of zein/CS (Fig. 3.5B), and TOC loading percentage (Fig. 3.5C). The 
release in SGF was mainly due to the enzymatic breakdown of zein resulting in the collapse 
of complex and the solubility of CS at low pH value. With increase of zein concentration or 
decrease of zein/CS weight ratio, the accumulative release of TOC in SGF reduced gradually 
(Fig. 3.5A and 3.5B). In the formulation with the smallest zein/CS weight ratio of 5/1, the 
release of TOC in SGF was only 30%. With thicker CS coating, it took longer for pepsin to 
pass through CS coating and hydrolyze zein, thus encapsulated TOC diffused from complex 
more slowly. The slow release may also be attributed to greater particle size of this 
formulation. The similar observation was also reported by Somchue et al. (2009), pointing 
out that by coating with a polysaccharide the release of TOC from protein-based delivery 
particles could be significantly retarded, and higher concentration of coating material showed 
better protection effect against SGI conditions. In particular, it was also reported that the 
hydrophilic shell may prevent aggregation and enzymatic degradation of the protein in 
biological fluids and consequently provide better protection of encapsulated ingredients 
(Kim, Chae, Jin, Sivasubramanian, Son, Choi, et al., 2010). The difference of release profile 
in SGF between TOC/zein nanoparticles and TOC/zein-CS complex at equivalent zein 
concentration and TOC loading percentage (Fig. 3.5B) was similar with kinetic release 
profile (Fig. 3.4B) in PBS as discussed above. The release in SGF was also reversely 





Fig. 3.5. Accumulative release profiles of TOC from TOC/zein-CS complex with 
different formulations in SGI with presence of enzymes.  
A, effect of zein concentration; B, effect of weight ratio of zein/CS; C, effect of TOC loading 
percentage. (The standard error of each measurement was within 10% of the mean, n=3).  
The treatment of SGI tract conditions refers to dissolution carried out in SGF with 0.1% 





After incubation in SGF for 0.5 h, all samples were further subjected to incubation in 
SIF with pancreatin for 6 h. The effects of zein concentrations and weight ratio of zein/CS on 
accumulative release of TOC in SIF were similar with their effects in SGF.  However, as 
increase of TOC loading percentage, there was an increase of TOC content released in SIF. 
This could be attributed to that as the polymeric matrix was hydrolyzed or eroded by 
enzymes, TOC in the inner part of matrix was exposed and more ready for release. Compared 
with TOC content released in SGF, it was found that much less TOC content released in SIF. 
According to a study of Liang et al. (2010), it was found that releasing rate of TOC from ß-
lactoglobulin emulsion gels was rather slow in SIF, compared with SGF. They proposed that 
the products of partial hydrolysis of ß-lactoglobulin formed after digestion in SGF may act as 
an emulsifier and adsorb to the oil droplet surfaces and thereby increase the resistance to be 
digested in SIF. Thus, the slow release profile of TOC from zein/CS complex observed in this 
study may also be explained by a similar mechanism that the hydrolytes of zein may adsorb 
to TOC droplet and therefore retard the release of TOC in SGF. 
3.4.6 Schematic Illustration 
 
Fig. 3.6. Schematic illustration of formation of zein/chitosan complex for encapsulation 
of TOC. 
 
Recently, polymer complexes or composites have drawn increasing interests. Due to 
cationic properties of CS, many anionic natural polymers have been intensively investigated 




alginate, carrageenan, pecin, xanthan gum, hyaluronic acid, etc (Hamman, 2010; Saether, 
Holme, Maurstald, Smidsrod, & Stokke, 2008). In this study, although zein only carried a few 
negative charges, the prepared zein/CS complex might still be considered as a polyelectrolyte 
complex based on our results. Herein, a schematic illustration for the formation of TOC 
encapsulated zein-CS complex was proposed and shown in Fig. 3.6. As TOC was added to 
zein solutions, zein molecules would wrap up TOC to form a thin film on its surface, and the 
forces of hydrogen bonds and hydrophobic attraction between two molecules could induce 
the formation of TOC encapsulated nanoparticles with relatively large particle size about 800 
nm. As soon as CS solution was added to the system, the positively charged CS would 
interact with negatively charged TOC/zein nanoparticles; CS coating around the surface of 
TOC/zein nanoparticles would then be formed and consequently disperse them into uniform 
and smaller size nanoparticles with diameter about 200-300 nm. At the same time, with the 
formation of smaller complex, some of TOC would become only adsorbed to the surface of 
complex resulting in fast release, which can be compromised by thicker CS coatings. 
3.5 Conclusion 
In the present study, TOC/zein-CS complex was successfully prepared under mild 
conditions. Physicochemical analyses suggested that electrostatic interactions, hydrogen 
bond, and hydrophobic interactions are the main forces in TOC/zein-CS complex. By coating 
TOC/zein nanoparticles with CS, particle size was dramatically reduced and zeta potential 
was increased to be highly positive, depending on different formulations. CS coating did not 
affect the encapsulation efficiency but greatly improved the controlled release of TOC in both 
PBS and SGI conditions, indicating that TOC/zein-CS complex can be developed as a novel 
TOC supplementation or treatment. In near future, the in vitro and in vivo evaluation of 





Chapter 4: Development of Zein Nanoparticles Coated with 
Carboxymethyl Chitosan for Encapsulation and Controlled 
Release of vitamin D3 
Luo, Y., Teng, Z., Wang, Q. Journal of agricultural and food chemistry, 60 (3), 836-
843 
4.1 Abstract 
In this study, zein nanoparticles coated with carboxymethyl chitosan (CMCS) 
were prepared to encapsulate vitamin D3 (VD3). VD3 was first encapsulated into 
zein nanoparticles using a low-energy phase separation method, and coated with 
CMCS simultaneously. Then, calcium was added to crosslink CMCS to achieve 
thicker and denser coatings. The nanoparticles with CMCS coatings had a spherical 
structure with particle size from 86‒200 nm. The encapsulation efficiency was greatly 
improved up to 87.9% after CMCS coating, compared with 52.2% of that using zein 
as a single encapsulant. The physicochemical properties were characterized by 
differential scanning calorimetry and Fourier transform infrared spectroscopy. 
Nanoparticles with coatings provided better controlled release of VD3 in both PBS 
medium and simulated gastrointestinal tract. The photostability against UV-light was 
significantly improved after encapsulation. Encapsulating of hydrophobic nutrients in 
zein nanoparticles with CMCS coatings is a promising approach to enhance chemical 





Vitamin D (VD) is an essential nutrient to human health. It is one of the fat 
soluble vitamins and consists of two major physiologically forms, vitamin D2 
(ergocalciferol) (VD2) and vitamin D3 (cholecalciferol) (VD3). VD is a prohormone 
and can be synthesized from a precursor in the skin under sunlight exposure. Dietary 
source of VD3 is very limited, and only fish are found to be the abundant source 
(Picciano, 2010). Recently, VD has been intensively investigated to be not only 
important for calcium absorption and homeostasis regulation, but also essential for 
many other chronic diseases, such as type 2 diabetes, hypertension, cardiovascular 
disease, etc (Picciano, 2010; Pittas, Chung, Trikalinos, Mitri, Brendel, Patel, et al., 
2010). It was found that for the elderly people in chronic disease and those with 
insufficient exposure to sunlight, VD deficiency is very frequent, especially in the US 
and Europe where 30-60% populations have been diagnosed as VD deficiency 
(Ginter & Simko, 2009). Furthermore, based on the data drawn from National Health 
and Nutrition Examination Surveys (NHANES), it has been shown that the mean 
serum VD status in the year of 2000 – 2004 was significantly lower than that in the 
year of 1988 – 1994 (Looker, Pefeiffer, Lacher, Schleicher, Picciano, & Yetley, 
2008). As a result, FDA encouraged the addition of VD to milk and cereals to prevent 
rickets in children and osteoporosis in adults. Also, the Recommended Daily 
Allowance of VD in Dietary Guideline for Americans newly released by USDA in 
2010 has increased to 600 IU per day for children and 800 IU per day for most adults 




number of evidence has demonstrated that the increasing attention and importance 
have been given to improve VD status. 
 As a lipophilic vitamin, VD is not soluble in water and very sensitive to 
various environmental factors. For example, light, heat, and oxygen could rapidly 
induce isomerization or oxidation of VD3, and then adversely affect its chemical 
structure and physiological benefits (Nelson, Ballard, Zhu, & Seburg, 2007). In recent 
development in food and nutraceutical industries, encapsulation of lipophilic 
bioactive compounds has received tremendous interests as this technology is able to 
constitute an appropriate mean to increase their stability and preserve health-
promoting properties during processing and storage (Huang, Yu, & Ru, 2010). 
Another benefit of encapsulation is that it might further provide target delivery and 
controlled release of nutraceuticals, thus enhancing bioactivity and diminishing side-
effects of potential hypervitaminosis due to high administration dose (Gonnet, 
Lethuaut, & Boury, 2010). Although the encapsulation of VD has been reported since 
1998 (Delaurent, Siouffi, Pepe, 1998), many disadvantages still exist, inhibiting 
further application and industrialization of VD supplementation. For instance, 
encapsulation of VD3 into cyclodextrin involved high temperature (50oC) during the 
preparation which would cause loss of VD3 (Delaurent, 1998). Microencapsulation of 
VD2 has been later developed using chitosan/ethylcellulose complex microcapsule by 
Shi and Tan (2002). In their study, although high encapsulation efficiency (>95%) 
and controlled release were achieved, the toxic solvents were used, such as 
tetrachloride and petroleum ether, which would pose potential side effects to final 




encapsulate VD2 into a natural nano-capsular vehicle prepared with bovine casein 
micelle (Semo, Kesselman, Danino, & Livney, 2007). However, it was found that the 
loading capacity (vitamin/protein ratio) was as low as 0.05% which means large 
amount of protein is needed to encapsulate a few amount of vitamin, and only around 
27.5% of VD2 was incorporated into micelles and the rest of vitamin was only bound 
to the surface of casein molecules, resulting in little protection against UV exposure. 
 Zein is a maize prolamine protein with three quarter of lipophilic and one 
quarter of hydrophilic amino acid residues, leading to its unique aqueous-alcohol 
solubility and film forming property. Zein has been extensively investigated for its 
capability to form self-assemble nanoparticles encapsulating bioactive compounds in 
food and pharmaceutical applications, such as fish oil (Zhong, Tian, & Zivanovic, 
2009), essential oil (Parris, Cooke, & Hicks, 2005), gitoxin (Muthuselvi & 
Dhathathreyan, 2006), and fluorouracil (Lai & Guo, 2011). Chitosan (CS),  a natural 
polysaccharide has been considered as a versatile polymer for encapsulation and 
delivery of active ingredients. In order to improve its solubility in neutral pH, its 
derivative, carboxymethyl chitosan (CMCS), is widely used for biomedical 
applications. It is soluble in neutral aqueous solution, and it has been shown that 
negatively charged CMCS is able to form nanoparticles spontaneously with positively 
charged ions (Shi, Du, Yang, Zhang, & Sun, 2006). Several bioactive compounds 
have already been successfully encapsulated into CMCS nanoparticles to achieve 
controlled release and target delivery properties (Anitha, Maya, Deepa, Chennazhi, 
Nair, Tamura, et al., 2011; Kim, Jeong, Choi, Roh, Kang, Jang, et al., 2006). CMCS 




to deliver anticancer drug with higher targeting efficiency and longer retention time in 
liver than that of pure drug solution (Wang, Jiang, Li, Liu, Zhang, Wang, et al., 
2008). In addition, it is newly elucidated that negatively charged CMCS nanoparticles 
with particle size around 150 nm had a better in vitro cellular uptake and more 
efficient in vivo targeting delivery of entrapped drug to tumor (He, Hu, Yin, Tang, & 
Yin, 2010). In our previous studies, zein/CS complex nanoparticles were developed 
as delivery systems for both hydrophilic and hydrophobic nutrients (Luo, Wang, 
Zhang, Whent, & Yu, 2011; Luo, Zhang, Cheng, & Wang, 2010). The physico-
chemical properties, including encapsulation efficiency and controlled release profile, 
of complex nanoparticles were greatly improved than nanoparticles prepared by the 
single polymer (i.e. zein or CS). 
 In present study, VD3 was first encapsulated into zein nanoparticles prepared 
by phase separation. Then, CMCS was applied to coat zein nanoparticles and 
hardened by calcium ions. The preparation conditions, such as zein concentration, 
zein/CMCS ratio, as well as CMCS/calcium ratio, were optimized to obtain 
nanoparticles with small particle size, high zeta potential and high encapsulation 
efficiency. The encapsulation of VD3 was evidenced by Diffraction Scanning 
Calorimetry (DSC). The in vitro release profile and stability of VD3 in nanoparticles 
were also studied.   
4.3 Materials and Methods 
4.3.1 Materials 
Vitamin D3 (VD3) of 99% purity was purchased from Alfa Aesar (Ward Hill, MA). 




(Tokyo, Japan). CMCS was purchased from Nantongxingcheng Biological Product Inc., 
Nantong, Jiangsu Province, China), with a deacetylation degree of 96% and carboxylation 
degree of 65%. Phosphate buffer saline was bought from EMD Chemicals Incorporation 
(Gibbstown, NJ). Simulated gastric fluid (SGF) and simulated intestinal fluid with pancreatin 
(SIF) were purchased from RICCA Chemical Company (Arlington, TX). All other materials, 
including pepsin, hexane, ethyl acetate, are of analytical grade and purchased from Sigma–
Aldrich Chemical Co. Ltd. (St. Louis, MO). 
4.3.2 Preparation of Nanoparticles 
Table 4.1. Formulations of nanoparticle complexes. 
Samples VD3 loading Z/CMCS (m/m) CMCS/Ca (m/m) 



















Z, zein, used as 2 mg/ml; CMCS, carboxymethyl chitosan; VD3, vitamin D3. ZV represents 
VD3 encapsulated zein nanoparticles. VD3 loading percentage was calculated as mass ratio 
of VD3 to zein polymer. A0-A20 represent formulations with different mass ratio of 
CMCS/Calcium, prepared with mass ratio zein/CMCS as 1:1. B0-B20 represent formulations 
with different mass ratio of CMCS/Calcium, prepared with mass ratio zein/CMCS as 1:2. C0-
C20 represent formulations with different mass ratio of CMCS/Calcium, prepared with mass 
ratio zein/CMCS as 2:1. 
 
VD3 (1 mg/ml) was dissolved in pure ethanol as stock solution. Zein was dissolved 




method as previously reported with some modifications (Lai et al., 2011). Briefly, 0.3 ml of 
VD3 solution (1 mg/ml) was added dropwise into 2 ml of zein solution (2 mg/ml) with mild 
stirring for 30 min. Then, the above VD3 encapsulated zein solution was rapidly poured into 
5 ml of CMCS solution (0.8, 1.6, or 0.4 mg/ml), dissolved in pure water. After stirring for 30 
min, 1 ml of calcium solution in different concentrations was then dropwise added into the 
above solution. After 30 min stirring, the obtained opaque single phase solution was then 
freeze dried for 48 hours. The control nanoparticles without CMCS and/or calcium were also 
prepared in parallel. Please refer to Table 4.1 for detailed description of various formulations. 
All samples were prepared in triplicate and all procedures were performed in darkness under 
room temperature. 
4.3.3 Fourier Transform Infrared Spectroscopy (FTIR) and Differential Scanning 
Calorimetry (DSC) 
The chemical structure of preparation ingredients (i.e. zein and CMCS) and 
nanoparticles (i.e. ZV, B0, and B20) were monitored by FTIR of Jasco 4100 series with an 
attenuated total reflection (ATR) cell (Jasco Inc. Easton, MO). Samples were first cast-dried 
on an aluminum tray for 24 h, and then mounted onto ATR crystal directly. The spectra were 
acquired at 750-4000 cm-1 wavenumbers with a 4 cm-1 resolution.  
DSC analysis of pure ingredients (i.e. zein, CMCS, and VD3), mixture of zein and 
VD3, and nanoparticles  (i.e. ZV and B20) were performed using TA Q100-DSC thermal 
analyzer (TA Instruments, New Castle, DE), calibrated with indium. The mass ratio of zein 
and VD3 in the physical mixture was the same as that in nanoparticles. Each sample (5 mg) 
was placed onto a standard aluminum pan, crimped and heated from room temperature to 
230oC, with constant heating rate of 10 oC/min under continuous purging of nitrogen (20 




4.3.4 Morphological Observation 
Morphological structures of nanoparticles were observed by a SEM (Hitachi SU-70 
Pleasanton, CA). Samples were first cast-dried on an aluminum pan before cutting into an 
appropriate size, and then adhered to conductive carbon tapes (Electron Microscopy Sciences, 
Ft. Washington, PA). Subsequently, they were mounted on specimen stubs and coated with a 
thin (<20 nm) conductive gold and platinum layer using a sputter coater (Hummer XP, 
Anatech, CA). Representative SEM images were reported. 
4.3.5 Particle Size and Zeta Potential 
The freshly prepared nanoparticle samples were used for particle size and zeta 
potential measurement. Hydrodynamic diameters of different treatments were measured by a 
dynamic light scattering instrument (DLS, BI-200SM, Brookhaven Instruments Corp., 
Holtsville, NY), which was equipped with a 35mW HeNe laser beam at a wavelength of 637 
nm. All DLS measurements were performed at 25ºC. The polydispersity index (PDI) 
reflecting the particle size distribution of nanoparticles was also reported. Electrophoretic 
mobility of different samples was measured by a laser Doppler velocimetry (Zetasizer Nano 
ZS90, Malvern, UK), using a fold capillary cuvette (Folded Capillary Cell - DTS1060, 
Malvern, UK).  Zeta potential was obtained by converting the measured electrophoretic 
mobility using the Smoluchowski theory. All the measurements were performed in three 
replicates. 
4.3.6 Encapsulation Efficiency (EE) 
EE was measured according to the method of Wang Liu, Sun, Wang, and Zhang, 
(2005) with minor modifications. Briefly, 10 mg of lyophilized nanoparticles samples were 
flushed with 1 ml ethyl acetate for three times, using No. 1 Whatman filter paper. Then, the 




The ethyl acetate elute containing free VD3 was dried using vacuum rotary evaporator 
(Büchi, DE), and then VD3 was extracted by hexane and determined by an UV/VIS 
spectrophotometer (Beckman Coulter, DU-730, Fullerton, CA) at 264 nm. The VD3 
encapsulated in lyophilized nanoparticles  was also extracted based on the method described 
by Wang, Tian and Chen (2011), in order to calculate recovery rate . Five milliliter ethanol 
was added and vigorously shaken on a vortex mixer for 30 seconds and then 5 ml of hexane 
was added. The obtained mixture was vigorously shaken for another 30 seconds. Five 
milliliters of pure water was then added into the above mixture, and the tube was then sealed 
tightly and shaken on a Multi-Purpose Rotator/Rocker (Scientific Industries Inc., NY, USA) 
for 30 min. After the mixture was centrifuged at 800 x g for 5 min at 4 oC to quickly separate 
hexane phase and water/ethanol phase, the VD3 in hexane layer was measured as described 
above. The free VD3 in elute and encapsulated VD3 extracted from lyophilized nanoparticles 
were added up to calculated the recovery rate of VD3 measurement, which was found to be 








4.3.7 Release Profile 
The lyophilized samples after removal of free VD3 were used for in vitro kinetic 
release test in simulated gastrointestinal tract (SGI). For kinetic release test in PBS, certain 
amount of samples (10 mg) was resuspended in PBS (pH 7.4) containing tween 20 (Tw, 
0.5%, w/v) that was to provide sink condition and increase VD3 solubility, at 37°C. At 
designated time intervals, samples were centrifuged at 10,000 g for 5 min to withdrawn the 




withdrawn medium was extracted and measured as described in EE section above. The VD3 
percentage released was calculated and plotted as a function of time (up to 6.5 h). The 
accumulated release profiles of the nanoparticles in the SGI with digestive enzymes were 
obtained using the method as previously reported (Luo et al., 2011). The weighted samples 
(10 mg) were first incubated in 30 ml simulated gastric fluid (SGF) with 0.1% pepsin (w/v) 
for 0.5 h. The digestion was stopped by raising pH to 7.5 using NaOH, and then centrifuged 
to separate aggregates from supernatant which was collected for VD3 measurement. 
Subsequently, the 30 ml of simulated intestinal fluid (SIF) with 1.0% pancreatin (w/v) at 
37°C was added and digested for 6 h under mild stirring. After digestion, the supernatant was 
collected by centrifugation and used for VD3 measurement. All measurements were 
performed in three replicates. 
4.3.8 Photochemical-Stability Measurement 
The freshly prepared samples (i.e. ZV, B0, and B20) as described in section 
“preparation of nanoparticles” together with VD3 dispersion in water as control, were used 
for VD3 stability measurement. VD3 dispersion was prepared by dissolving a small amount 
of VD3 in ethanol followed by dispersing into water, with the final concentration of VD3 
equivalent to nanoparticle samples. Samples in transparent glass vials were placed in a light-
proof cabinet, and exposed to two 352 nm UV light bulbs (15 W) for up to 9.5 hours. At 
exposure time intervals of 0.5, 1.0, 1.5, 3.5, 6.5, and 9.5 h, 200 µl sample was withdrawn 
from each treatment and then VD3 was extracted and measured according to the method 
described in previous sections. All measurements were performed in triplicate. 
4.3.9 Statistical Analysis 
All the experiments were conducted in triplicate with data reported as mean ± 




9.2, SAS Institute Inc., Cary, NC). The analysis of variance (ANOVA) Tukey’s multiple 
comparison tests was used in analysis of differences between physicochemical properties of 
nanoparticles in different formulations. The significance level (P) was set at 0.05. 
4.4 Results and Discussion 
4.4.1 Optimization of the Formulation 
Particle size and zeta potential are both paramount parameters to prepare stable 
nanoparticles targeting at nutritional and medical applications. The effects of preparation 
parameters on particle size and zeta potential in different formulations are summarized in 
Table 4.2. The particle size of VD3-encapsulated zein nanoparticles without CMCS coating 
was as small as 120 nm with relative small polydispersity (PDI), indicating the size 
distribution was uniform. After CMCS coating was applied on zein nanoparticles, the particle 
size varied with calcium concentrations added. Generally, the largest particle size was 
obtained without both CMCS and calcium (A0). The lower the calcium concentration was 
added, the smaller the particle size was. A20 sample (with CMCS/calcium ratio of 20:1) had 
the smallest particle size of 86.3 nm in all formulations (P<0.05). At higher concentration of 
CMCS, particles precipitated at CMCS/calcium ratio of 5:1 (B5) suggesting the aggregation 
would occur at high calcium concentration, which phenomenon was also observed previously 
(Shi et al., 2006). However, with same CMCS concentration, more calcium ions resulted in 
significant smaller PDI (A5 and C5, P<0.05) indicating that particle in these formulations 
may have more uniform particle size. The phase separation method has been considered as a 
reliable and simple method to produce zein nanoparticles. The preparation of zein 
nanoparticles was previously reported as shearing zein stock solution into water using a high 
speed homogenizer (Parris et al., 2005; Zhong & Jin, 2009a), with particle size around 100 




zein nanoparticles particularly when the zein concentration is high, this high-energy method 
generates heat during homogenization, which might cause loss of labile ingredients 
encapsulated as we have observed when preparing VD3-loaded zein nanoparticles. To avoid 
this potential disadvantage, an alternative method to produce zein nanoparticles in low 
concentration was adopted in this study by pouring zein stock solution into water with 
stirring. It was found that this low-energy method was applicable to produce zein 
nanoparticle with diameter of 100 nm, and similar observation was also reported previously 
(Lai et al., 2011). 
Table 4.2. Particle size, polydispersity (PDI), zeta potential, and encapsulation efficiency 
(EE) of nanoparticles in different formulations. 
Samples Particle size (nm) PDI 
Zeta potential 
(mV) LC (%) EE (%) 
ZV 120.2 ± 2.2bc 0.21 ± 0.02d -26.5 ± 2.8f 3.9 ± 0.1f 52.2  ± 1.7a 
A0 200.9 ± 5.9e 0.19 ± 0.01d -26.8 ± 2.3f 2.4 ± 0.3bcd 64.1 ± 7.3ab 
A5 156.6 ± 5.4d 0.07 ± 0.01ab -13.1 ± 0.5ab 2.2 ± 0.2abc 65.1 ± 3.1ab 
A10 116.7 ± 2.9b 0.16 ± 0.02d -17.0 ± 0.8abc 2.0 ± 0.2abc 56.9 ± 6.6ab 
A20 86.3 ± 2.0a  0.18 ± 0.01d -20.5 ± 1.2cde 2.5 ± 0.1cd 69.5 ± 3.6b 
B0 139.5 ± 5.8cd 0.17 ± 0.01d -25.8 ± 0.6ef 1.8 ± 0.1ab 71.5 ± 2.5b 
B5 Large aggregates 
B10 145.3 ± 6.4d 0.15 ± 0.01cd -16.5 ± 1.9bcd 1.7 ± 0.1a 74.7 ± 5.7c 
B20 109.5 ± 11.3b 0.20 ± 0.01d -20.2 ± 1.7cde 2.1 ± 0.1abc 87.9 ± 1.8c 
C0 119.1 ± 5.5bc 0.19 ± 0.02d -27.2 ± 1.8def 3.2 ± 0.3e 63.5 ± 6.9ab 
C5 200.8 ± 16.7e 0.04 ± 0.01a -11.8 ± 0.3a 2.5 ± 0.2cd 53.1 ±3.7a 
C10 113.1 ± 1.9b 0.10 ± 0.00bc -16.3 ± 1.4abcd 3.0 ± 0.4ed 62.9 ±2.8ab 
C20 109.8 ± 2.9b 0.15 ± 0.01cd -21.0 ± 1.2cef 3.5 ± 0.2ef 72.1 ± 4.3bc 
Z, zein; CMCS, carboxymethyl chitosan; VD3, vitamin D3. ZV represents VD3 encapsulated 
zein nanoparticles. A0-A20 represent formulations with different mass ratio of 
CMCS/calcium, prepared with mass ratio zein/CMCS as 1:1. B0-B20 represent formulations 
with different mass ratio of CMCS/Calcium, prepared with mass ratio zein/CMCS as 1:2. C0-
C20 represent formulations with different mass ratio of CMCS/Calcium, prepared with mass 
ratio zein/CMCS as 2:1. Please refer to Table 4.1 for detailed description of formulations. 
PDI, polydispersity index. Values with different letters represent significant difference within 





Zeta potential of VD3-encapsulated zein nanoparticles without CMCS coating was –
26.5 mV, and remained the same as CMCS coating was added. As more calcium was added 
and crosslinked with CMCS through electrostatic interaction, zeta potential became less 
negative, ranging  from –21.0 to –11.8 mV. It was suggested from these results that higher 
calcium content caused decrease of the absolute value of zeta potential, thus resulted in the 
polymer aggregation. It was reported that different CMCS/calcium ratio was required to form 
nanoparticles when the molecular weight of CMCS varied (Shi et al., 2006), showing that 
CMCS with molecular weight of 38.9 kDa needed only a small amount of calcium to form 
nanoparticles and excessive calcium would cause aggregation. It is suggested in their study 
that longer molecular chain was much easier to roll-up when coordinated with calcium ions, 
compared to shorter chains. Based on the above results, due to much higher molecular weight 
of CMCS (67 – 79 kDa) used in our study, it was observed that CMCS/calcium ratio of 20/1 
could be an appropriate formulation, which generated nanoparticles with particle size less 
than 110 nm and absolute value of zeta potential higher than 20 mV. 
After removal of unencapsulated or loosely attached VD3 from nanoparticles, the 
effects of different parameters on EE are shown in Table 4.2. The EE of zein nanoparticles 
without CMCS was around 52.2%, and increased up to 71.5% after CMCS was added to the 
system depending on the CMCS concentration (P<0.05). With addition of calcium to the 
system, the EE increased further up to 87.9% significantly at 20:1 CMCS/calcium and 2:1 
CMCS/zein ratios (P<0.05). This could be ascribed to the crosslink between calcium and 
CMCS through electrostatic interactions, resulting in a thicker and denser coatings on the 
surface of zein nanoparticles and therefore increase of encapsulation efficiency. Due to the 
decreased surface charges of nanoparticles, too much calcium could cause aggregation of 
CMCS/calcium particles resulting in lower EE of VD3 (i.e. B5), compared to the 




range of 1.7 – 3.9%, almost 40 times higher than the previously reported LC of VD2 using 
bovine casein micelle, which is 0.05% (11). The LC of ZV and samples in C group were 
higher than samples in A and B groups, which were made with higher CMCS concentration 
at constant VD3 loading percentage. Therefore, consistently with the observation of particle 
size and zeta potential, the results of EE also suggested that the optimal formulation was the 
sample B20. 
 
4.4.2 Physicochemical Characterization  
4.4.2.1 Morphological Observation 
As shown in Fig. 4.1A, the VD3-encapsulated zein nanoparticles without CMCS 
coatings shared features of a spherical shape and smooth surfaces, with uniform particle size 
around 100 nm. However, most of the particles were clumped and connected to each other 
and it was hard to see individual ones, unlike other reported studies, where the individual zein 
nanoparticles were clearly observed in SEM pictures (Parris et al., 2005; Zhong et al., 2009). 
This difference might be caused by the low-energy method used in our study instead of high-
energy method using high-speed homogenizer in other studies. After zein nanoparticles were 
coated by CMCS, it was still unable to see individual particles clearly (Fig. 4.1B), which 
might be attributed to the highly hydrophilic CMCS coating on the surface of zein 
nanoparticles. Interestingly, the addition of calcium made clearer partition of nanoparticles 
(Fig. 4.1C), showing the effect of crosslinking between CMCS and calcium ions. The Fig. 
4.1D showed the SEM image of B20 nanoparticle after one week storage under room 
temperature. While the particle size increased a little compared to that of the original 
nanoparticles (Fig. 4.1C), it still maintained the spherical shape and smooth surface, 




nanoparticles still maintained intact structure and shape after reconstitution into 25% ethanol-
aqueous solution (data not shown). 
 
Fig. 4.1. Scanning electron microscopy (SEM) images of prepared nanoparticles.  
A, ZV sample, VD3 encapsulated zein nanoparticles; B, B0 sample, VD3 encapsulated zein-
CMCS nanoparticle complex without calcium; C, B20 sample, VD3 encapsulated zein-
CMCS nanoparticle complex with calcium; D, B20 sample after one week storage under 
room temperature. Please refer to Table 4.1 for detailed information of formulations. The 
white bar in each image represents 100 nm. 
 
4.4.2.2 FTIR Study 
Fig. 4.2 showed the representative FT-IR spectrum of zein, CMCS and their 
corresponding VD3 encapsulated complex nanoparticles in different formulations (i.e. B0 and 
B20). In the infrared spectra, an interesting characterization peak was in the range of 3200 – 
3400 cm-1, indicating the hydrogen bonding. The hydrogen bonding in zein and CMCS 
polymer was at 3312 and 3279 cm-1 respectively, and they shifted to 3323 and 3291 cm-1 after 
VD3 was encapsulated, suggesting the hydrogen bonding was formed between VD3 and 
zein/CMCS. Therefore, the hydrogen bonding among zein, CMCS, and VD3 was considered 
as one of the major forces facilitating nanoparticles formation. The vibration peaks of 1500 – 
1700 cm-1, corresponding to amide I and II bond, had no obvious shift in all formulations. 




vibrations of carboxyl groups (Xiao, Luo, Luo, & Wang, 2011), and it shifted significantly to 
1468 cm-1 in the B20 sample, indicating the strong electrostatic interactions between carboxyl 
groups in CMCS and calcium ions. Since both zein and VD3 are highly hydrophobic 
molecules, the hydrophobic interactions could also contribute to the formation of 
nanoparticles, besides the hydrogen bonds and electrostatic interactions.  
 
 
Fig. 4.2 Fourier transform infrared spectroscopy (FTIR) spectra of different samples.  
Z, zein powder; CMCS, carboxymethyl chitosan powder; ZV, VD3 encapsulated zein 
nanoparticles; B0, VD3 encapsulated zein-CMCS nanoparticle complex without calcium; 
B20, VD3 encapsulated zein-CMCS nanoparticle complex with calcium. Please refer to 
Table 4.1 for detailed information of formulations. 
 
4.4.2.3 Thermal Property Study 
The DSC thermograms corresponding to zein, CMCS, VD3, physical mixture of zein 
and VD3 (i.e. sample Z+VD3), ZV, and B20 nanoparticles are shown in Fig. 4.3. The DSC 
curve of zein and CMCS exhibited broad endothermic peaks at 74.8 and 91.1 oC (Fig. 4.3A), 
respectively. These characteristic endotherms could correspond to the evaporation of bound 
water from polymer molecules, and the peak for hydrophobic polymer zein was at lower 
temperature than hydrophilic polymer CMCS, due to the stronger affinity between CMCS 




of VD3 displayed a single melting peak at 88.1oC (Fig. 4.3A). For the physical mixture of 
zein and VD3, both melting peak of VD3 and endothermic peak of zein had been detected 
(Fig. 4.3B). However, only endothermic peaks of zein and CMCS were detected in samples 
of ZV and B20 nanoparticles, respectively (Fig. 4.3B), giving the evidence that VD3 was 
molecularly dispersed in polymeric matrix and hence encapsulated in the nanoparticles. 
Similar observation was also reported by Lai and Guo (2011), showing that the absence of 
endotherm peak of drugs provided the evidence of encapsulation. Interestingly, the small 
characteristic peak of zein at around 180 oC was also observed in Z+VD3 and ZV 
nanoparticles. However, this endotherm peak is not shown in B20 nanoparticles, suggesting 
that zein might be molecularly dispersed and entrapped in CMCS-calcium matrix. 
 
Fig. 4.3. Differential scanning calorimetry (DSC) thermograms of different samples.  
A, thermograms of each ingredient, i.e., zein, CMCS, VD3. B, thermograms of nanoparticle 
complex, i.e., ZV, VD3 encapsulated nanoparticles; Z+D, physical mixture of zein and VD3; 
B20, VD3 encapsulated zein-CMCS nanoparticle complex with calcium. Please refer to 




4.4.3 Kinetic Release in PBS and Accumulative Release in SGI 
Both of the kinetic release profile of nanoparticles in PBS and accumulative release 
profile in simulated gastricintestinal fluids with digestive enzymes were evaluated and are 
shown in Fig 4.4A and 4.4B, respectively. In PBS medium, all formulations showed a first-
order release profile, with biphasic kinetic releasing trend, i.e. a burst effect within 1.5 h 
followed by a sustained release for up to 7 h. ZV and B0 showed similar burst effect occurred 
at 1.5 h with nearly 60% VD3 released, while less than 40% VD3 was released for B20 
sample. In the following sustained release phase, VD3 from B20 was released much more 
slowly with only about 50% of total VD3 was released after 6.5 h incubation, compared with 
ZV and B0, both of which had more than 80% VD3 was released. Under the SGI condition 
with digestive enzymes, ZV and B0 nanoparticles also performed similarly in release profile, 
with almost 60% being released in gastric fluid and 40% in intestinal fluid. However, release 
profile in SGI was significantly improved after calcium was added into the system. For the 
sample B20, only 30% of VD3 was released in gastric fluid and 25% of VD3 was released in 
intestinal fluid, indicating it had controlled release property in SGI tract. However, almost 







Fig. 4.4 Release profile of VD3 from nanoparticles.  
(A) Kinetic release of VD3 from nanoparticles in PBS. (B) Accumulative release of 
nanoparticles in simulated gastrointestinal (SGI) tract (the standard error of each 
measurement was within 10% of the mean, n = 3). SGF, simulated gastric fluid; SIF, 
simulated intestinal fluid; ZV sample, VD3 encapsulated zein nanoparticles; B0 sample, VD3 
encapsulated zein-CMCS nanoparticle complex without calcium; B20 sample, VD3 
encapsulated zein-CMCS nanoparticle complex with calcium. Please refer to Table 4.1 for 
detailed information of formulations. 
 
 
 The delivery system of VD3 in our study was considered as the nanoparticles with 
hydrophobic core and hydrophilic shell, which has been extensively studied for encapsulating 
hydrophobic drugs and nutrients through hydrophobic interactions (Luo et al., 2011; Li, Liu, 
Huang, & Xue, 2011). Based on above results, the zein nanoparticles with CMCS and 




blood condition. In addition, a more significant effect in SGI tract was observed in this study, 
which could be explained from several aspects. First, only the nanoparticles with addition of 
CMCS and calcium had the morphology of clear and sphere particles, which could provide a 
better barrier against release of VD3 than those particles with aggregated bulk morphology. 
Second, calcium ions served as a crosslinker resulting in formation of dense CMCS coatings 
on the surface of zein nanoparticles. It was previously reported that the addition of 
tripolyphosphate anions to self-assembled oleoyl-carboxymethyl chitosan nanoparticles was 
able to slower the release of entrapped drugs (Li, Zhang, Meng, Chen, & Ren, 2011). Third, 
the slow release of B20 in gastric fluid might be due to the fact that although CMCS was 
fully soluble in water at neutral pH, it formed gels when contacting with acidic medium. 
Therefore, it could form CMCS gel layer, being a barrier against diffusion of VD3 and also 
slowed down the digestion of zein by enzymes. Compared with our previous study (Luo et 
al., 2011), it was suggested that the zein nanoparticles coated with CMCS could provide 
better controlled release in gastric fluid than that coated with native chitosan, because native 
chitosan is highly soluble under pH of gastric fluid and might decompose quickly. 
Additionally, the products of partially hydrolyzed zein in gastric fluid may act as emulsifying 
agents and adsorb onto oil droplets and hence increase its resistance to be degraded in 
intestinal fluid, resulting in slow release of VD3 in intestinal fluid (Luo et al., 2011; Subirade, 
Liang, Line, & Remondetto, 2010). 
4.4.4 Photochemical Stability Against UV-Light 
The freshly prepared samples were put in a light-proof chamber and exposed to UV 
light for the UV-stability measurement. As shown in Fig. 4.5, the control sample VD3 
underwent a photochemical degradation very quickly when exposure to 352 nm UV-light. In 
9.5 h, only around 30% of VD3 remained in the control. All the nanoparticle samples were 




VD3 remained in samples after 9.5 h UV-light exposure.  Especially for the sample B20, 
around 80% of VD3 had not been degraded, showing the greatest protection among the tested 
samples. The photochemical stability of VD3 is one of the major hurdles for 
commercialization of supplement or fortified food products, such as infant formula and milk 
(Nelson et al., 2007). Encapsulation of labile VD3 into polymeric matrix is a proper way to 
provide protection against harsh environment. A previous study also demonstrated that 
encapsulation of vitamin D2 into casein micelles provided partial protection against UV-light 
induced degradation (Semo et al., 2007). One possible protection mechanism of the protein 
matrix against photochemical-degradation of VD3 was that protein with aromatic side groups 
and double bonds can absorb UV light and hence reduce the absorption of UV-light by VD3. 
 
Fig. 4.5. Photochemical stability of different samples against UV-light.  
Control, VD3 dispersion in water; ZV sample, VD3 encapsulated zein nanoparticles; B0 
sample, VD3 encapsulated zein-CMCS nanoparticle complex without calcium; B20 sample, 
VD3 encapsulated zein-CMCS nanoparticle complex with calcium. Please refer to Table 4.1 
for detailed information of formulations. 
 
4.5 Conclusion 
In conclusion, zein/CMCS complex nanoparticles were successfully developed as a 




potential, particle size, and encapsulation efficiency can be modulated with different 
preparation parameters. The hydrogen bonding, electrostatic interaction as well as 
hydrophobic interaction were considered as the major forces to facilitate the formation of 
complex nanoparticles. In terms of their release properties in PBS solution and at SGI 
conditions, addition of calcium to crosslink with CMCS was found critical for the optimal 
performance. The photochemical stability against UV light was thought to be mainly 
contributed from zein protein, given the fact that no significant difference was observed 
between samples with and without CMCS/calcium. Thus, encapsulation of hydrophobic 
nutrients in zein/CMCS complex nanoparticles would achieve the controlled release property 
and improved the stability of labile nutrients. The bioavailability of such complex 
nanoparticles is currently being studied in our lab using both in vitro and in vivo approaches 




Chapter 5: Encapsulation of Indole-3-carbinol and 
Diindolylmethane in Zein/Carboxymethyl Chitosan 
Nanoparticles with Controlled Release Property and Improved 
Stability 
Luo, Y., Wang, T., Teng, Z., Chen, P., Sun, J., Wang, Q. Food Chemistry (Minor 
revision for acceptance) 
5.1 Abstract 
Indole-3-carbinol (I3C) and diindolylmethane (DIM) are two bioactive 
compounds from Cruciferous vegetables. The stabilities of these compounds are 
major challenges for  pharmaceutical applications. In this study, zein and 
zein/carboxymethyl chitosan (zein/CMCS) nanoparticles have been prepared to 
encapsulate I3C and DIM by a liquid-liquid phase separation and ionic gelation 
method. The particle sizes of zein and zein/CMCS nanoparticles are around 250 and 
100 nm, respectively. The zeta potentials are around -10 and -20 mV, respectively. 
The encapsulation efficiency of zein nanoparticles was greatly improved after being 
coated with CMCS. Both nanoparticle formulations provided the controlled release of 
I3C and DIM in PBS medium. In this study, the effects of encapsulation on the 
stabilities of I3C and DIM were studied under UV-light exposure and thermal (37°C) 
treatments. Zein and zein/CMCS nanoparticles provided similar protection for both 
I3C and DIM against UV-light, attributed to the contribution of zein protein. Under 
thermal conditions, I3C control degraded and oligomerized to form DIM and other 




degradation, but also inhibited the dimerization to DIM and other products, showing 
significantly better protection than zein nanoparticles. Based on our results, the 
encapsulation of hydrophobic bioactives in zein/CMCS nanoparticles is a promising 
approach to improve stability against harsh conditions, and may provide a possible 
way to determine the efficacy of I3C and DIM. 
5.2 Introduction 
Cruciferous vegetables, such as broccoli and cabbage, are well-known health-
promoting vegetables because they are rich in glucosinolates, the sulfur-containing 
compounds. Glucosinolates can be broken down through hydrolysis into different 
products, among which indole-3-carbinol (I3C) is the major compound attributed to 
beneficial effects. I3C has been extensively studied in in vitro and in in vivo 
carcinogenesis models and the results consistently indicated its potency to influence 
carcinogenesis during initiation and promotion phases of cancer development, 
including cancers of lung, breast, stomach, colon, and prostate (Kim & Milner, 2005).  
However, the stability of I3C is the major problem for elucidating its efficacy. Under 
acidic conditions, I3C molecules undergo oligomerization to form a mixture of 
compounds, known collectively as acid condensation products (Shertzer & Senft, 
2000). 3,3-Diindolylmethane (DIM) is  the dimerization products of I3C, a major 
oligomerization product. DIM has also been proven to have potent cancer prevention 
effects (Abdelrahim, Newman, Vanderlaag, Samudio, & Safe, 2006; Shorey, 
Hagman, Williams, Ho, Dashwood, & Benninghoff, 2012; Wang, Schoene, Milner, & 
Kim, 2012). The in vivo bioavailability of I3C is still not clear, because the rapid acid 




determined and differentiated from its oglimerization products, such as DIM. 
Recently, the stability of I3C in neutral cell culture media has been studied, showing 
that more than 50% of I3C undergoes dimerization into DIM in 24 h at 37°C 
conditions (Bradlow & Zeligs, 2010). Some animal studies on the efficacy of I3C 
were based on the oral administration by gavage to the stomach (Choi, Kim, Park, 
Lee, & Park; Qian, Melkamu, Upadhyaya, & Kassie, 2011), but one recent study 
pointed out that the clearance time for I3C was within 1 h after oral administration of 
I3C (250 mg/kg) in  mice (Anderton, Manson, Verschoyle, Gescher, Lamb, Farmer, 
et al., 2004), and many other condensation products were detected. Therefore, the in 
vivo biological activity of I3C has been considered to be at least partially contributed 
by the oligomerization products during digestion in stomach. Also, I3C in vegetables 
or supplements degrades quickly under different processing conditions, such as heat 
and light (Vallejo, Tomas-Barberan, & Garcia-Viguera, 2002). Given the issues of 
instability of I3C under various conditions, it is difficult to predict the efficacy of a 
pure compound of I3C during storage or after oral consumption; and the dimerization 
of I3C to DIM, makes it even more difficult to determine its efficacy in terms of 
cancer prevention.  
Encapsulation technology, as a novel approach, has drawn increasing attention 
for its applications in the food industry, with the aim to protect labile compounds 
from harsh conditions, namely, to preserve sensitive bioactive compounds, mask off-
odor of some ingredients, as well as provide controlled release and target delivery 
properties (Arvanitoyannis, 2009; de Vos, Faas, Spasojevic, & Sikkema, 2010). 




natural bioactives (e.g. ascorbic acid, β- Carotene, caffeic acid, anthocyanins) to 
extend the shelf life and preserve the functionalities (Coimbra, Isacchi, van Bloois, 
Torano, Ket, Wu, et al., 2011; Han, Guenier, Salmieri, & Lacroix, 2008; Oidtmann, 
Schantz, Mäder, Baum, Berg, Betz, et al., 2011).   Zein, the prolamine protein from 
corn, and chitosan, the derivative of natural polysaccharide chitin, are both food 
biopolymers that have been extensively investigated for their ability to encapsulate 
food bioactives (Dudhani & Kosaraju, 2010; Elzoghby, Samy, & Elgindy, 2012; Hu, 
Ting, Zeng, & Huang, 2012; Patel, Hu, Tiwari, & Velikov, 2010; Xiao & Zhong, 
2011). The complex nanoparticles prepared with the combination of zein and chitosan 
or its derivatives have been developed in our lab as versatile delivery systems for 
various bioactives with wide range of hydrophobicity (Luo, Teng, & Wang, 2012; 
Luo, Zhang, Cheng, & Wang, 2010). For example, chitosan/tripolyphosphate 
nanoparticles coated with zein were used to encapsulate hydrophilic micronutrient 
(selenite) to improve release profile and bioactivities (Luo, Zhang, Cheng, & Wang, 
2010). Carboxymethyl chitosan (CMCS) is one of the water soluble derivatives of 
chitosan and has been reported to form nanoparticles with calcium ions through ionic 
gelation for drug delivery (Shi, Du, Yang, Zhang, & Sun, 2006; Snima, Jayakumar, 
Unnikrishnan, Nair, & Lakshmanan, 2012). Zein nanoparticles coated with CMCS 
have  proven to be a promising delivery system to improve release profile and 
enhance photo-stabilities of hydrophobic nutrients, such as vitamin D3 (Luo, Teng, & 
Wang, 2012).  
Therefore, it is of great interest to study if the encapsulation of I3C and DIM 




stabilities from harsh environmental conditions. In the current study, I3C and DIM 
were encapsulated into zein nanoparticles, and then CMCS was applied to form a 
coating  on the nanoparticles. The comparison of two delivery systems was studied, in 
terms of physicochemical properties of nanoparticles and their protective effects on 
stabilities of I3C and DIM, including thermal- and photo-stability. The effect of 
encapsulation on the dimerization of I3C to DIM was monitored during the stability 
test. 
5.3 Materials and Methods 
5.3.1 Materials 
I3C and DIM were purchased from Sigma-Aldrich Chemical Co. Ltd. (St. Louis, 
MO). Zein with a minimum protein content of 97% was provided by Showa Sangyo (Tokyo, 
Japan). CMCS was purchased from Nantongxingcheng Biological Product Inc. (Nantong, 
Jiangsu Province, China), with a deacetylation degree of 96% and a carboxylation degree of 
65%. Acetonitrile and tert-butyl methyl ether were of HPLC-grade and other chemicals were 
of analytical grade, purchased from Sigma-Aldrich. 
5.3.2 Preparation of Nanoparticles 
I3C (5 mg/ml) was dissolved in pure ethanol as a stock solution. Zein (5 mg/ml) was 
dissolved in 70% aqueous-alcohol solution. CMCS (1 mg/ml) was dissolved in pure water. 
Zein nanoparticles were prepared by a liquid-liquid phase separation method as reported in 
our previous study (Luo, Teng, & Wang, 2012). Briefly, 80 μL of I3C solution (5 mg/ml) was 
added into 2 mL of zein solution in a dropwise manner under mild stirring for 30 min. Then, 
the above zein-I3C solution was immediately poured into 5 mL of pure water or CMCS 




formed. Then, 1 mL of calcium chloride solution (0.25 mg/ml) was added under stirring. The 
obtained opaque nanoparticles dispersion was freeze-dried for 48 h. The control nanoparticles 
were prepared by replacing CMCS and calcium solution with pure water in parallel. I3C and 
DIM- encapsulated zein nanoparticles were defined as Z/I and Z/D, respectively. And I3C 
and DIM- encapsulated zein nanoparticles with CMCS coating were defined as ZC/I and 
ZC/D, respectively. 
5.3.3 Morphological Observation 
Morphological structures of nanoparticles were observed by a scanning electron 
microscopy (SEM, Hitachi SU-70, Pleasanton, CA). Samples were first cast-dried on an 
aluminum pan and then cut to an appropriate size and adhered to conductive carbon tapes 
(Electron Microscopy Sciences, Fort Washington, PA). Subsequently, they were mounted on 
specimen stubs and coated with a thin (<20 nm) conductive gold and platinum layer using a 
sputter coater (Hummer XP, Anatech, Union City, CA). Representative SEM images were 
reported. 
5.3.4 X-Ray Diffraction (XRD) 
The X-ray diffraction (XRD) patterns of each individual ingredient, nanoparticles, as 
well as the physical mixture of zein and I3C/DIM were recorded on a Bruker D8-Advance 
Diffractometer (Bruker AXS Inc., Madison, WI, USA) with backgroundless sample holders. 
The physical mixture of zein and I3C/DIM was in the ratio of 25:1, which was the same ratio 
as the nanoparticles. The working parameters are  as follows: voltage of 40 kV, current of 40 
mA, and scanning rate of 3 min−1. 
5.3.5 Particle Size and Zeta Potential 
The freshly prepared nanoparticle samples were used for particle size and zeta 




scattering instrument (DLS, BI-200SM, Brookhaven Instruments Corp., Holtsville, NY). DLS 
is equipped with a 35mW HeNe laser beam at a wavelength of 637 nm. The polydispersity 
(PDI) was also reported, representing for the distribution of particle size. All DLS 
measurements were performed at 25°C. Surface charge of different samples were measured 
by a laser Doppler velocimetry (Zetasizer Nano ZS90, Malvern, UK), using a fold capillary 
cuvette (Folded Capillary Cell– DTS1060, Malvern, UK). Surface charge was expressed by 
zeta potential, which was converted from the measured electrophoretic mobility using the 
Smoluchowski theory. All measurements were performed in triplicate. 
5.3.6 Encapsulation Efficiency (EE) 
EE was measured based on our previous method with minor modifications (Luo, 
Teng, & Wang, 2012). Briefly, 10 mg of lyophilized nanoparticle samples were flushed with 
1 ml ethyl acetate three times, using No.1 Whatman filter paper. Then the washed samples 
were dried in a vacuum oven (VWR international, PA). The ethyl acetate elute containing 
free compounds was dried in the presence of 30 μl DMSO under a stream of nitrogen gas. 
The residue was then suspended in 600 μl of acetonitrile. Samples were filtered through 0.2 
μm membrane and the filtrate was transferred to amber vials and analyzed by HPLC. 
5.3.7 Release Profile 
It is important to understand how I3C and DIM release from nanoparticles in 
different medium. The release profile measurements were carried out in phosphate buffer 
saline (PBS) medium, according to our previous method (Luo, Teng, & Wang, 2012). Briefly, 
certain amount of freeze-dried nanoparticles (10 mg) were incubated in 30 ml PBS (pH 7.4) 
containing Tween-20 (0.5%) to create sink conditions for I3C and DIM, at 37°C. At 




containing Tween20. The removed medium was then freeze dried for 24 h, extracted, and 
analyzed by HPLC. 
5.3.8 Effects of Encapsulation on Stabilities of I3C and DIM 
The photo-stability and thermal stability of encapsulated-I3C and -DIM were 
evaluated as a function of time. Photo-stability was carried out under exposure of ultraviolet 
light (UV, 15W) for 10 h.  Freshly prepared samples were subjected to a stability test. The 
control sample was prepared by adding the compound (I3C or DIM dissolved in ethanol) in 
the same amount of aqueous-alcohol system without zein or CMCS, to obtain the final 
concentration of the compound equivalent to nanoparticle samples. Samples in transparent 
glass vials were placed in a light-proof cabinet and exposed to two 352 nm UV light bulbs 
(15 W) for up to 10 h. At the designated time intervals, 400 μl was withdrawn from each 
sample and then analyzed by HPLC. For the thermal stability test, nanoparticle samples were 
incubated in 37°C water bath for up to 4 d. Freshly prepared samples were transferred to 15 
ml centrifuge tubes with screw caps. The control samples were also prepared as described 
above. All the samples were placed in 37°C water bath, 400 μl was withdrawn from each 
sample on day 1, 2, 3 and 4, then analyzed by HPLC. All measurements were performed in 
triplicate. 
5.3.9 High Performance Liquid Chromatography (HPLC) 
For release and stability tests, the withdrawn samples were placed in a screw cap 
centrifuge tube and extracted according to a previously described method with a slight 
modification (Anderton, Jukes, Lamb, Manson, Gescher, Steward, et al., 2003). Briefly, the 
withdrawn samples were first freeze-dried for 24 h. The lyophilized powder of each sample 
was extracted three times with tert-butyl methyl ether (TBME, 1 ml) involving 5 m sonication 




extraction, the samples were centrifuged at 6000 g for 10 m and the supernatant was 
transferred to a new tube. For each sample, the combined TBME layers were evaporated 
rapidly under nitrogen gas in the presence of 15 μl DMSO. The extracted sample in DMSO 
was then reconstituted in acetonitrile (300 μl) and filtered through a 0.2 μm membrane into 
amber vials for measurement. 
HPLC analysis of extracted samples was performed on a Hewlett Packard 1100 series 
HPLC system (Palo Alto, CA), equipped with DAD phototiode array detector and an auto-
sampler operated by a Chemstation. The column heater was set at 25 oC. The extracted 
standard/sample (10 µl) was injected into the HPLC system. Chromatography was achieved 
using a Phenomenex C18 (250 × 2 mm, 5 µm) column in tandem with a guard column. The 
mobile phase consisted of water (A) and acetonitrile (B). The gradient is  as follows: 15% B 
to 60% B from 0 to 20 min; linear gradient to 75% B from 20 to 25 min; linear gradient to 
85% B from 25 to 30 min, and kept at 85% B from 30 to 38 min; linear gradient to 15% B 
from 38 to 40 min, and then kept at 15% B for 5 min. Total run time was 45 min, and the 
flow rate was 0.25 ml/min. Samples were quantified by a UV detector at 280 nm. 
 
5.4 Results and Discussion 
5.4.1 Physicochemical Characterization 
          
    Indole-3-carbinol (I3C)    Diindolylmethane (DIM)  





Protein is considered a promising biomaterial to develop nanoparticles for 
encapsulation, however, in many cases protein itself as a single encapsulant may not be 
enough to provide appropriate protection and controlled release property for encapsulated 
drugs or nutrients (Chen & Subirade, 2005; Gunasekaran, Ko, & Xiao, 2007). Hence, a 
second layer, usually a polysaccharide is usually applied to coat protein nanoparticles to 
improve the physicochemical properties for certain applications. Zein nanoparticles coated 
with CMCS have been developed in our lab as a promising approach to encapsulate fat-
soluble bioactive compounds with improved stability and prolonged release property (Luo, 
Teng, & Wang, 2012). In the current study, zein/CMCS nanoparticles are investigated to 
encapsulate two labile fat-soluble phytonutrients, i.e. I3C and DIM (Fig. 5.1), in order to 
improve their stability during storage and preserve their efficacy after oral consumption. 
Based on our previous study, mass ratio of zein/CMCS and CMCS/calcium are determined as 
1:1 and 20:1, respectively.  
Table 5.1. Characterization of nanoparticles. 
Samples a Particle size (nm) PDI Zeta potential EE 
Z/I 252.8 ± 7.3 0.11 ± 0.01 -11.20 ± 0.26 63.77 ± 1.34 
ZC/I 113.5 ± 2.7 0.19 ± 0.01 -19.53 ± 2.26 77.79 ± 3.79 
Z/D 250.8 ± 6.4 0.04 ± 0.00 -9.98 ± 1.64 69.66 ± 1.52 
ZC/D 89.1  ± 4.3 0.19 ± 0.00 -19.80 ± 0.80 78.08 ± 0.69 
a, Z/I and Z/D represent I3C- and DIM-encapsulated zein nanoparticles, respectively; ZC/I 
and ZC/D represent I3C- and DIM-encapsulated zein/CMCS nanoparticles. PDI, 
polydispersity; EE, encapsulation efficiency. 
 
Table 5.1 summarizes the characterization of the nanoparticles, including particle 
size, PDI, zeta potential, as well as EE. Particle size of zein nanoparticles is around 250 nm 
for encapsulation of both bioactive compounds. As a result of being coated with CMCS, the 
particle size decreased to 113 nm for I3C and 89 nm for DIM. This difference may be in part 




via stronger hydrophobic interactions upon phase separation process resulting in 
nanoparticles with more compact structure. The PDI of all nanoparticle formulations were 
within 0.2, indicating small distribution of particle size. The zeta potential of zein 
nanoparticles of I3C and DIM were –11.2 mV and –9.98 mV, respectively, and dropped to 
around -20 mV after zein nanoparticles were coated by CMCS. The decrease of zeta potential 
indicated the adsorption of CMCS of the surface of zein nanoparticles. The EE of zein 
nanoparticles were within 60 – 70% for both compounds, but significantly increased to 
almost 80% after nanoparticles were coated with CMCS. This observation is similar to our 
previous study that CMCS coating on zein nanoparticles could improve vitamin D3 
encapsulation efficiency. Several other studies also reported the beneficial effects on 
encapsulation efficiency by coating nanoparticles with a second polymer (Briones & Sato, 
2010; Trapani, Sitterberg, Bakowsky, & Kissel, 2009). 
5.4.2 Morphological Observation 
As demonstrated in Fig. 5.2, I3C and DIM-encapsulated zein nanoparticle is 
successfully fabricated in our study by liquid-liquid phase separation method. Both 
nanoparticles shared similar features of spherical shape and smooth surface (Fig. 5.2, Z/I and 
Z/D). The CMCS coating caused the particle size of both nanoparticles to decrease and more 







Fig. 5.2. Morphological observation with scanning electron microscopy (SEM).  
Z/I and Z/D represent I3C- and DIM-encapsulated zein nanoparticles, respectively; ZC/I and 
ZC/D represent I3C- and DIM-encapsulated zein/CMCS nanoparticles. 
 
 
5.4.3 XRD Analysis 
The XRD patterns of nanoparticles, pure ingredients as well as their physical 
mixtures are shown in Fig. 5.3. The major characteristic peaks of I3C and DIM are  at 11.48°, 
17.16° and 13.59°, 18.70°, respectively, indicating their highly crystalline nature, which is  
consistent with reported literature (Maciejewska, Wolska, Niemyjska, & Żero, 2005). These 
characteristic peaks were also detected in the physical mixture of zein + I3C and zein + DIM 
samples, but the intensity of these peaks were significantly decreased due to the small mass 
ratio to zein protein. In contrast, zein protein showed two flatter peaks instead of sharp peaks, 
indicating the amorphous nature of the protein. After encapsulation, the characteristic peaks 




DIM were converted into amorphous state in nanoparticles, providing additional evidence of 
encapsulation. This phenomenon was also reported by other studies that the disappearance of 
characteristic peaks of encapsulated crystal compounds after encapsulation confirmed the 
encapsulation process (Teng, Luo, & Wang, 2012). 
 
 
Fig. 5.3. XRD patterns of physical mixture and nanoparticles.  
Z/I and Z/D represent I3C- and DIM-encapsulated zein nanoparticles, respectively; ZC/I and 






4.4.4 Controlled Release Profile 
 
 
Fig. 5.4. Release profile of I3C and DIM from nanoparticles.  
Z/I and Z/D represent I3C- and DIM-encapsulated zein nanoparticles, respectively; ZC/I and 
ZC/D represent I3C- and DIM-encapsulated zein/CMCS nanoparticles. 
 
 
Fig. 5.4 shows the release profiles of I3C (A) and DIM (B) from nanoparticles in the 
PBS system. All formulations of nanoparticles showed a first-order release profile, consisting 
of biphasic trend of burst effect and sustained release. Both I3C and DIM-encapsulated 
nanoparticles demonstrated a similar trend, the burst effect occurred within 0.5 h; followed by 
sustained release for more than 6 h. For zein nanoparticles without CMCS coating, around 
45-50% of the compounds released out from nanoparticles, while for CMCS coated 




coating also helped reduce the sustained release for 6.5 h, and this effect was more significant 
in I3C-encapsulated nanoparticles. The effects of various coatings on the improvement of 
release profile of compounds from nanoparticles have been well documented (Grenha, 
Remunan-Lopez, Carvalho, & Seijo, 2008; Luo, Zhang, Cheng, & Wang, 2010; Luo, Zhang, 
Whent, Yu, & Wang, 2011). Compared with our previous study (Luo, Teng, & Wang, 2012), 
however, the effect of CMCS coating on kinetic release profile was not as prominent as 
before. The possible reason of this phenomenon might be, in part, due to the strong 
hydrophobicity of the I3C and DIM and that the surfactant (Tween-20) was added during the 
nanoparticles preparation procedure, resulting in the increase of diffusion rate and the 
solubility of the encapsulated compounds into the release medium. This observation was also 
reported in a previous study pointing out that inclusion of Tween-20 into microspheres 
accelerated the release of encapsulated antimicrobial compounds (Xiao, Gommel, Davidson, 
& Zhong, 2011). 
5.2.5 Thermal Stability 
 







Fig. 5.6. Effects of encapsulation on thermal stability of I3C under 37°C.  
A, C, E represent I3C levels in I3C control, Z/I, ZC/I samples, respectively, at the beginning 
of incubation (0 day); B, D, F represent I3C levels in I3C control, Z/I, ZC/I samples, 
respectively, after 24 h (1 day) incubation under 37°C. Z/I and ZC/I represent I3C-
encapsulated zein and zein/CMCS nanoparticles, respectively. a and b represent 1-(3-
hydroxymethyl)-indolyl-3-indolylmethane (HI-IM) and [2-(indol-3-ylmethyl)-indol-3-
yl]indol-3-ylmethane (LTr), respectively. 
 
 
The effects of encapsulation on the thermal stability of I3C and DIM were tested 
after incubation in 37°C water bath for 3 days. The chromatography of the standard mixture 
of I3C and DIM is shown in Fig. 5.5, with retention time around 12.5 and 28.5 min, 
respectively. Fig. 5.6 shows the thermal stability of I3C after 24 h incubation. The control 
sample of pure I3C compound demonstrated the fastest degradation rate, followed by I3C 
encapsulated zein and zein/CMCS nanoparticles. From comparison of initial chromatography 
of I3C control and after 24 h incubation (Fig. 5.6A and B), it is suggested that DIM is the 
major dimerization product, along with other two products whose retention time are 22.5 m 
(peak a) and 31.8 m (peak b). According to the reference method (Anderton, et al., 2004), it 
could be postulated that peak a and b stand for the I3C condensation products 1-(3-
hydroxymethyl)-indolyl-3-indolylmethane (HI-IM) and [2-(indol-3-ylmethyl)-indol-3-
yl]indol-3-ylmethane (LTr), respectively. Zein nanoparticles provided little protection of I3C 




with CMCS, the protection effect was so greatly improved that only a small amount of DIM 
and HI-IM were formed after 24 h incubation (Fig. 5.6E and F). During the thermal stability 
measurement, the precipitation of zein nanoparticles after 24 h incubation was clearly 
observed, due to the denaturation of zein protein under heat treatment. The denaturation of 
zein protein resulted in the collapse of nanoparticle structure and thus lost the protection of 
encapsulated I3C. CMCS, as a coating on zein nanoparticles, may decrease the denaturation 
rate of zein protein and preserve the protective effects. Chitosan nanoparticles have also been 
studied to encapsulate L-ascorbic acid and its stability during heat processing was greatly 
improved than unencapsulated L-ascorbic acid (Jang & Lee, 2008). Unlike I3C, DIM was 
much more stable to thermal treatment, as shown in Fig. 5.7. The DIM control maintained 
80% of its original concentration even after 4 days of incubation in 37°C condition. The 
protective effects of zein and zein/CMCS nanoparticles on DIM thermal degradation showed 
a similar trend to that of I3C. The zein nanoparticles demonstrated very little protection on 
DIM degradation, but the CMCS coating on zein nanoparticles provided prominent protection 
of around 90% and remained intact after 4 days incubation. 
 
 
Fig. 5.7. Effects of encapsulation on thermal stability of DIM.  






Table 5.2. I3C and DIM levels in I3C control, Z/I and ZC/I nanoparticles under 37°C 
incubation for 3 days. 
Samples a 
0 Day 1 Day  2 Day 3 Day 
I3C DIM I3C DIM I3C DIM I3C DIM 
I3C control 49.50 - 26.97 ± 1.47 10.36 ± 0.28 9.71 ± 0.99 4.98 ± 0.07 8.30 ± 1.00 5.18 ± 0.07 
Z/I NPs 49.50 - 27.60 ± 4.11 10.25 ± 1.00 6.51 ± 1.75 4.38 ± 0.79 5.53 ± 1.00 3.38 ± 0.25 
ZC/I NPs 44.05 - 39.59 ± 0.84 3.06 ± 0.23 20.67 ± 0.38 3.39 ± 0.14 19.80 ± 0.38 3.88 ± 0.20 
a, Z/I and Z/D represent I3C- and DIM-encapsulated zein nanoparticles, respectively; ZC/I 
and ZC/D represent I3C- and DIM-encapsulated zein/CMCS nanoparticles, respectively. 
 
Although the stabilities of I3C and DIM in acidic conditions have been extensively 
studied, their thermal stabilities are rarely reported in the literature. From our study, the 
thermal stability of I3C is much poorer than DIM at 37°C. Ciska et al. investigated the effect 
of boiling on the content of I3C and DIM in fermented cabbage (Ciska, Verkerk, & Honke, 
2009). In their study, the content of I3C detected in both boiling water and cabbage decreased 
with boiling time within 30 min before reaching a plateau, due to its thermal instability; 
however, the DIM concentration kept increasing for 50 min. Another recent study pointed out 
the I3C dimerized to DIM during cell culture experiment conditions at 37°C (Bradlow & 
Zeligs, 2010).  It has been well documented that I3C undergoes oligomerization in aqueous 
acidic medium, and the acid condensation products include 7 compounds (Grose & 
Bjeldanes, 1992). Our study shows that I3C oligomerized to three products during the thermal 
treatment, with DIM as the major compound. The contents of I3C and DIM in different 
samples during 3 days of thermal treatment were also recorded quantitatively and 
summarized in Table 5.2. After 1 day of thermal treatment, the I3C contents in I3C control 
and Z/I nanoparticles, only 55% of original I3C was remained and large amount of DIM 
(around 10.00 μg/ml for both samples) was detected. Whereas in nanoparticles with CMCS 
coating (ZC/I) sample, 90% of I3C was intact and minimal DIM formation was found (3.26 




control and Z/I nanoparticle samples, respectively, however, 45% of I3C was preserved in 
ZC/I nanoparticles. 
5.4.6 Photo-Stability against UV-Light 
 
Fig. 5.8. Effects of encapsulation on photo-stability of I3C/DIM against UV.  
Z/I and Z/D represent I3C- and DIM-encapsulated zein nanoparticles, respectively; ZC/I and 
ZC/D represent I3C- and DIM-encapsulated zein/CMCS nanoparticles, respectively. 
 
 
In addition to temperature, light is another major factor causing oxidation, 
isomerization, and oligomerization of phytonutrients. Both I3C and DIM are the 
phytochemicals with aromatic rings possessing UV absorption ability which may result in 




stabilities is shown in Fig. 5.8. Both I3C and DIM were extremely susceptible to UV light 
exposure, and I3C degraded faster than DIM. Within 6 h of UV light exposure, there was 
only less than 20% of I3C left in the control sample (Fig. 5.8A). Both of nanoparticle 
formulation preserved I3C content to as high as 80% for the first 6 h exposure. At the end of 
10 h, I3C in control sample was not detectible, but around 50% and 70% of I3C was detected 
in zein and zein/CMCS nanoparticles, respectively. Compared with I3C, DIM was relatively 
stable given that a lag phase was observed before the rapid degradation began (Fig. 5.8B). At 
4 h of incubation, there was more than 80% of DIM in all samples but the content decreased 
rapidly to less than 20% in the control sample in the following incubation. The HPLC 
chromatograph of UV-exposed samples indicated that I3C oglimerized to DIM, HI-IM as 
well as LTr but in smaller amount (data not shown) than thermal treatment. Because of the 
hydroxyl group in the carbinol side chain connecting to indole structure, I3C is much more 
reactive than DIM, resulting in the fast formation of cations and consequent photo-oxidation 
initiated by UV light exposure (Bloch-Mechkour, Bally, & Marcinek, 2011). Encapsulation 
of DIM into nanoparticles prolonged the lag phase to 8 h, with more than 75% intact. At the 
end of 10 h incubation, more than 40% and 60% of DIM was remained in zein and 
zein/CMCS nanoparticles, respectively. Therefore, encapsulation of I3C into nanoparticles 
provided greater protection against UV light, and slightly better protection was observed for 
CMCS coated zein nanoparticles. The protection against UV light was mainly contributed by 
zein protein containing aromatic side groups and double bonds which can absorb UV light. 







In summary, zein and zein/CMCS nanoparticles were successfully prepared to 
encapsulate hydrophobic bioactives I3C and DIM. The encapsulation was evidenced by 
XRD. Zein/CMCS nanoparticles showed better encapsulation efficiency and smaller particle 
size, than zein nanoparticles. Both nanoparticle formulations provided controlled release of 
the bioactive compounds. The stabilities of I3C and DIM were significantly improved after 
they are encapsulated in nanoparticles. Compared with zein nanoparticles, zein/CMCS 
nanoparticles provided better protection of I3C against degradation and dimerization under 
UV-light and thermal conditions. The study on the effects of encapsulation on their in vivo 




 Chapter 6:  Development of Carboxymethyl Chitosan Hydrogel 
Beads in Alcohol-Aqueous Binary Solvent for Nutrient Delivery 
Applications 
Luo, Y., Teng, Z., Wang, X., Wang, Q. 2013. Food Hydrocolloids (Accepted) 
6.1 Abstract 
Carboxymethyl chitosan (CMCS) hydrogel beads were normally prepared from a 
composite formulation with other polymers, such as alginate. In present study, a novel 
method was developed to prepare CMCS, as a single compound, to form hydrogel beads in an 
alcohol-aqueous binary solvent. The morphology and shape of the CMCS hydrogel beads 
were highly dependent on alcohol concentration of the binary solvent. The most spherical 
hydrogel beads were prepared with 3% calcium dissolving in 30% alcohol solution. The 
chemical crosslinking agent, glutaraldehyde, was required to maintain the hydrogel integrity 
and morphology. The effects of drying processes on the swelling ratio and release profile of 
prepared CMCS hydrogel beads in simulated gastrointestinal conditions were studied. Some 
underlying mechanisms for CMCS hydrogel beads formation in binary solvents were also 
discussed. Vitamin D3 was encapsulated into the CMCS hydrogel beads to explore delivery 
applications for hydrophobic nutrient. The CMCS hydrogel beads prepared in 30% alcohol-
aqueous binary solvent may be considered as a promising delivery system for hydrophobic 
nutrients or drugs. 
6.2 Introduction 
Hydrogels are the networks of hydrophilic polymeric chains that can hold a 




2002). Hydrogel may be physically crosslinked between polymeric polyelectrolytes and 
multivalent ions or chemically crosslinked by crosslinking agents, such as glutaraldehyde. 
Hydrogels fabricated from natural polymers are the biomaterials of particular interests in 
biomedical applications, such as drug and cell carriers, and tissue engineering matrices. 
Chitosan (CS) is the N-deacetylated product of chitin, a natural biopolymer from 
exoskeleton of crustacean, insects, and fungi. CS and its derivatives have been extensively 
studied for their drug delivery applications in various forms (Dash, Chiellini, Ottenbrite, & 
Chiellini, 2011), including nano-/microparticles (Dass, Contreras, Dunstan, & Choong, 2007; 
Luo, Zhang, Cheng, & Wang, 2010), nanofibers (Uygun, Kiristi, Oksuz, Manolache, & 
Ulusoy, 2011), films (Kithva, Grondahl, Martin, & Trau, 2010), membranes (Liu, et al., 
2012), and hydrogel beads (Torelli-Souza, Cavalcante Bastos, Nunes, Camara, & Amorim, 
2012). The major concern of its applications is the solubility problem that CS only dissolves 
in acidic medium with pH lower than 6. CS hydrogel beads have been prepared by 
electrostatic crosslinking between CS and tripolyphosphate (TPP). The challenge of CS/TPP 
hydrogel beads for oral drug delivery is that it may dissociate quickly under gastric 
conditions with low pH, therefore chemically crosslinking and/or secondary coating were 
generally applied to achieve controlled release of encapsulated drugs (Durkut, Elçin, & Elçin, 
2006; Jain, Jain, Gupta, & Ahirwar, 2007).   
 Carboxymethyl chitosan (CMCS) is one of the most investigated water-soluble 
derivatives of CS for biomedical applications (Mouryaa, Inamdara, & Tiwari, 2010). The 
drug delivery systems prepared from CMCS-based formulations have received increasing 
attention in recent years (Chen, Tian, & Du, 2004; El-Sherbiny, 2010; Luo, Teng, & Wang, 
2012; Snima, Jayakumar, Unnikrishnan, Nair, & Lakshmanan, 2012). Because of the 
carboxymethylation, CMCS possesses negative charges when dissolved in water, the CMCS 




polyelectrolyte biopolymers, or by chemically crosslinked with chemical agents. CMCS 
hydrogels were generally formed through cylindrical mould (Chen, et al., 2004) or cast 
drying (Chen, Wu, Mi, Lin, Yu, & Sung, 2004; Guo & Gao, 2007), in the form of a piece of 
gel. However, preparation and application of CMCS hydrogel in the form of beads are rarely 
reported. Unlike hydrogel formed in certain mould, the hydrogel beads are normally formed 
simultaneously via crosslinking between biopolymer molecules and crosslinker agents, no 
further cutting or shaping procedure is required. The chain rigidity and inefficient chain 
entanglement of CMCS in aqueous solution have been reported during the preparation of 
CMCS nano fiber (Du & Hsieh, 2008). A study on the CMCS-alginate hydrogel beads 
pointed out that the beads were formed when CMCS was crosslinked with calcium in the 
presence of alginate, otherwise an irregular shape of gel would form (Lin, Liang, Chung, 
Chen, & Sung, 2005). Although the CMCS-calcium hydrogel beads can be prepared when the 
CMCS with low molecular weight (2.5 ×104 Da) was used, the loading capacity and 
encapsulation efficiency of these beads were low unless they were further coated with CS (Z. 
H. Liu, Jiao, & Zhang, 2007). This report indicated that CMCS with low molecular weight 
has a shorter chain and less charged groups, which may be easier to be entangled.  
The objective of current study is to investigate the formation of CMCS hydrogel 
beads crosslinked with calcium in different alcohol-aqueous binary solvents. The shape of the 
beads will be further fixed by adding glutaraldehyde as a chemical crosslinking agent. The 




6.3 Materials and Methods 
6.3.1 Materials 
Chitosan with deacetylation degree of 77% with medium molecular weight was 
purchased from Sigma-Aldrich. Calcium chloride, 25% Glutaraldehyde (GA), vitamin D3 
(VD), and other reagents were of analytical grade and purchased from Sigma-Aldrich. 
6.3.2 Preparation of CMCS 
CMCS was prepared according to a previously published literature (Chen & Park, 
2003). Sodium hydroxide (27.2 g) was first dissolved in 40 ml water, and to which 160 ml of 
isopropanol was added. Then, 20 g chitosan was dispersed into the solution and kept at 50°C 
for 1 h under mild stirring. After that, 30 g of monochloroacetic acid dissolved in 40 ml of 
isopropanol was added to the mixture dropwise and reacted at 50°C for 4 h. The reaction 
solution was then filtered, and washed with 80% alcohol until the filtrate solution was 
neutral. The resulting solid was dried overnight in an oven at 60°C to obtain CMCS. 
6.3.3 Characterization of Prepared CMCS 
The molecular weight of CMCS was determined by viscosity measurement 
(Brookfield) and calculated according to classic Mark–Houwink equation [η] = 7.92×10–5 M 
(Sun, Zhou, Mao, & Zhu, 2007). The degree substitution (DS) was determined by 
potentiometric titration (Vaghani, Patel, & Satish, 2012). Briefly, 0.1 g of CMCS was 
dissolved in 100 ml of 0.05 M HCl with mild stirring and the pH was adjusted to 2.0 by 0.1 
M NaOH. The CMCS solution was then titrated with 0.1 M NaOH by 0.5 ml increment up to 
26 ml, until the final pH of CMCS solution reached 12.0. The conductivity was monitored by 
using a Conductivity Meter (AP85 Series, Accumet). The titration curve was plotted to 
calculate DS shown in equation 1 as follows. The chemical structures of CS and CMCS were 




attenuated total reflection cell) (Jasco Inc., Easton, MO, USA). Dried powder of sample was 
placed onto ATR crystal directly. The spectra were acquired at 750 – 4000 cm-1 











                         Eq. 1
 
where DS is the degree of substitution of CMCS and DD is the degree of deacetylation of 
original chitosan. V1, V2, V3 were the consumed volume of NaOH in different linear section 
of the titration curve, as designated at Fig. 6.2. 
6.3.4 Zeta Potential of CMCS Solution in Binary System 
The zeta potential of CMCS in different binary solution was also investigated. CMCS 
(3%) was dissolved in distilled water as stock solution. Then, 200 μl of CMCS stock solution 
was diluted by 1.8 ml of water and alcohol to obtain different CMCS binary solutions, 
ranging from 10% to 90% alcohol concentrations. The freshly prepared samples were 
subjected to zeta potential measurement using a laser Doppler velocimetry (Zetasizer Nano 
ZS90, Malvern, UK). All measurements were performed in triplicate. 
6.3.5 Preparation of Crosslinked CMCS Hydrogel Beads 
The CMCS hydrogel beads in this study were prepared by a reported method (Lin, et 
al., 2005) with modifications. The 3% calcium solution was dissolved in different alcohol-
aqueous binary solutions, with alcohol concentration ranging from 0% - 90%. Then, 2 ml of 
3% CMCS solution was added dropwise into 10 ml of the above calcium binary solution 
through a pipette tip (1000 μl) with gently stirring. Hydrogel beads were formed 
instantaneously. The beads were cured in binary solution for 1 h, followed by the addition of 
20 μl of 25% glutaraldehyde. The final concentration of glutaraldehyde in crosslinking 




then rinsed with 10 ml distilled water four times to remove unreacted calcium chloride and 
glutaraldehyde, and subsequently dried under room temperature for 48 h. The freeze drying 
method was also studied to explore the effect of drying process on prepared CMCS hydrogel 
beads. Briefly, the freshly prepared beads were collected and pre-dried under -80ºC overnight 
and then freeze-dried (Labconco) for 24 h. 
6.3.6 Morphological Observation 
The surface morphology of prepared hydrogel beads were examined by a scanning 
electron microscopy (SEM, Hitachi SU-70, Pleasanton, CA). Samples were dried and 
mounted on metal stub and then coated with gold using gold sputter coater machine (Hummer 
XP, Anatech, Union City, CA, USA). Representative SEM images were reported. 
6.3.7 Swelling Property 
The dried hydrogel beads were carefully weighed and placed into 10 mL simulated 
gastric fluid (pH 1.2, without pepsin) for 2 h, and then transferred into 10 mL simulated 
intestinal fluid (pH 7.4, without pancreatin) for 4 h. At designated time intervals, the swelling 
medium was carefully decanted and the hydrogel beads were carefully weighted after blotted 
with a piece of paper towel to remove the excess water on the surface. The swelling ratio was 
determined from the following expression:  
Swelling ratio = (Ws – Wd) / Wd, 
Where Ws is the weight of swollen hydrogel beads, and Wd is the weight of dried hydrogel 
beads. 
6.3.8 Delivery Potential of Hydrophobic Nutrient 
To evaluate the drug delivery applications of CMCS hydrogel beads, VD was used as 
a model nutrient and encapsulated into the beads. Briefly, VD of 10 mg/ml was dissolved in 
ethanol as stock solution. Then VD ethanol solution (0.25 ml) was mixed with CMCS (10 ml) 




prepared as described aforementioned at 30% alcohol-aqueous binary solution. After the 
beads were formed, the crosslinking solution was collected for the VD measurement to 
calculate encapsulation efficiency (EE). The 5 mL of the crosslinking solution was collected 





 UV-visible spectrophotometer was applied to determine VD concentration. Five 
milliliter of withdrawn sample was freeze-dried for 48 h. The lyophilized samples were then 
extracted with 2 ml of hexane for two times, with 2 min of sonification for the first time and 
20 s vortexing for second time. Subsequent to each extraction, samples were centrifuged at 
6000 g for 10 min, and the supernatant was collected. The combined hexane layer was then 
measured using a UV-visible spectrophotometer at 264 nm (Beckman Coulter, DU-730, 
Fullerton, CA). 
6.3.9 Release of Nutrient from CMCS Hydrogel Beads 
The release profile of encapsulated VD was evaluated in simulated gastrointestinal 
fluid at 37°C. Fifty milligrams of dried hydrogel beads were incubated in 30 ml of simulated 
gastric fluid (pH 1.2) for 2 h, then transferred to 30 ml of simulated intestinal fluid (pH 7.4) 
for 4 h. At designated time intervals, certain amount of release medium was withdrawn and 
replaced with fresh medium. The VD content in the withdrawn release medium was 





6.4 Results and Discussion 
6.4.1 Characterization of Prepared CMCS 
Carboxymethylation is one of the most investigated methods to modify chitosan with 
aims to expand its biomedical applications with improved water solubility. In order to 
characterize the prepared CMCS, both FTIR and conductimetric titration were used to 
monitor its molecular structure and carboxymethylation efficiency, respectively. The 
molecular weight of prepared CMCS was 1.39 ×105 Da, estimated by Mark–Houwink Eq 1. 
The chemical structures of CS and CMCS were monitored and compared by FT-IR, as shown 
in Fig. 6.1. The spectrum of CS showed characteristic peak of amino group, as observed at 
1664 cm-1. In contrast, the spectrum of CMCS showed a characteristic peak of carboxylic 
acid salt (―COO– stretch), as observed at 1602 cm-1. The presence of this peak indicated 
successful addition of carboxymethyl groups onto CS chains. Another vibration area of 
interest was between 1000 and 1100 cm-1, indicating the C–O stretch. The peaks of 1044 and 
1047 cm-1 were assigned to primary hydroxyl group (–CH2–OH in primary alcohols), and 
peaks of 1069and 1078 cm-1 were assigned to secondary hydroxyl group (–CH–OH in cyclic 
alcohols), in CS and CMCS spectrum, respectively. Since the secondary hydroxyl was not 
affected during carboxymethylation, it can act as an internal control. The change of the 
intensity ratio of secondary and primary hydroxyl groups was indicative to the 
carboxymethylation on primary hydroxyl group (Chen, et al., 2004). This ratio in CS was 
1.09 and changed to 0.94 in CMCS after modification, providing further evidence that 
carboxymethyl group was substituted to –CH2–OH at C6 position. 
The conductimetric titration curve is shown in Fig. 6.2. The titration typically 
consists of four linear portions. The first portion (0 – V1) corresponded to the volume of 
NaOH used to neutralize the excess amount of HCl; the second portion (V1 – V2) related to 




(V2 – V3) was contributed to the volume of NaOH used to react with NH3+, which was 
proportional to the deacytelation degree of the native CS; the forth portion indicated the 
excess amount of NaOH. As per equation 1, the calculated DS was 0.67 for the prepared 
CMCS. Similar results were also reported in previous literature (Vaghani, et al., 2012). 
 
 
Fig. 6.1. FT-IR spectra of CS and CMCS. 
 
 




6.4.2 Formation of CMCS Hydrogel Beads in Binary Solution 
Since the previous literature pointed out that CMCS itself cannot form hydrogel 
beads in the calcium aqueous solution (Lin, et al., 2005), it may be of great interests to test 
whether the CMCS hydrogel beads can be formed in a binary solution. Herein, the effects of 
alcohol-aqueous binary solution were investigated in present study. Fig. 6.3 shows the digital 
photo of hydrogel beads prepared in different alcohol-aqueous binary calcium solutions. It is 
clearly observed that homogeneous and spherical beads were formed when the alcohol 
concentration was less than 50%. Rough and irregular-shaped beads were formed when the 
alcohol concentration was 50% and higher. Hydrogel beads are generally formed by trapping 
certain amount of water via molecular entanglements and/or secondary forces including ionic, 
H-bonding, and hydrophobic forces. Therefore, factors that affect these driving forces, such 
as solvent composition, temperature, and solids concentration, will also affect beads 
formation during the gelling process (Hoffman, 2002). Based on our results, solvent 
composition played an important role in CMCS hydrogel beads formation. This is explained 
in the following three aspects. First, the H-bonding between water and alcohol increased 
when the alcohol concentration increased in the solution, resulting in disruption of the H-
bonding between CMCS chains and water. Second, the increase of alcohol concentration 
increased the surface hydrophobicity of CMCS molecules, which might create stronger 
intermolecular and hydrophobic interactions, and hence facilitated the entanglement of 
CMCS chains and the formation of hydrogel beads. Third, if the alcohol concentration was 
higher than 50%, it turned out that water concentration might be too low for CMCS to hold 
sufficient amount of water inside its network to form spherical beads, and therefore the beads 





Fig. 6.3. Digital photos of CMCS hydrogel beads prepared in different alcohol-aqueous 
binary solutions.  
The percentage below each photo represents the alcohol concentration for preparation of each 
bead. 
 
After the CMCS hydrogel beads were formed, it was cured in calcium alcohol-
aqueous solution for 1 h before drying and some beads were further crosslinked with 
gluraraldehyde for 1 h. Fig. 6.4 showed the digital photos of CMCS hydrogel beads with and 
without chemical crosslinking. The formed hydrogel beads were spherical at the time of 
preparation (Fig. 6.4a), however, after the beads were removed from calcium binary solution 
for drying, they redissolved very quickly within 0.5 h in the water (Fig. 6.4b). This 
observation indicated that the physically crosslinked CMCS hydrogel beads cannot maintain 
its network upon leaving the crosslinking solution, which may be partly due to the 
evaporation of alcohol from the CMCS hydrogel matrix. The decrease of alcohol 
concentration may reinforce the H-bonding between CMCS molecules and water, resulting in 
the disrupture of CMCS network. Therefore, the chemical crosslinking agent is needed to fix 
the structure and maintain the spherical shape. As shown in Fig. 6.4c, the beads crosslinked 
with calcium and glutaraldehyde maintained the spherical structure after drying. 
Glutaraldehyde reacted with amino groups on the CMCS chains to form amide bond. 
Therefore, although the alcohol was evaporated during drying process, the covalent bonds 





Fig. 6.4. Digital photos of CMCS hydrogels beads crosslinked with different crosslinking 
reagents.  
a, bead immediately removed from 3% calcium in 30% alcohol-aqueous solution; b, bead a 
after dried at room temperature for 0.5 h; c, bead crosslinked with glutaraldehyde and dried at 
room temperature for 0.5 h. 
 
6.4.3 Morphological Observation 
The digital photographs and SEM images of hydrogel beads dried under different 
conditions are compared in Fig. 6.5. The digital photographs revealed that the hydrogel beads 
dried at room temperature were yellow in color with diameter of 1.08 mm (Fig. 6.5A), while 
the beads dried by lyophilization were white with diameter of 1.72 mm (Fig. 6.5D). This 
difference in size and color may be due to the fact that the crosslinking agent, glutaraldehyde, 
continuously reacted with CMCS during the drying process at room temperature whereas this 
reaction was inhibited by low temperature during lyophilization. At low magnification (Fig. 
6.5B), a slight depression was observed at the center on one side of the surface of beads dried 
at room temperature , which was probably due to the surface shrinkage during drying. The 
lyophilization process, on the other hand, resulted in a very smooth surface without any 
depression (Fig. 6.5D). Similar observations were also noticed in the case of preparation of 
zinc-pectin-chitosan beads (Das, Chaudhury, & Ng, 2011) and calcium-pectinate beads 
(Bourgeois, et al., 2008) dried at room temperature. The SEM image at high magnification 
exhibited rugged and rough surface for the room temperature dried beads (Fig. 6.5C), but 





Fig. 6.5. Photographs of CMCS hydrogel beads prepared at 30% alcohol-aqueous 
binary solution.  
A and D, digital photograph of hydrogel beads dried at room temperature and lyophilization, 
respectively, the scale bar represents 1 mm; B, C and E, F, the scanning electron microscopy 
(SEM) images of one bead, dried at room temperature and lyophilization, respectively.  The 
scale bar represents 100 μm; B, morphology of the surface, the scale bars in B and E 
represent 100 μm, and the scale bars in C and F represent 10 μm. 
 
6.4.4 Zeta Potential 
With the aim to investigate the underlying mechanism of how binary solvents 
affected the gelling properties of CMCS, surface charge of CMCS molecules in different 
binary solvent were measured. As shown in Fig. 6.6, the CMCS hydrogel beads carried high 
negative charges when dissolved in distilled water, showing the zeta potential of –55 mV. As 
the alcohol concentration increased from 10 to 90%, the absolute value of zeta potential of 
CMCS decreased gradually to nearly zero, showing the –4.8 and –5.4 mV in 80% and 90% 
alcohol-aqueous solution, respectively. Surface charge of polymer chains may serve as a 
paramount parameter contributing to gelling property. The high surface charge on CMCS 
chains may provide strong repulsion forces resulting in long persistent length and hence stiff 




alcohol concentration and decrease of water content, CS had less and less charge fraction, 
which made CS more solvophobic and resulted in gel formation. Another fact supporting for 
this observation is that the dielectric constant of water is close to 80, much higher than 
alcohol which is only 24. Therefore, significant decrease of ionic dissociation of CMCS 
molecules was expected upon increasing alcohol concentration in a binary solvent. This 
phenomenon was also evidenced in our study. In terms of the CMCS hydrogel beads 
formation with most spherical morphology, 30 – 40% alcohol-aqueous binary composition 
may be the optimal solvent with zeta potential ranging between –28 and –21 mV. 
 
Fig. 6.6. Zeta potential of CMCS in different alcohol-aqueous binary solvents. 
 
5.4.5 Swelling Properties 
To explore the drug delivery potentials of prepared CMCS hydrogel beads, the 
swelling properties in response to physiological conditions were studied. Fig. 6.7 shows the 
swelling ratio of CMCS hydrogel beads in simulated gastrointestinal fluid at 37°C. For 
CMCS beads dried at room temperature, a burst swelling of 2 times of dry weight was 
observed in the first hour in simulated gastric fluid, followed by a slight swelling. After the 
CMCS hydrogel beads were transferred into simulated intestinal fluid, their weight kept 
increasing at a very low speed for the following 4 h, even for the next 24 h (data now shown). 




similar swelling pattern with a significantly higher swelling ratio was observed for the 
lyophilized CMCS hydrogel beads, i.e. a burst swelling of 10 times of its dry weight in 
gastric fluid within 1 h followed by sustained swelling. The swelling ratio of lyophilized 
beads was more than 12 after 24 h. The swelling is a process of hydration. Therefore, the 
hydrophilicity and amount of charged groups of the beads will have great effect on their 
swelling property. The swelling in gastric fluid may be attributed to the repulsion forces from 
protonated NH3+ groups as well as the disruption of Ca2+–COO- interaction caused by the 
protonation of COO- groups at acidic condition. These two factors led to the migration of 
water into the dried beads together with the release of unassociated Ca2+ from the hydrogel 
beads to the gastric fluid. When the beads were transferred to simulated intestinal fluid (pH 
7.4), the carboxylic group on CMCS was deprotonated and carried negative charges, while 
the Ca2+ –COO- interaction  was weakened because of the release of Ca2+. Therefore, the 
CMCS molecules became more negatively charged, resulting in stronger electrostatic 
repulsion and thus facilitating the swelling of the beads (Lin, et al., 2005). The different 
swelling ratio for room-temperature dried and lyophilized beads may be due to the size of 
dried beads. As shown in Fig. 6.7A and D, the size of lyophilized beads was 1.7 folds greater 
than room temperature dried beads, and the larger size may facilitate water molecules to 
migrate into the beads network. 
 
Fig. 6.7. Swelling properties and release profile of CMCS in simulated gastrointestinal 
conditions. 





Several factors may affect the swelling properties, including molecular weight and 
surface charge of the polymer(s) used, crosslinking method (physical or chemical), swelling 
medium. A previous literature investigating the hydrogel beads prepared from CMCS of low 
molecular weight, pointed out the maximum swelling ratio of CMCS beads were around 20 
times in pH 7.4 tris/HCl buffer for 10 h. Because the medium molecular weight of CMCS in 
our study possessed stiffer chains and stronger electrostatic repulsion between chains, and the 
use of chemical crosslinker during the preparation, the swelling capability of prepared CMCS 
beads was demonstrated to be strictly limited. The polymeric matrix composition also 
affected the swelling capability, i.e., matrix of two or three polymers may show a better 
swelling property than using single polymer. For instance, the hydrogel beads with 
composition of alginate and CMCS showed swelling ratio of 32 in 6 h, showing a significant 
improvement than the beads of alginate itself, the swelling ratio of which was only 5 (Lin, et 
al., 2005). Similar to previous literature (Vaghani, et al., 2012), the small swelling ratio of 
prepared CMCS hydrogel beads was due to the chemical crosslinking agent, glutaraldehyde, 
which created covalent bonds and formed a tight and irreversible network between CMCS 
chains. 
6.4.6 Drug Delivery Applications 
The drug delivery applications of prepared CMCS hydrogel beads were investigated. 
The CMCS hydrogel beads were formed due to the reinforcing of hydrophobicity and 
disrupting of H-bonding of CMCS chains in alcohol-aqueous binary solvents, therefore, it 
might be an ideal delivery system for hydrophobic nutrients and drugs. Vitamin D (VD) was 
tested as the model nutrient, to study the delivery capability of prepared CMCS hydrogel 
beads. The encapsulation efficiency (EE) of VD was 96.9±0.9%, which is higher than other 




Tan, 2002). The high EE may be partly due to the strong hydrophobic interactions between 
VD and CMCS, and their co-precipitation in crosslinking solution. As shown in Fig. 6.8, the 
kinetic release of VD demonstrated two similar biphasic profiles in simulated gastric fluid 
and intestinal fluid. Under gastric condition, a burst effect was observed within the first hour 
with 20% of VD released, and then a slow sustained release in the following hours for the 
CMCS hydrogel beads dried at room temperature. This phenomenon was corresponded to the 
burst swelling ratio (Fig. 6.7), resulting in the burst release of peripherally encapsulated VD 
from the swollen matrix. As the pH raised to 7.4 from 1.2 by transferring beads to intestinal 
condition, CMCS chains may become more expanded due to the electrostatic repulsion. A 
sustained release was observed in the following hours. For the lyophilized CMCS hydrogel 
beads, a similar release profile with milder burst effect was observed that only 12% of VD 
was released in the first hour of incubation in simulated gastric fluid. The accumulated 
release of VD from CMCS hydrogel beads after 6 h in simulated gastrointestinal fluid was 
41%, which was much slower than other CMCS-based hydrogel beads (Lin, et al., 2005; 
Vaghani, et al., 2012). While a previous study pointed out that the lyophilization drying may 
accelerate the release rate of hydrophilic protein drug by producing beads with higher 
porosity, our study revealed that the release rate of hydrophobic drug/nutrient may become 
slower after lyophilization, partly due to the stronger hydrophobic interaction between 
polymer and drug during freeze-drying process (Sriamornsak, 1999). The particle size may 
also contribute to the release profile. The CMCS beads dried at room temperature had smaller 






Fig. 6.8. Release profile of VD from CMCS hydrogel beads in simulated gastrointestinal 
condition.  
A, room temperature dried CMCS hydrogel beads; B, lyophilized CMCS hydrogel beads. 
 
6.4.7 Schematic illustration 
 
Fig. 6.9. Schematic illustration of the development of CMCS hydrogel beads. 
 
The schematic illustration of the CMCS hydogel beads in alcohol-aqueous binary 
solvents was summarized in Fig. 6.9. The CMCS was first dissolved into distilled water. 
Because the carboxyl groups on its chains were highly charged in water, strong repulsion 




into alcohol-aqueous binary solvents containing calcium ions, the surface charge of CMCS 
decreased significantly due to low dielectric constant of alcohol. Meanwhile the carboxyl 
groups were crosslinked by calcium, resulting in more entanglements and less repulsion 
forces of CMCS chains. As a result, the hydrogel beads were spontaneously formed. Upon 
leaving the gelation medium for drying, however, the calcium crosslinked hydrogel beads 
were unable to maintain its network, due to the evaporation of alcohol from the hydrogel 
matrix and consequently reinforced the H-bonding and strong repulsive forces. When the 
hydrogel beads were further crosslinked chemically by glutaraldehyde, the covalent bonds 
provided adequate support to hold water and maintain the spherical structure of the beads 
after drying. Different drying methods resulted in different morphology of the beads. 
 
6.5 Conclusion 
The CMCS hydrogel beads were successfully prepared in alcohol-aqueous binary 
solvents, and 30% alcohol concentration turned out to be the optimal solvent to obtain the 
most spherical beads with smooth surface. The driving forces to form CMCS beads were 
attributed to the reduced surface charge and interchain H-bonding, enhanced hydrophobicity 
as well as increased chain entanglement in alcohol-aqueous binary solvent. The prepared 
CMCS hydrogel beads are believed to possess high potential as a drug delivery system for 
hydrophobic drugs or nutrients, with high encapsulation efficiency and sustained release 
profile in simulated gastrointestinal condition. The CMCS hydrogel beads prepared in current 
study may also be considered for many other applications, including enzyme immobilization 





Chapter 7: Cellular Evaluation of Zein Nanoparticles using 
Caco-2 Cells 
7.1 Abstract 
Zein nanoparticles can be easily produced by liquid-liquid phase separation, while 
the cellular evaluations were quite limited due to the poor redispersibility after drying. 
Caseinate stabilized zein nanoparticles have been recently developed with better 
redispersibility in salt solutions. In this study, zein-caseinate nanoparticles were prepared 
with different zein/caseinate mass ratios. The prepared nanoparticles demonstrated good 
stabilities to maintain particle size (120-140 nm) in cell culture medium and buffer solutions 
at 37°C. The nanoparticles showed no cytoxicity in Caco-2 cells for 72 h. Coumarin 6 was 
encapsulated into zein nanoparticles for cell uptake study. Caseinate in zein nanoparticle 
formulations favored cell uptake in a concentration-dependent manner over time. The cell 
uptake of zein nanoparticles indicated an energy dependent endocytosis process. The 
fluorescent microscopy clearly showed the internalization of the zein nanoparticles. Transport 
of zein nanoparticles were also tested using Caco-2 cell monolayers, showing that caseinate 
improved zein nanoparticles transport and 60% of nanoparticles were accumulated on cell 
monolayers. These results for the first time clearly demonstrated the cell uptake and transport 
of zein nanoparticles and discussed the possible mechanisms, and may shed some light on the 
cellular evaluations of hydrophobic protein nanoparticles. 
7.2 Introduction 
It has become clear that cellular evaluation of polymeric delivery systems plays a 
critical role to explore their potential efficacy and understand specific mechanisms in certain 




prepared with biodegradable and biocompatible polymeric materials, it is not unusual to 
encounter toxic or side effects of nanoparticle made from GRAS biomaterials, when the in 
vitro cellular evaluation is performed. For instance, the CS nanoparticles of small particle size 
(<30 nm) could be internalized by Caco-2 cells to inflict extensive damage to the intracellular 
organells (Loh, Saunders, & Lim, 2012), as well as be toxic in a dose-dependent manner in 
human hepatocytes (Loh, Yeoh, Saunders, & Lim, 2010). CS nanoparticles of larger sizes 
(400 nm) have also been recently shown to be toxic at low concentrations (Liang, Li, Fang, 
Yang, An, Zhao, et al., 2011).  
Zein, as a natural corn protein, has been extensively studied for its delivery 
application in encapsulation and controlled release of hydrophobic drugs/nutraceuticals. 
However, due to its unique solubility, the cellular evaluation studies on zein nanoparticles are 
not fully explored. The zein can only be dissolved in 60-85% aqueous-alcohol binary 
solutions, and the liquid-liquid phase separation method was usually adopted to prepare zein 
nanoparticles by sheering zein solution into distilled water (Zhong & Jin, 2009a). While 
extensive studies have been done to investigate the fabrication parameters and encapsulation 
of different drugs, the in vivo and in vitro evaluation of efficacy and toxicity of zein 
nanoparticles are limited. A recent study reported that the zein nanoparticle suspensions can 
provide target delivery to liver and prolonged blood residence time of the encapsulated drug 
by intravenous injection (Lai & Guo, 2011). In our previous trials, after zein nanoparticles 
were freeze dried the nanoparticles powders cannot be redispersed in water or buffer 
solutions, and even diluting zein dispersion (before freeze-drying) into different buffers 
would also destabilize zein nanoparticles. Recently, Patel and colleagues prepared sodium 
caseinate stabilized zein colloidal nanoparticles, which retained good stability against a wide 
range ionic strength (15 mM−1.5 M NaCl) and good redispersibility after drying (Patel, 




caseins (αs1, αs2, β, and κ) with various portions of both hydrophobic and hydrophilic 
groups. It has been widely used in food industry as a nutritional ingredient and a functional 
component serving as emulsifier and stabilizer (Dickinson, 1997).  
Therefore, it may be interested to explore the cellular evaluation of caseinate 
stabilized zein nanoparticles, in order to shed some light on cytotoxicity and cell uptake of 
zein nanoparticles. In present study, in addition to cell viability and cell uptake of 
nanoparticles by Caco-2 cell, the Caco-2 cell monolayer was also used to investigate 
epithelial transport of zein nanoparticles. The possible mechanisms of cell uptake and 
transport were also discussed. 
7.3 Materials and Methods 
7.3.1 Materials 
Zein sample with a minimum protein content of 97% was provided by Showa Sangyo 
(Tokyo, Japan). Sodium caseinate (CAS), coumarin-6 of 98% purity were purchased from 
Sigma-Aldrich. Dulbecco’s modified Eagle medium (DMEM), fetal bovine serum (FBS), 100 
× nonessential amino acids, 100× penicillin and streptomycin, 0.25% trypsin (w/v) with 
EDTA, and 1 M 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), phosphate 
buffer  saline were all purchased from Life Technologies. Transwell permeable polycarbonate 
inserts (0.4 μm) and 12-well cell culture plates were obtained from Corning. 
7.3.2 Preparation of Nanoparticles 
 Zein nanoparticles were prepared by liquid-liquid phase separation method, and 
sodium caseinate was used as a stabilizer. Briefly, zein (10 mg/ml) was first dissolved in 70% 
aqueous-alcohol solution, and was dissolved in distilled water as stock solution. The 5 ml of 
zein solution was rapidly poured into 12.5 ml of CAS solution with vigorously stirring for 30 




nanoparticles with three different zein to CAS mass ratios were prepared, namely 1:0.5, 
1:1,1:2 and defined as sample A, B, and C, respectively. Then, ethanol was removed under 
nitrogen stream. The nanoparticle suspensions were centrifuged at 2,000 g for 10 min to 
separate out a few aggregates. The nanoparticle suspensions were freeze-dried for 48 h to 
obtain dry powders. 
7.3.3 Particle Size and Zeta Potential 
Hydrodynamic diameter of selenite-loaded CS/TPP nanoparticles was measured by a 
dynamic light scattering instrument (DLS, BI-200SM, Brookhaven Instruments Corporation, 
Holtsville, NY, USA). DLS is equipped with a 35 mW HeNe laser beam at a wavelength of 
637 nm. All DLS measurements were performed at 25°C. Surface charges of the 
nanoparticles were measured by a laser Doppler velocimetry (Zetasizer Nano ZS90, Malvern, 
UK), using a fold capillary cuvette (Folded Capillary Cell-DTS1060, Malvern, UK). The 
freshly prepared nanoparticle suspensions were used for particle size and surface charge 
measurement. All measurements were conducted in triplicate. 
7.3.4 Stability of Nanoparticles 
Stabilities of nanoparticles were investigated in different conditions. The freshly 
prepared nanoparticles were subjected to freeze drying process for 48 h to obtain dry 
powders. The nanoparticle powders were redispersed into different conditions to test 
stabilities, namely, distilled water, HBSS, DMEM. The nanoparticles in different conditions 
were then incubated at 37°C and the particle size was measured as a function of time. 
7.3.5 Cell Culture 
Caco-2 cell was generously provided by Dr. Liangli (Lucy) Yu, Department of 
Nutrition and Food Science, University of Maryland. Caco-2 cells were cultivated in DMEM 




environment with 5% CO2. The medium was changed every other day and the cells were 
subcultured after reaching 80-90% confluence. Caco-2 cells between 10-15 passages were 
used in this study. 
7.3.6 Cytoxicity of Nanoparticles 
The freeze-dried nanoparticles powders were dissolved in DMEM to different 
concentrations, i.e. 0.2, 0.5 and 1.0 mg/ml. Caco-2 cells were seeded in 96-well microplates 
(Corning, USA) at seeding density of 2 × 104 cells/well. Cells were incubated for 24 h to 
allow cell attachment. Then, cells were treated with DMEM containing different samples. 
Each treatment had six replicates. At designated time intervals (24, 48 and 72 h), the medium 
was removed and cells were washed with PBS three times to remove free nanoparticles. 
Then, 100 μL of DMEM containing MTT (10 μL, 5 mg/ml in PBS) was added into each well. 
After incubation for 4 h, the culture solution was carefully aspirated and residue was left in 
the wells. Subsequently, 100 μL of DMSO was added to each well to solubilize the formazan 
crystals formed. The absorbance at 550 nm was measured by a multilabel microplate reader 
(Victor X3, PerkinElmer 2030, MA, USA). The cell viability was calculated by the 
absorbance percentage of nanoparticles treated cells versus blank cells (treated with cell 
culture medium only). 
7.3.7 Cell Uptake of Nanoparticles 
To investigate the cell uptake of nanoparticles, coumarin-6, as a fluorescent marker, 
was encapsulated into the nanoparticles, and both quantitative and qualitative studies were 
carried out according to previous literature (Zhang & Feng, 2006). The zein solution 
containing 0.02% coumarin 6 (dissolved in 80% ethanol solution) was used in preparation of 
fluorescent nanoparticles, all other conditions remained the same. The cell uptake 




7.3.7.1 Quantitative Study 
Caco-2 cells were seeded in 96-well black plates (BD Falcon, NJ, USA) and 
incubated until a confluent monolayer was formed. Then, the cell culture medium was 
replaced with transport buffer (HBSS supplemented with 25 mM HEPES, pH 7.4) pre-
warmed at 37°C for equilibration for 20 min. The cell uptake was initiated by incubating cells 
with 200 μL of different samples dissolved in HBSS at various concentrations for 0.5 – 4 h. 
At designated intervals of every 30 min, cell monolayer was washed with PBS three times to 
remove free nanoparticles. Cells were then treated with100 μl of lyse buffer (0.5% Triton X-
100 in 0.2N NaOH solution) to permeabilize cell membrane and expose the internalized 
nanoparticles. The fluorescent intensity was then measured with excitation at 485 nm / 
emission at 535 nm. The uptake efficiency was expressed as the percentage of fluorescent 
intensity in cells versus the original intensity present in feed medium (Yinwin & Feng, 2005).  
7.3.7.2 Qualitative Study 
Caco-2 cell were seeded on Lab-Teks chambered cover glasses (Nalge Nunc 
International, Naperville, IL, USA), and incubated until cells were about 80% confluence. 
Prior to uptake test, the growth medium were replaced with transport medium, HBSS 
buffered with 25 mM HEPES (pH 7.4) and equilibrated for 20 min at 37°C. Then, 
nanoparticles dissolved in HBSS (1 mg/ml) was added into the wells and incubated for 4 h. 
At the end, cells were washed thrice with cold PBS to remove free nanoparticles. Cells were 
then fixed by 70% ethanol for 15 min under –20°C and subsequently nuclei were stained by 
DAPI. GFP channel was used for green fluorescence of coumarin 6, and DAPI channel for 
red fluorescence of DAPI. Fluorescent images were taken after deconvolution using 
AxioVision Release 4.7.2.0 coupled to a Zeiss Axio Observer Z1m fluorescence microscope 




7.3.8 Transport of Nanoparticles via Caco-2 Cell Monolayer 
The maintenance of caco-2 cell monolayer was followed by the published protocol 
(Hubatsch, Ragnarsson, & Artursson, 2007). Briefly, Caco-2 cells were seeded on the tissue-
culture-treated polycarbonate filter (diameter 12 mm, growth area 1.1 cm2) in Costar 
Transwell 12 wells/plate (Corning Costar Corp., NY, USA) at a seeding density of 3 × 105 
cells/cm2. The medium was replaced every 48 h for the first 6 days and every 24 h thereafter. 
The cultures were used for the transport experiments 21 – 29 days after seeding. The 
Transepithelial electrical resistance (TEER) values of the Caco-2 cell monolayer was 
monitored using EVEO2 with Edohm chamber (World Precision Instrument, FL). The TEER 
values in the range of 600 – 800 Ω/cm2 were used. The TEER value of the monolayer was 
measured at every half hour during 2 h transport study.  To initiate the transport experiments, 
the culture media in the donor and acceptor compartments were carefully aspirated, and the 
cells were rinsed twice with pre-warmed transport media (HBSS supplemented 25 mM 
HEPES, pH 7.4). Following a 30 min equilibration with the transport media at 37°C, the cells 
were incubated for 2 h for transport study. For apical-to-basolateral transport (a-b), 1.2 ml of 
transport media was added in the basolateral part and 0.4 ml of nanoparticles dissolved in 
HBSS-HEPES solution (1 mg/ml). At designated time intervals, 0.6 ml of basolateral 
transport media was withdrawn for fluorescent intensity measurement, and replenished with 
fresh 0.6 ml transport media. For basolateral-to-apical transport (b-a), 1.2 ml of nanoparticles 
dissolved in HBSS-HEPES solution (1 mg/ml) was added in the basolateral part and 0.4 ml of 
transport media was added into apical part. At designated time intervals, 0.2 ml of apical 
transport media was withdrawn for fluorescent intensity measurement, and replenished with 
equal volume of fresh HBSS-HEPES solution. To determine the coumarin 6 recovery rate of 
the transport study, at the end of the experiment, the media from both apical and basolateral 












where ∂ Q/ ∂  t is the permeability rate, A is the surface area of the membrane filter, and C0 is 
the initial concentration in donor compartment (apical compartment in A-B transport study, 
basolateral compartment in B-A transport study). 
7.3.9 Inhibition Study 
To evaluate the specific mechanism of nanoparticles involved in uptake process, cell 
uptake studies were performed under three different blocking conditions (He, Hu, Yin, Tang, 
& Yin, 2010). For the first condition, Caco-2 cells were incubated with nanoparticles at 4°C 
for 4 h. For the other two conditions, Caco-2 cells were pre-incubated with the metabolic 
inhibitor sodium azide (10 μM) and endocytosis inhibitor colchicines (5 μg/ml) for 30 min 
before adding nanoparticles, and then incubated for 4 h at 37°C for cell uptake experiment. 
The positive control was the cells incubated without inhibitors. The results were expressed as 
the inhibition percentage versus control. 
7.3.10 Statistical Analysis 
 All the experiments were conducted in triplicate with data reported as mean ± 
standard deviation. Experimental statistics were performed using the SAS software (Version 
9.2, SAS Institute Inc., Cary, NC, USA). The analysis of variance (ANOVA) Tukey’s 
multiple comparison tests was performed to compare the significant difference. The 




7.4 Results and Discussion 
7.4.1 Stability of Nanoparticles 
It is of great significance to evaluate the dispersibilities and stabilities of 
nanoparticles in different media at 37°C. The nanoparticles were prepared at three different 
zein to caseiante mass ratios, namely, 1:0.5 (A), 1:1 (B), 1:2 (C). The caseinate stabilized zein 
nanoparticles were highly negatively charged with the zeta potential around –30 mV, 
indicating the high stability of the colloidal system. After freeze drying for 48 h, the 
nanoparticle powders of different formulations were obtained, which were then redispersed 
into three media, water, DMEM, HBSS-HEPES. DMEM is a culture medium of most 
mammalian cell lines. HBSS-HEPES is a buffer solution generally used for cell uptake and 
monolayer transport study. In order to accurately perform the cellular evaluation of the 
nanoparticles, the nanoparticles should be stable and maintain its particle size during the 
incubation at 37°C during the period of cell experiments. The stabilities results are shown in 
Fig. 7.1. The freeze dried powder in all formulations possessed good redispersibility in three 
solutions (1 mg/ml). The opaque nano-suspensions without any large aggregates were easily 
obtained after gentle vortex. When the samples were incubated in 37°C, during the first hour, 
the particle size of all nanoparticles remained as the same as the original size before freeze 
drying, i.e. 120-130 nm. After that, the particle size increase slightly by 5-10 nm. The 
dispersibility of nanoparticles in DMEM resulted in greater augment of particle size of all 
formulations. The particle sizes were 150-160 nm in DMEM before the 37°C incubation, but 
increased to 225 nm for the A nanoparticles, which contains the least caseinate amount. For 
the B and C nanoparticles, only a slight increase by 5-10 nm was observed. The larger 
particle size of dispersion in DMEM may be due to its high glucose content, which may 
interact with protein nanoparticles to form larger particles. Better stabilities of particle size 




Sodium caseinate has been studied in previous literature that the minimum of zein 
/caseinate ratio 1:0.3 was required to avoid large aggregates during preparation and provide 
good stability during storage in phosphate buffer (Patel, Bouwens, & Velikov, 2010). In our 
study, zein/caseiante ratio of 1:0.5 was sufficient to provide good stability at three tested 
medium at 37°C for 48 h. Since no large aggregates nanoparticle formulations were formed 
for 37°C incubation for 48 h, they were all suitable to incubate with cells while maintained 
stable particle size. As a amphiphilic stabilizer, caseinate was able to adsorb to the surface of 
zein nanoparticles due to the strong hydrophobic interactions. Additionally, caseinate also 
carries a large portion of negatively charged groups, therefore, it provides electrosteric 
stabilization of zein nanoparticles against aggregation. 
7.4.2 Cytotoxicity of Nanoparticles 
The cell viability of Caco-2 cells was tested for each nanoparticle formulation at 
three concentrations, 0.1, 0.5, 1.0 mg/ml. Fig. 7.2 demonstrated that all caseinate stabilized 
nanoparticles showed no toxic effect on cell viability at all concentrations, up to 72 h 
incubation. Our results agree with the previous literature that zein showed a higher cyto-
compatibility compared with many other biomaterials. The same study also pointed out that 
the cell adhesion rate of zein film was even higher than that on collagen film (Sun, Dong, 






Fig. 7.1. Particle size in different medium at 37°C. A, nanoparticles of zein/caseinate 1:0.5; 





Fig. 7.2. Cell cytotoxicity of zein nanoparticles. A, nanoparticles of zein/caseinate 1:0.5; B, 




7.4.3 Cell Uptake 
To investigate the cell uptake of zein nanoparticles, coumarin 6 was selected as a 
fluorescent marker. Coumarin 6 is one of the most common and suitable fluorescent marker 
to study cell uptake of nanoparticles by many researchers (Liu, Wang, Sun, Feng, Zhou, 
Yang, et al., 2010; Zhang, Tan, & Feng, 2012). It has relative high fluorescent intensity and 
interacts with polymeric nanoparticles via strong hydrophobic interactions. It has also been 
reported that free coumarin 6 cannot be directly internalized by Caco-2 cells (Dong & Feng, 
2005). Therefore, the fluorescence detected represents the uptake of coumarin 6 encapsulated 
nanoparticles. 
7.4.3.1 Quantitative Study 
The cell uptake of zein nanoparticles was measured by the fluorescence intensity of 
coumarin 6 in Caco-2 cells as a function of nanoparticle concentration and incubation time, as 
shown in Fig. 7.3. Among three formulations, the nanoparticles A showed the minimal 
uptake by Caco-2 cells. During the 4 h of incubation, the cell uptake of all nanoparticle 
formulations increased gradually. The uptake increased from 5% to 10% during the first hour, 
but the increase rate of nanoparticles A was much gentler than nanoparticles B and C after 1 h 
incubation. The uptake of nanoparticles was also concentration dependent, showing that the 
nanoparticles with higher concentration had a significant higher uptake. The accumulative 
uptake of nanoparticles A was 16.0% for the concentration of 1 mg/ml, while the 
accumulative uptake of nanoparticles B and C reached 37.2% and 39.8%, respectively, at the 





Fig. 7.3. Cell uptake of zein nanoparticles at different concentrations. A, nanoparticles of 
zein/caseinate 1:0.5; B, nanoparticles of zein/caseinate 1:1; C, nanoparticles of zein/caseinate 




Based on our results, it can be concluded that the sodium caseinate enhanced the cell 
uptake of zein nanoparticles in a dose-dependent manner. Caseinate is a common emulsifier 
and stabilizer to produce stable nano-emulsions or nanoparticles, in order to increase the 
solubility of hydrophobic nutrients. For instance, sodium caseinate has been used to produce 
the nanodispersion of a poorly soluble carotenoid pigment, and it was found that caseinate 
enhanced the diffusivity of the nanoparticles and facilitated the cell uptake by human colonic 
epithelial cells (Anarjan, Tan, Ling, Lye, Malmiri, Nehdi, et al., 2011). Another recent study 
pointed out that the dietary proteins, especially casein and zein, signicantly improved the cell 
uptake of heme iron by Caco-2 cells (Villarroel, Flores, Pizarro, de Romana, & Arredondo, 
2011), suggesting that certain peptides from zein and casein are necessary to activate uptake 
mechanisms in the enterocyte. Another possible mechanism of the enhanced uptake effect of 
caseinate on zein nanoparticles may be that the adsorption of caseinate on zein surface could 
lower the interfacial tension and hence improve the interaction between zein nanoparticles 
and cell membranes. The higher ratio of caseinate in nanoparticle formulation resulted in 
higher surface charge. The surface carboxyl groups have also been reported to play an 
important role in cell uptake of nanoparticles, and the higher surface charge will result in a 
higher efficiency of cell uptake (Dausend, Musyanovych, Dass, Walther, Schrezenmeier, 
Landfester, et al., 2008; He, Hu, Yin, Tang, & Yin, 2010). 
The cell uptake of polymeric nanoparticles with particle size smaller than 150 nm has 
been previously characterized as endocytotic internalization (Conner & Schmid, 2003). In 
order to investigate the possible mechanisms involved in cell uptake of zein nanoparticles, 
three blocking conditions against endocytosis were tested on Caco-2 cell uptake, as shown in 
Fig. 7.4. The cell uptake of all nanoparticles was significantly inhibited at 4°C, the inhibition 
percentage was more than 85%. Both sodium azide and colchicine also significantly inhibited 




condition. The remarkable inhibition of cell uptake at 4°C was due to the low metabolic 
activity and poor membrane fluidity, and the 10-15% cell uptake may be attributed to 
physical adhesion or binding of nanoparticles to the cell membrane (He, Hu, Yin, Tang, & 
Yin, 2010; Liu, et al., 2010). Sodium azide is a metabolic inhibitor that blocks cellular ATP 
synthesis. The decrease of cell uptake, but not completely inhibition, of nanoparticles could 
be the utilization of exogenous ATP by cells (Gratton, Ropp, Pohlhaus, Luft, Madden, 
Napier, et al., 2008). The inhibition by 4°C condition and sodium azide suggested that the 
cell uptake of zein nanoparticles was through an active endocytosis, an energy-dependent 
process. During endocytotic internalization, it has been reported that actin polymerization and 
rearrangement were required in the clathrin- and caveolae- mediated process (Harush-
Frenkel, Rozentur, Benita, & Altschuler, 2008; He, Hu, Yin, Tang, & Yin, 2010). Therefore, 
the actin polymerization inhibitor, colchicine, was also tested and again observed to reduce 
cell uptake nanoparticles significantly. This may indicate that the receptor-mediated 
endocytosis was involved in the cell uptake process. The detailed mechanisms involved in the 
entry route and pathway of cell uptake of zein nanoparticles required further investigation. 
 
Fig. 7.4. Cell uptake inhibition percentage of zein nanoparticles under different 
blocking conditions. A, nanoparticles of zein/caseinate 1:0.5; B, nanoparticles of 




7.4.3.2 Qualitative Study 
The qualitative study was carried out using a fluorescent microscopy to visualize the 
cell uptake of zein nanoparticles. As shown in Fig. 7.5, the zein nanoparticles were 
internalized into Caco-2 cells, strongly supporting the aforementioned quantitative 
measurement of cell uptake. Negligible fluorescence was detected in free coumarin 6 control 
(figure not shown), which was consistent with previous report that coumarin 6 cannot be 
directly be internalized by Caco-2 cell (Yin Win & Feng, 2005). Therefore, the coumarin 6 
detected was due to the internalization of nanoparticles. Zein nanoparticles were found 
throughout the cytoplasm surrounding the nucleus. The fluorescence intensity was different 
in three nanoparticles, showing the strongest intensity in nanoparticles C, which had highest 
ratio of caseinate. This observation was consistent with quantitative study in previous section 
and confirmed that caseinate favored the cell uptake of zein nanoparticles. 
 
Fig. 7.5. Fluorescent microscopic images for Caco-2 cells after 4 h incubation with zein 
nanoparticles in different formulations. The first column showed cell nuclei stained DAPI 
(blue); the second column showed cytoplasm filled with coumarin 6-encapsulated 
nanoparticles (green); the third column was the merged images. A, nanoparticles of 





7.4.4 Transport Study 
Based on the cell uptake study, nanoparticles of 1 mg/ml had the highest uptake 
efficiency and hence were selected for permeability study using Caco-2 cell monolayer. Both 
A-B and B-A transport were evaluated for three nanoparticle formulations, as shown in Fig. 
7.6. For a-b transport, the Papp for nanoparticles A and B were 0.24 ×10-6 and 0.25 ×10-6 cm/s, 
respectively. However, Papp of nanoparticle C was remarkably increased to 0.32 ×10-6 cm/s, 
significantly different from nanoparticles A and B. Similar trends was observed for B-A 
transport that nanoparticles C had an enhanced permeability rate. The higher ratio of 
caseinate in nanoparticle favored the transport of zein nanoparticles. The higher b-a 
permeability of nanoparticles than a-b direction may be, in part, due to the tighter junction of 
Caco-2 cells monolayer in the apical membrane than basolateral membrane, as also observed 
in other literatures (El-Sayed, Ginski, Rhodes, & Ghandehari, 2002; Pisal, Yellepeddi, 
Kumar, Kaushik, Hildreth, Guan, et al., 2008).  
 
Fig. 7.6. Transport of nanoparticles through Caco-2 cell monolayer. A, nanoparticles of 
zein/caseinate 1:0.5; B, nanoparticles of zein/caseinate 1:1; C, nanoparticles of zein/caseinate 







Fig. 7.7. Recovery rate of coumarin 6 from Caco-2 cell monolayer transport study 
(Apical to basolateral). A, nanoparticles of zein/caseinate 1:0.5; B, nanoparticles of 
zein/caseinate 1:1; C, nanoparticles of zein/caseinate 1:2. The values sharing the different 
letter were signicantly different.  
 
To further investigate the tranepithelial tranposrt of zein nanoparticles, the mass 
balance was checked after the transport study. As shown in Fig. 7.7, the coumarin 6 control 
(free compound dissolved in DMSO and diluted with HBSS) showed a 75% recovery rate, 
indicating mass balance of free coumarin was good. However, for the coumarin 6 
encapsulated in nanoparticles, the recovery rate was much lower, 31%, 36%, and 36% for 
nanoparticles A, B, and C, respectively. This observation suggested that some of the zein 
nanoparticles were accumulated in the cells, which might indicate the endocytosis and 
transcellular transposrt of zein nanoparticles. Further, the TEER values were monitored 
throughout the 2 h transport study. The TEER values were not altered significantly in all 
nanoparticle formulations, compared with the control (data not shown). Because the Caco-2 
cell monolayers were characterized to carry negative surface charges due to glycoproteins on 
its surface, the negative charged nanoparticles may only have limited capability to open tight 
junctions of the monolayers. Hafner and coworkers also reported that negatively charged 








 The caseinate stabilized zein nanoparticles were prepared in different zain/caseianate 
mass ratios, and the effects of caseinate on the stabilities, cytotoxicity, cell uptake, epithelial 
transport were investigated on Caco-2 cells. Three formulations showed similar good 
stabilities to maintain particles size in cell culture medium and buffer solutions at 37°C. Zein-
caseinate nanoparticles showed no cytotoxicity for 72 h. The caseinate content in zein 
nanoparticles favored the cell uptake by concentration- and time- dependent manner. The cell 
uptake of nanoparticles was also visualized by fluorescent microscopy, showing that zein 
nanoparticles were seen throughout the cytoplasm surrounding the nucleus. The Caco-2 cell 
monolayers transport study demonstrated that zein-caseinate nanoparticles transported via 
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